Document:

Exhibit 4.1

 EXHIBIT 4.1 
 EXECUTION COPY 
 KAMAN CORPORATION 

as Issuer 
 AND

 THE BANK OF NEW YORK 
 MELLON TRUST COMPANY, N.A. 
 as Trustee 

INDENTURE 

Dated as of November 19, 2010 
 3.25% Convertible Senior Notes due 2017 

 Table of Contents 

 

							
	 	  	 	  	Page	 
	 ARTICLE I
 DEFINITIONS
	   

  

			
	 SECTION 1.01
	  	Definitions	  	 	7	  
	
	 ARTICLE II
 ISSUE, DESCRIPTION, EXECUTION, REGISTRATION
 AND EXCHANGE OF NOTES
	   

  
   

			
	 SECTION 2.01
	  	Form and Dating	  	 	19	  
	 SECTION 2.02
	  	Execution and Authentication	  	 	20	  
	 SECTION 2.03
	  	Registrar Paying Agent and Conversion Agent	  	 	21	  
	 SECTION 2.04
	  	Paying Agent to Hold Money and Shares in Trust	  	 	22	  
	 SECTION 2.05
	  	Holder Lists	  	 	22	  
	 SECTION 2.06
	  	Transfer and Exchange	  	 	22	  
	 SECTION 2.07
	  	Replacement Notes	  	 	26	  
	 SECTION 2.08
	  	Outstanding Notes	  	 	26	  
	 SECTION 2.09
	  	Temporary Notes	  	 	27	  
	 SECTION 2.10
	  	Cancellation	  	 	27	  
	 SECTION 2.11
	  	Persons Deemed Owners	  	 	27	  
	 SECTION 2.12
	  	Transfer of Notes	  	 	27	  
	 SECTION 2.13
	  	CUSIP and ISIN Numbers	  	 	32	  
	 SECTION 2.14
	  	Additional Notes; Repurchases	  	 	33	  
	
	ARTICLE III	  
	SATISFACTION AND DISCHARGE	  
			
	 SECTION 3.01
	  	Satisfaction and Discharge	  	 	33	  
	
	ARTICLE IV	  
	PARTICULAR COVENANTS OF THE COMPANY	  
			
	 SECTION 4.01
	  	Payment of Principal, Interest and Additional Interest	  	 	34	  
	 SECTION 4.02
	  	Maintenance of Office or Agency	  	 	35	  
	 SECTION 4.03
	  	Appointments to Fill Vacancies in Trustee’s Office	  	 	36	  
	 SECTION 4.04
	  	Provisions as to Paying Agent	  	 	36	  
	 SECTION 4.05
	  	Existence	  	 	37	  
	 SECTION 4.06
	  	SEC and Other Reports; Additional Interest	  	 	37	  
	 SECTION 4.07
	  	Stay, Extension and Usury Laws	  	 	39	  
	 SECTION 4.08
	  	Compliance Certificate; Statements as to Defaults	  	 	39	  
	 SECTION 4.09
	  	Further Instruments and Acts	  	 	39	  

							
	
	ARTICLE V	  
	DEFAULTS AND REMEDIES	  
			
	 SECTION 5.01
	  	Events of Default	  	 	39	  
	 SECTION 5.02
	  	Acceleration	  	 	41	  
	 SECTION 5.03
	  	Additional Interest	  	 	42	  
	 SECTION 5.04
	  	Payments of Notes on Default; Suit Therefor	  	 	43	  
	 SECTION 5.05
	  	Application of Monies Collected by Trustee	  	 	44	  
	 SECTION 5.06
	  	Proceedings by Noteholders	  	 	45	  
	 SECTION 5.07
	  	Proceedings by Trustee	  	 	46	  
	 SECTION 5.08
	  	Remedies Cumulative and Continuing	  	 	46	  
	 SECTION 5.09
	  	Direction of Proceedings and Waiver of Defaults by Majority of Noteholders	  	 	46	  
	 SECTION 5.10
	  	Notice of Defaults	  	 	47	  
	 SECTION 5.11
	  	Undertaking to Pay Costs	  	 	47	  
	
	ARTICLE VI	  
	CONCERNING THE TRUSTEE	  
			
	 SECTION 6.01
	  	Duties and Responsibilities of Trustee	  	 	47	  
	 SECTION 6.02
	  	Reliance on Documents, Opinions, Etc.	  	 	49	  
	 SECTION 6.03
	  	No Responsibility for Recitals, Etc.	  	 	50	  
	 SECTION 6.04
	  	Trustee, Paying Agents, Conversion Agents or Registrar May Own Notes	  	 	50	  
	 SECTION 6.05
	  	Monies to Be Held in Trust	  	 	51	  
	 SECTION 6.06
	  	Compensation and Expenses of Trustee	  	 	51	  
	 SECTION 6.07
	  	Officers’ Certificate as Evidence	  	 	51	  
	 SECTION 6.08
	  	Conflicting Interests of Trustee	  	 	52	  
	 SECTION 6.09
	  	Eligibility of Trustee	  	 	52	  
	 SECTION 6.10
	  	Resignation or Removal of Trustee	  	 	52	  
	 SECTION 6.11
	  	Acceptance by Successor Trustee	  	 	53	  
	 SECTION 6.12
	  	Succession by Merger, Etc.	  	 	54	  
	 SECTION 6.13
	  	Limitation on Rights of Trustee as Creditor	  	 	54	  
	 SECTION 6.14
	  	Trustee’s Application for Instructions from the Company	  	 	55	  
	 SECTION 6.15
	  	Lists of Noteholders	  	 	55	  
	 SECTION 6.16
	  	Preservation and Disclosure of Lists	  	 	55	  
	 SECTION 6.17
	  	Reports by Trustee	  	 	55	  
	
	ARTICLE VII	  
	CONCERNING THE NOTEHOLDERS	  
			
	 SECTION 7.01
	  	Action by Noteholders	  	 	56	  
	 SECTION 7.02
	  	Proof of Execution by Noteholders	  	 	56	  
	 SECTION 7.03
	  	Who Are Deemed Absolute Owners	  	 	56	  
	 SECTION 7.04
	  	Company-Owned Notes Disregarded	  	 	57	  
	 SECTION 7.05
	  	Revocation of Consents; Future Noteholders Bound	  	 	57	  

  
 2 

							
	
	ARTICLE VIII	  
	NOTEHOLDERS’ MEETINGS	  
			
	 SECTION 8.01
	  	Purpose of Meetings	  	 	58	  
	 SECTION 8.02
	  	Call of Meetings by Trustee	  	 	58	  
	 SECTION 8.03
	  	Call of Meetings by Company or Noteholders	  	 	58	  
	 SECTION 8.04
	  	Qualifications for Voting	  	 	58	  
	 SECTION 8.05
	  	Regulations	  	 	59	  
	 SECTION 8.06
	  	Voting	  	 	59	  
	 SECTION 8.07
	  	No Delay of Rights by Meeting	  	 	60	  
	
	ARTICLE IX	  
	SUPPLEMENTAL INDENTURES	  
			
	 SECTION 9.01
	  	Supplemental Indentures Without Consent of Noteholders	  	 	60	  
	 SECTION 9.02
	  	Supplemental Indentures With Consent of Noteholders	  	 	61	  
	 SECTION 9.03
	  	Effect of Supplemental Indentures	  	 	62	  
	 SECTION 9.04
	  	Notation on Notes	  	 	62	  
	 SECTION 9.05
	  	Evidence of Compliance of Supplemental Indenture to Be Furnished to Trustee	  	 	62	  
	
	ARTICLE X	  
	CONSOLIDATION, MERGER, SALE, CONVEYANCE AND LEASE	  
			
	 SECTION 10.01
	  	Company May Consolidate, Etc. on Certain Terms	  	 	63	  
	 SECTION 10.02
	  	Successor Corporation to Be Substituted	  	 	63	  
	 SECTION 10.03
	  	Opinion of Counsel to Be Given to Trustee	  	 	64	  
	
	ARTICLE XI	  
	 IMMUNITY OF INCORPORATORS, STOCKHOLDERS,

OFFICERS AND DIRECTORS
	   

  

			
	 SECTION 11.01
	  	Indenture and Notes Solely Corporate Obligations	  	 	64	  
	
	ARTICLE XII	  
	CONVERSION OF NOTES	  
			
	 SECTION 12.01
	  	Conversion Privilege and Consideration	  	 	64	  
	 SECTION 12.02
	  	Conversion Procedure	  	 	67	  
	 SECTION 12.03
	  	Settlement Upon Conversion.	  	 	69	  
	 SECTION 12.04
	  	Increased Conversion Rate Applicable to Certain Notes Surrendered in Connection with Make-Whole Fundamental Changes	  	 	71	  
	 SECTION 12.05
	  	Adjustment of Conversion Rate	  	 	73	  
	 SECTION 12.06
	  	Shares to Be Fully Paid	  	 	82	  
	 SECTION 12.07
	  	Effect of Reclassification, Consolidation, Merger or Sale	  	 	82	  
	 SECTION 12.08
	  	Certain Covenants	  	 	85	  
	 SECTION 12.09
	  	Responsibility of Trustee	  	 	85	  
	 SECTION 12.10
	  	Notice to Noteholders Prior to Certain Actions	  	 	86	  
	 SECTION 12.11
	  	Stockholder Rights Plans	  	 	87	  

  
 3 

							
	
	ARTICLE XIII	  
	REPURCHASE OF NOTES AT OPTION OF HOLDERS	  
			
	 SECTION 13.01
	  	Repurchase at Option of Noteholders upon a Fundamental Change	  	 	87	  
	 SECTION 13.02
	  	Withdrawal of Fundamental Change Purchase Notice	  	 	90	  
	 SECTION 13.03
	  	Deposit of Fundamental Change Purchase Price	  	 	90	  
	
	ARTICLE XIV	  
	MISCELLANEOUS PROVISIONS	  
			
	 SECTION 14.01
	  	Provisions Binding on Company’s Successors	  	 	91	  
	 SECTION 14.02
	  	Official Acts by Successor Corporation	  	 	91	  
	 SECTION 14.03
	  	Addresses for Notices, Etc.	  	 	91	  
	 SECTION 14.04
	  	Governing Law	  	 	92	  
	 SECTION 14.05
	  	Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee	  	 	92	  
	 SECTION 14.06
	  	Legal Holidays	  	 	93	  
	 SECTION 14.07
	  	No Security Interest Created	  	 	93	  
	 SECTION 14.08
	  	Trust Indenture Act	  	 	93	  
	 SECTION 14.09
	  	Benefits of Indenture	  	 	93	  
	 SECTION 14.10
	  	Table of Contents, Headings, Etc.	  	 	94	  
	 SECTION 14.11
	  	Authenticating Agent	  	 	94	  
	 SECTION 14.12
	  	Execution in Counterparts	  	 	95	  
	 SECTION 14.13
	  	Severability	  	 	95	  
	 SECTION 14.14
	  	Waiver of Jury Trial	  	 	95	  
	 SECTION 14.15
	  	Force Majeure	  	 	95	  
	 SECTION 14.16
	  	Calculations in Respect of the Notes	  	 	95	  

  
 4 

 EXHIBITS 

							
			
	Exhibit A	  	Form of Note	  	 	A-1	  
	Exhibit B	  	Form of Notice of Conversion	  	 	B-1	  
	Exhibit C	  	Form of Fundamental Change Purchase Notice	  	 	C-1	  
	Exhibit D	  	Form of Assignment and Transfer	  	 	D-1	  
	Exhibit E	  	Restricted Stock Legend	  	 	E-1	  

  
 5 

 CROSS-REFERENCE TABLE 

 

			
	 TIA Section
	  	Indenture Section
	 310(a)(1)
	  	6.09
	 (a)(2)
	  	6.09
	 (a)(3)
	  	N.A.
	 (a)(4)
	  	N.A.
	 (a)(5)
	  	6.09
	 (b)
	  	6.08
	 311(a)
	  	6.13
	 (b)
	  	6.13
	 312(a)
	  	6.17
	 (b)
	  	6.17
	 (c)
	  	6.17
	 313(a)
	  	6.18
	 (b)(1)
	  	N.A.
	 (b)(2)
	  	N.A.
	 (c)
	  	14.03
	 (d)
	  	6.18(b)
	 314(a)
	  	4.06; 4.08
	 (b)
	  	N.A.
	 (c)(1)
	  	14.05
	 (c)(2)
	  	14.05
	 (c)(3)
	  	N.A.
	 (d)
	  	N.A.
	 (e)
	  	14.05
	 (f)
	  	N.A.
	 315(a)
	  	6.01; 6.02
	 (b)
	  	5.10
	 (c)
	  	6.01
	 (d)
	  	6.01
	 (e)
	  	5.04
	 316(a)(last sentence)
	  	7.04
	 (a)(1)(A)
	  	5.09
	 (a)(1)(B)
	  	5.09
	 (a)(2)
	  	N.A.
	 (b)
	  	9.02
	 (c)
	  	7.01
	 317(a)(1)
	  	5.04; 5.07
	 (a)(2)
	  	5.04
	 (b)
	  	4.04
	 318(a)
	  	14.08

  

“N.A.” means not applicable 
 Note:
This Cross-Reference table shall not, for any purpose, be deemed to be part of this Indenture. 

  
 6 

 INDENTURE dated as of November 19, 2010 between Kaman Corporation, a Connecticut
corporation, as issuer (the “Company”) and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”). 
 W I T N E S S E T H: 
 WHEREAS, for its lawful corporate purposes, the Company has
duly authorized the issue of its 3.25% Convertible Senior Notes due 2017 (hereinafter sometimes called the “Notes”), initially in an aggregate principal amount not to exceed $100,000,000 (or $115,000,000 if the Initial Purchasers
exercise their option to purchase additional Notes in full as set forth in the Purchase Agreement), and in order to provide the terms and conditions upon which the Notes are to be authenticated, issued and delivered, the Company has duly authorized
the execution and delivery of this Indenture; 
 WHEREAS, the Form of Note, the certificate of authentication to be borne by
each Note, the Form of Notice of Conversion, the Form of Fundamental Change Purchase Notice and the Form of Assignment and Transfer to be borne by the Notes are to be substantially in the forms hereinafter provided for; and 

WHEREAS, all acts and things necessary to make the Notes, when executed by the Company and authenticated and delivered by the Trustee or
a duly authorized authenticating agent, the valid, binding and legal obligations of the Company, and to constitute a valid agreement according to its terms, have been done and performed, and the execution of this Indenture and the issue hereunder of
the Notes have in all respects been duly authorized. 
 NOW, THEREFORE, THIS INDENTURE WITNESSETH: 

That in order to declare the terms and conditions upon which the Notes are, and are to be, authenticated, issued and delivered, and in
consideration of the premises and of the purchase and acceptance of the Notes by the holders thereof, the Company covenants and agrees with the Trustee for the equal and proportionate benefit of the respective holders from time to time of the Notes
(except as otherwise provided below), as follows: 
 ARTICLE I 

DEFINITIONS 
 SECTION 1.01 Definitions. The terms defined in this Section 1.01 (except as herein otherwise expressly provided) for all purposes of this Indenture and of any indenture supplemental hereto
shall have the respective meanings specified in this Section 1.01. All other terms used in this Indenture that are defined in the Trust Indenture Act or that are by reference therein defined in the Securities Act (except as herein otherwise
expressly provided) shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date of the execution of this Indenture. The words “herein,” “hereof,”
“hereunder,” and words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision. The terms defined in this Article Include the plural as well as the singular. 

  
 7 

 “Additional Interest” means all amounts, if any, payable pursuant to
Sections 4.06(b) and 5.03, as applicable, hereof. 
 “Affiliate” of any specified Person means any other
Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control,” when used with respect to any specified Person means the
power to direct or cause the direction of the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and
“controlled” have meanings correlative to the foregoing. 
 “Agent Members” shall have the meaning
specified in Section 2.12(e). 
 “Applicable Procedures” means, with respect to any transfer or
transaction involving a Global Note or any beneficial interest therein, the rules and procedures of the Depositary for such Note, in each case to the extent applicable to such transfer or transaction and as in effect from time to time. 

“Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.

 “Board of Directors” means the board of directors of the Company. 

“Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to
have been duly adopted by the Board of Directors, and to be in full force and effect on the date of such certification, and delivered to the Trustee. 
 “Business Day” means each Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which the banking institutions in The City of New York are authorized or obligated by law or
executive order to close or be closed. 
 “Capital Stock” means, for any entity, any and all shares, interests,
rights to purchase, warrants, options, participations or other equivalents of or interests in (however designated) stock issued by that entity. 
 “Cash Election” shall have the meaning specified in Section 12.03(a)(2). 
 “Cash Percentage” shall have the meaning specified in Section 12.03(a)(2)(i). 
 “Cash Percentage Notice” shall have the meaning specified in Section 12.03(a)(2)(i). 
 “Certificated Notes” means Notes that are in registered definitive form. 
 “close of business” means 5:00 p.m. (New York City time). 

“Commission” means the U.S. Securities and Exchange Commission. 

  
 8 

 “Common Equity” of any Person means Capital Stock of such Person that is
generally entitled (a) to vote in the election of directors of such Person or (b) if such Person is not a corporation, to vote or otherwise participate in the selection of the governing body, partners, managers or others that will control
the management or policies of such Person. 
 “Common Stock” means, subject to Section 12.07, shares of
common stock of the Company, par value $1 per share, at the date of this Indenture or shares of any class or classes resulting from any reclassification or reclassifications thereof and that have no preference in respect of dividends or of
amounts payable in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company and that are not subject to redemption by the Company; provided that if at any time there shall be more than one such resulting
class, the shares of each such class then so issuable shall be substantially in the proportion that the total number of shares of such class resulting from all such reclassifications bears to the total number of shares of all such classes resulting
from all such reclassifications. 
 “Company” means Kaman Corporation, a Connecticut corporation, and subject
to the provisions of Article 10, shall include its successors and assigns. 
 “Company Order” means a
written request or order signed in the name of the Company (i) by its Chairman, its President, Chief Executive Officer or a Vice President—Finance and (ii) by its Chief Financial Officer, its Treasurer or an Assistant Treasurer and
delivered to the Trustee; provided, however, that such written request or order may be signed by any two of the officers or directors listed in clause (i) above in lieu of being signed by one of such officers or directors listed
in such clause (i) and one of the officers listed in clause (ii) above. 
 “Continuing Director”
means a director who either was a member of the Board of Directors on November 19, 2010 or who becomes a member of the Board of Directors subsequent to that date and whose election, re-election, appointment or nomination for election by the
stockholders of the Company is duly approved by a majority of the Continuing Directors on the Board of Directors at the time of such approval, either by a specific vote or by approval of the proxy statement issued by the Company on behalf of the
entire Board of Directors in which such individual is named as nominee for director. 
 “Conversion Agent”
shall have the meaning specified in Section 2.03. 
 “Conversion Date” shall have the meaning specified in
Section 12.02(a)(i). 
 “Conversion Obligation” shall have the meaning specified in Section 12.01(a).

 “Conversion Price” means as of any date, $1,000, divided by the Conversion Rate as of such date. 

“Conversion Rate” means 29.4499 shares of Common Stock, per $1,000 principal amount of Notes, subject to adjustment as
set forth in Sections 12.04 and 12.05. 
 “Corporate Trust Office” means the office of
the Trustee at which at any time its corporate trust business shall be administered, which office at the date hereof is located at 525 William Penn Place, 38th Floor, Pittsburgh, PA 15259, Attention: Corporate Trust Department,

  
 9 

 
or such other address as the Trustee may designate from time to time by notice to the Noteholders and the Company, or the principal corporate trust office of any successor Trustee (or such other
address as such successor Trustee may designate from time to time by notice to the Noteholders and the Company). 

“Custodian” means the Trustee, as custodian for the Depositary, with respect to the Global Notes, or any successor
entity thereto. 
 “Daily Conversion Value” means, for each of the 40 consecutive VWAP
Trading Days in an Observation Period, one fortieth
(1/40th) of the product of (i) the Conversion
Rate in effect on such VWAP Trading Day and (ii) the Daily VWAP on such VWAP Trading Day. 
 “Daily Settlement
Amount” means, for each of the 40 consecutive VWAP Trading Days in an Observation Period: 
 (a) an amount of cash equal to the lesser of (i) one fortieth
(1/40th) of $1,000 and (ii) the Daily Conversion
Value (such minimum, the “Daily Principal Portion”); and 
 (b) to the
extent the Daily Conversion Value for such VWAP Trading Day exceeds one fortieth (1/40th) of $1,000, a number of shares of the Common Stock (the “Daily Share Amount”), subject to the Company’s right to pay cash in lieu of all or a portion of such number of shares
of the Common Stock pursuant to Section 12.03(a)(2), equal to the fraction, the numerator of which equals the excess of (i) the Daily Conversion Value for such VWAP Trading Day over (ii) the Daily Principal Portion for such Trading
Day, and the denominator of which equals the Daily VWAP for such VWAP Trading Day. 
 “Daily Share Amount” has
the meaning specified in the definition of “Daily Settlement Amount.” 
 “Daily VWAP” means, for each
of the 40 consecutive VWAP Trading Days in an Observation Period, the per share volume-weighted average price of the Common Stock as displayed under the heading “Bloomberg VWAP” on Bloomberg page “KAMN <equity> AQR” (or any
successor thereto if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such VWAP Trading Day (or if such volume-weighted average price is
unavailable, the market value of one share of the Common Stock on such VWAP Trading Day, using a volume-weighted average method, determined in a commercially reasonable manner by the Board of Directors). The Daily VWAP will be determined without
regard to after hours trading or any other trading outside of the regular trading session trading hours. 

“Default” means any event that is, or after notice or passage of time, or both, would be, an Event of Default.

 “Defaulted Interest” means any interest (including any Additional Interest) on any Note that is payable, but
is not punctually paid or duly provided for, on any May 15 or November 15 of each year, beginning May 15, 2011. 

  
 10 

 “Depositary” means, with respect to the Global Notes, the Person specified
in Section 2.01(a) as the Depositary with respect to such Notes, until a successor shall have been appointed and become such pursuant to the applicable provisions of this Indenture, and thereafter, “Depositary” shall mean or include
such successor. 
 “Distributed Property” shall have the meaning specified in Section 12.05(c).

 “DTC” means The Depository Trust Company, a limited purpose trust company organized under the laws of the
State of New York. 
 “Effective Date” shall have the meaning specified in Section 12.04(a). 

“Event of Default” shall have the meaning specified in Section 5.01. 

“Ex-Dividend Date” means the first date on which shares of the Common Stock trade on the applicable exchange or in the
applicable market regular way without the right to receive the issuance, dividend or distribution in question from the Company or, if applicable, from the seller of the shares of the Common Stock on such exchange or market (in the form of due bills
or otherwise) as determined by such exchange or market. 
 “Exchange Act” means the Securities Exchange Act of
1934, as amended, and the rules and regulations promulgated thereunder. 
 “Expiration Date” shall have the
meaning specified in Section 12.05(e). 
 “Expiration Time” shall have the meaning specified in
Section 12.05(e). 
 “Fiscal Quarter” means a fiscal quarter of any Fiscal Year. 

“Fiscal Year” means a fiscal year of the Company. 

“Freely Tradable” means, with respect to the Notes and the shares of Common Stock issuable upon conversion of the Notes,
if any, that such Notes or such shares of Common Stock, if any, (i) are eligible to be sold by a Person who has not been an Affiliate of the Company during the preceding three months without any volume or manner of sale restrictions under the
Securities Act, (ii) do not bear a Restricted Securities Legend or Restricted Stock Legend and (iii) with respect to Global Notes only, are identified by an unrestricted CUSIP number in the facilities of the Depositary. 

“Free Trade Date” means the date that is one year after the last date of original issuance of the Notes. 

“Fundamental Change” means the occurrence after the original issuance of the Notes of any of the following events:

 (a) any “person” or “group” within the meaning of Section 13(d) of the Exchange Act,
other than the Company or its Subsidiaries, files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the direct or indirect ultimate “beneficial owner,” as defined in
Rule 13d-3 under the Exchange Act, of the Company’s Common Equity representing more than 50% of the voting power of the Company’s Common Equity; 

  
 11 

 (b) consummation of any binding share exchange, exchange offer, tender
offer, consolidation or merger of the Company pursuant to which the Common Stock will be converted into cash, securities or other property or any sale, lease or other transfer in one transaction or a series of transactions of all or substantially
all of the consolidated assets of the Company and its Subsidiaries, taken as a whole, to any Person other than one or more of the Company’s Subsidiaries (any such exchange, offer, consolidation, merger, transaction or series of transactions
being referred to herein as an “event”); provided, however, that any such event where the holders of more than 50% of shares of Common Stock immediately prior to such event, own, directly or indirectly, more than 50% of all
classes of Common Equity of the continuing or surviving person or transferee or the parent thereof immediately after such event shall not be a Fundamental Change; 

(c) the first day on which Continuing Directors cease to constitute at least a majority of the Board of Directors;

 (d) the stockholders of the Company approve any plan or proposal for the liquidation or dissolution of the
Company; or 
 (e) the Common Stock (or other common stock into which the Notes are then convertible) ceases to
be listed on the NASDAQ Global Select Market, the NASDAQ Global Market or the New York Stock Exchange, 
 provided, however, in
the case of an event described in clause (b) above, a Fundamental Change will not be deemed to have occurred if at least 90% of the consideration, excluding cash payments for fractional shares and cash payments made pursuant to dissenters’
appraisal rights, in the transaction or event constituting the Fundamental Change consists of shares of Publicly Traded Securities, and as a result of the transaction or event, the Daily Share Amount the holder of a Note is entitled to receive upon
conversion is deliverable solely in such Publicly Traded Securities (subject to the Company’s right to pay cash in lieu of all or a portion of such Publicly Traded Securities) and the Daily Conversion Value is based solely on the Daily VWAP of
such Publicly Traded Securities. 
 For purposes of this definition, whether a “person” is a “beneficial
owner” shall be determined in accordance with Rule 13d-3 under the Exchange Act and “person” includes any syndicate or group that would be deemed to be a “person” under Section 13(d)(3) of the Exchange Act.

 “Fundamental Change Company Notice” shall have the meaning specified in Section 13.01(b). 

“Fundamental Change Expiration Time” shall have the meaning specified in Section 13.01(b)(ix). 

  
 12 

 “Fundamental Change Purchase Date” shall have the meaning specified in
Section 13.01(a). 
 “Fundamental Change Purchase Notice” shall have the meaning specified in
Section 13.01(a)(i). 
 “Fundamental Change Purchase Price” shall have the meaning specified in
Section 13.01(a). 
 “Global Note” shall have the meaning specified in Section 2.01(a). 

“Global Securities Legend” means a legend set forth in Exhibit A. 

“Indenture” means this instrument as originally executed or, if amended or supplemented as herein provided, as so
amended or supplemented. 
 “Initial Dividend Threshold” shall have the meaning specified in
Section 12.05(d). 
 “Initial Purchasers” means Merrill Lynch, Pierce, Fenner & Smith
Incorporated, RBS Securities Inc. and the several initial purchasers named in Schedule A to the Purchase Agreement. 

“Interest Payment Date” means each May 15 and November 15 of each year, beginning on May 15, 2011;

 “Interest Record Date,” with respect to any Interest Payment Date, shall mean the May 1 or
November 1 (whether or not such day is a Business Day) immediately preceding the relevant Interest Payment Date, respectively. 
 “Last Reported Sale Price” of the Common Stock on any date means the closing sale price per share (or if no closing sale price is reported, the average of the last bid price and last ask
price or, if more than one in either case, the average of the average last bid prices and the average last ask prices) on that date as reported in composite transactions for the principal United States national or regional securities exchange on
which the Common Stock is listed for trading. The Last Reported Sale Price will be determined without reference to after-hours or extended market trading. If the Common Stock is not listed for trading on a United States national or regional
securities exchange on the relevant date, then the Last Reported Sale Price of the Common Stock will be the last quoted bid price for the Common Stock in the over-the-counter market on the relevant date as reported by the Pink OTC Markets Inc. or
similar organization. If the Common Stock is not so quoted, the Last Reported Sale Price of the Common Stock will be determined by a United States nationally recognized independent investment banking firm selected by the Company for this purpose.

 “Make-Whole Conversion Rate Adjustment” shall have the meaning specified in Section 12.04(a).

  
 13 

 “Make-Whole Fundamental Change” means any transaction or event that
constitutes a Fundamental Change under clause (a) or (b) of the definition thereof (in the case of any Fundamental Change described in clause (b) of the definition thereof, determined without regard to the proviso in such
clause (b), but subject to the paragraph immediately following clause (e) of the definition thereof). 

“Make-Whole Fundamental Change Period” shall have the meaning specified in Section 12.04(a). 

“Market Disruption Event” means, (i) a failure by the principal United States national or regional securities
exchange or market on which the Common Stock is listed or admitted for trading to open for trading during its regular trading session or (ii) on any Scheduled Trading Day for the Common Stock, the occurrence or existence prior to
1:00 p.m., New York City time, for more than a one half-hour period in the aggregate during regular trading hours, of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant
stock exchange or otherwise) in the Common Stock or in any options, contracts or future contracts relating to the Common Stock. 

“Maturity Date” means November 15, 2017. 
 “Measurement Period” shall have the meaning specified in Section 12.01(a)(ii). 
 “Merger Event” shall have the meaning specified in Section 12.07(a). 
 “Note” or “Notes” shall mean any note or notes, as the case may be, authenticated and delivered under this Indenture. 

“Noteholder” or “holder,” as applied to any Note, or other similar terms (but excluding the term
“beneficial holder”), shall mean any person in whose name at the time a particular Note is registered on the Note Register. 
 “Note Register” means the register maintained at the Corporate Trust Office pursuant to Section 4.02. 
 “Note Registrar” means the Trustee for the purpose of registering Notes and Transfers of Notes as herein provided. 

“Notice of Conversion” shall have the meaning specified in Section 12.02(a). 

“Observation Period” means, with respect to any Note, (i) if the Conversion Date of such Note
occurs prior to the 60th Scheduled Trading Day immediately
preceding the Maturity Date, the 40 consecutive VWAP Trading Day period beginning on and including the second Scheduled Trading Day (or, if such Scheduled Trading Day is not a VWAP Trading Day, the immediately following VWAP Trading Day) after such
Conversion Date, and (ii) if the Conversion Date of such Note occurs on or after the 60th Scheduled Trading Day immediately preceding the Maturity Date, the 40 consecutive VWAP Trading Day period beginning on and including the 42nd Scheduled Trading Day (or, if such Scheduled Trading Day is not a
VWAP Trading Day, the immediately following VWAP Trading Day) immediately preceding November 15, 2017. 

  
 14 

 “Offering Memorandum” means the final offering memorandum dated
November 15, 2010 relating to the offering and sale of the Notes. 
 “Officer” means, with respect to the
Company, (i) the Chairman of the Board, the Chief Executive Officer, the President, any Vice President or the Chief Financial Officer, and (ii) the Treasurer or any Assistant Treasurer or the Secretary or any Assistant Secretary.

 “Officers’ Certificate” means a certificate signed by two officers of the Company, one of whom must be
the principal executive officer, the principal financial officer or the principal accounting officer of the Company. Each Officers’ Certificate (other than certificates provided pursuant to TIA Section 314(a)(4)) shall include the
statements provided for in TIA Section 314(e). 
 “open of business” or “opening of
business” means 9:00 a.m. (New York City time). 
 “Opinion of Counsel” means an opinion in
writing signed by legal counsel, who may be an employee of or counsel to the Company, or other counsel acceptable to the Trustee, that is delivered to the Trustee. Each such opinion shall include the statements provided for in Section 14.05 if
and to the extent required by the provisions of such Section. 
 “outstanding,” when used with reference to
Notes, shall, subject to the provisions of Section 7.04, mean, as of any particular time, all Notes authenticated and delivered by the Trustee under this Indenture, except: 

(f) Notes theretofore canceled by the Trustee or accepted by the Trustee for cancellation; 

(g) Notes that have been paid pursuant to Section 2.09 or Notes in lieu of which, or in substitution for which, other
Notes shall have been authenticated and delivered pursuant to the terms of Section 2.07 unless proof satisfactory to the Trustee is presented that any such Notes are held by protected purchasers in due course; 

(h) Notes that have become due and payable, whether at the Maturity Date, any Fundamental Change Purchase Date, upon
conversion or otherwise, for which the Company has deposited with the Trustee or delivered to Noteholders, as applicable, cash or cash and shares of Common Stock, if any (solely to satisfy the Company’s Conversion Obligation, if applicable),
sufficient to pay all of the outstanding Notes and all other sums due payable under this Indenture by the Company; and 
 (i) Notes converted pursuant to Article 12. 
 “Paying Agent”
shall have the meaning specified in Section 2.03. 

  
 15 

 “Person” means an individual, a corporation, a limited liability company,
an association, a partnership, a joint venture, a joint stock company, a trust, an unincorporated organization or a government or an agency or a political subdivision thereof. 
 “Predecessor Note” of any particular Note means every previous Note evidencing all or a portion of the same debt as that evidenced by such particular Note; and, for the purposes of this
definition, any Note authenticated and delivered under Section 2.07 in lieu of or in exchange for a mutilated, lost, destroyed or stolen Note shall be deemed to evidence the same debt as the mutilated, lost, destroyed or stolen Note that it
replaces. 
 “Publicly Traded Securities” means shares of common stock or depositary receipts evidencing
interests in ordinary shares or common equity that are traded on the NASDAQ Global Select Market, the NASDAQ Global Market or the New York Stock Exchange or that will be so traded when issued or exchanged in connection with a Fundamental Change
described in clause (b) of the definition thereof. 
 “Purchase Agreement” means that certain Purchase
Agreement, dated as of November 15, 2010, among the Company and Merrill Lynch, Pierce, Fenner & Smith Incorporated and RBS Securities Inc., as representatives of the Initial Purchasers. 

“QIBs” shall have the meaning specified in Section 2.01(a). 

“Record Date” shall mean, with respect to any dividend, distribution or other transaction or event in which the holders
of Common Stock (or other security) have the right to receive any cash, securities or other property or in which the Common Stock (or other applicable security) is exchanged for or converted into any combination of cash, securities or other
property, the date fixed for determination of stockholders entitled to receive such cash, securities or other property (whether such date is fixed by the Board of Directors or by statute, contract or otherwise). 

“Reference Property” shall have the meaning specified in Section 12.07. 

“Register” shall have the meaning specified in Section 2.03. 

“Registrar” shall have the meaning specified in Sections 2.03. 

“Resale Restriction Termination Date” shall have the meanings set forth in Exhibit A and Exhibit E. 

“Responsible Officer” means, when used with respect to the Trustee, any officer within the corporate trust department of
the Trustee with direct responsibility for the administration of this Indenture or any other officer of the Trustee to whom any corporate trust matter is referred because of such person’s knowledge of and familiarity with the particular
subject. 
 “Restricted Note” shall have the meaning specified in Section 2.06(f)(i). 

  
 16 

 “Restricted Securities Legend” means a legend in the form set forth in
Exhibit A, or any other substantially similar legend indicating the restricted status of the Notes under Rule 144. 

“Restricted Stock Legend” means a legend in the form set forth in Exhibit E, or any other substantially similar legend
indicating the restricted status of the shares of Common Stock under Rule 144. 
 “Rule 144” means Rule
144 under the Securities Act. 
 “Rule 144A” means Rule 144A under the Securities Act. 

“Rule 144A Information” shall be such information as is specified pursuant to Rule 144A(d)(4) under the
Securities Act. 
 “Scheduled Trading Day” means a day that is scheduled to be a Trading Day on the principal
United States national or regional securities exchange or market on which the Common Stock is listed or admitted for trading. If the Common Stock is not so listed or admitted for trading, “Scheduled Trading Day” means a Business Day.

 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated
thereunder. 
 “Significant Subsidiary” means, at any date of determination, any Subsidiary that would
constitute a “significant subsidiary” within the meaning of Article 1 of Regulation S-X promulgated under the Securities Act as in effect on November 15, 2010. 

“Specified Corporate Transaction” has the meaning specified in Section 12.01(a)(iv). 

“Specified Corporate Transaction Notice” has the meaning specified in Section 12.01(a)(iv). 

“Spin-off” shall have the meaning specified in Section 12.05(c). 

“Stock Price” means (a) in the case of a Make-Whole Fundamental Change described in clause (b) of the
definition of Fundamental Change in which holders of Common Stock receive solely cash consideration in connection with such Make-Whole Fundamental Change, the amount of cash paid per share of the Common Stock and (b) in the case of any other
Make-Whole Fundamental Change, the average of the Last Reported Sale Prices per share of Common Stock over the period of five consecutive Trading Days ending on, and including, the Trading Day immediately preceding the Effective Date of such
Make-Whole Fundamental Change. The Board of Directors will make appropriate adjustments, in its good faith judgment, to account for any adjustment to the Conversion Rate that becomes effective, or any event requiring an adjustment to the Conversion
Rate where the Ex-Dividend Date of the event occurs, during such five consecutive Trading Day period. 

  
 17 

 “Subsidiary” means, with respect to any Person, any corporation,
association, partnership or other business entity of which more than 50% of the total voting power of shares of Capital Stock or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote
in the election of directors, managers, general partners or trustees thereof is at the time owned or controlled, directly or indirectly, by (i) such Person; (ii) such Person and one or more Subsidiaries of such Person; or (iii) one or
more Subsidiaries of such Person. 
 “Successor Company” shall have the meaning specified in
Section 10.01(a). 
 “Temporary Notes” shall have the meaning specified in Section 2.09. 

“Trading Day” means a day on which (i) trading in the Common Stock generally occurs on the NASDAQ Global Select
Market or, if the Common Stock is not then listed on the NASDAQ Global Select Market, on the principal other United States national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then listed
on a United States national or regional securities exchange, on the principal other market on which the Common Stock is then traded, and (ii) a Last Reported Sale Price for our Common Stock is available on such securities exchange or market. If
the Common Stock (or other security for which a Last Reported Sale Price must be determined) is not so listed or traded, “Trading Day” means a Business Day. 
 “Trading Price” of the Notes on any date of determination means the average of the bona fide secondary market bid quotations obtained by the Company for $5.0 million principal amount
of Notes (expressed as a price per $1,000 principal amount) at approximately 3:30 p.m., New York City time, on such determination date from three independent United States nationally recognized securities dealers selected by the Company;
provided that if three such bids cannot reasonably be obtained by the Company, but two such bids are obtained, then the average of the two bids shall be used, and if only one such bid can reasonably be obtained by the Company, that one bid
shall be used. If the Company cannot reasonably obtain at least one bid for $5.0 million principal amount of Notes from a United States nationally recognized securities dealer, then the Trading Price per $1,000 principal amount of Notes will be
deemed to be less than 98% of the product of the Last Reported Sale Price of the Common Stock and the applicable Conversion Rate. 
 “Trading Price Product” shall have the meaning specified in Section 12.01(a)(ii). 
 “transfer” shall have the meaning specified in Section 2.06(i). 
 “Trust Indenture Act” or “TIA’ means the Trust Indenture Act of 1939, as amended, as it was in force at the date of execution of this Indenture, except as provided in
Section 9.03 and Section 12.07; provided, however, that in the event the Trust Indenture Act of 1939 is amended after the date hereof, the term “Trust Indenture Act” shall mean, to the extent required by such
amendment, the Trust Indenture Act of 1939, as so amended. 
 “Trustee” means the Person named as the
“Trustee” in the first paragraph of this Indenture until a successor Trustee shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Trustee” shall mean or include each Person who is then a
Trustee hereunder. 

  
 18 

 “Unit of Reference Property” shall have the meaning specified in
Section 12.07(a). 
 “Valuation Period” shall have the meaning specified in Section 12.05(c).

 “VWAP Trading Day” means a day on which (i) there is no Market Disruption Event and (ii) trading
in the Common Stock generally occurs on the NASDAQ Global Select Market or, if the Common Stock is not then listed on the NASDAQ Global Select Market, on the principal other United States national or regional securities exchange on which the Common
Stock is then listed or, if the Common Stock is not then listed on a United States national or regional securities exchange, on the principal other market on which the Common Stock is then traded. If the Common Stock (or any other security for which
a Daily VWAP must be determined) is not so listed or traded, “VWAP Trading Day” means a “Business Day.” 

“Weighted Average Consideration” shall have the meaning specified in Section 12.07(a). 

ARTICLE II 

ISSUE, DESCRIPTION, EXECUTION, REGISTRATION 
 AND EXCHANGE OF NOTES 
 SECTION 2.01 Form and Dating. The Notes and
the Trustee’s certificate of authentication shall be substantially in the form of Exhibit A, which is a part of this Indenture. The Notes may have notations, legends or endorsements required by law, stock exchange rule or usage. The Company
shall provide any such notations, legends or endorsements to the Trustee in writing. Each Note shall be dated the date of its authentication. Except as otherwise expressly permitted in this Indenture, all Notes shall be identical in all respects.
Notwithstanding any differences among them, all Notes issued under this Indenture shall vote and consent together on all matters as one class. 
 (a) Initial Notes. The Notes initially shall be offered and sold only to qualified institutional buyers as defined in Rule 144A (“QIBs”) in reliance on Rule 144A and
shall be issued in global form (a “Global Note”) that shall be deposited with the Trustee at its Corporate Trust Office, as custodian for the Depositary and registered in the name of DTC or the nominee thereof (DTC, or any successor
thereto, and any such nominee being hereinafter referred to as the “Depositary”), duly executed by the Company and authenticated by the Trustee as hereinafter provided. 

(b) Global Notes in General. Each Global Note shall represent the outstanding Notes as shall be specified therein and each Global
Note shall provide that it shall represent the aggregate principal amount of outstanding Notes from time to time endorsed thereon and that the aggregate principal amount of outstanding Notes represented thereby may from time to time be reduced or
increased, as appropriate, to reflect exchanges, purchases by the Company and conversions. 

  
 19 

 Any adjustment of the aggregate principal amount of a Global Note to reflect the amount of
any increase or decrease in the amount of outstanding Notes represented thereby shall be made by the Trustee in accordance with instructions given by the holder thereof as required by Section 2.12 hereof and shall be made on the records of the
Trustee and the Depositary. Payment of the principal, accrued and unpaid interest (including Additional Interest), if any, or payment of the Fundamental Change Purchase Price on the Global Note shall be made to the holder of such Note on the date of
payment, unless a record date or other means of determining holders eligible to receive payment is provided for herein. 
 (c)
Book-Entry Provisions. This Section 2.01(c) shall apply only to Global Notes deposited with or on behalf of the Depositary. The Company shall execute and the Trustee shall, in accordance with Section 2.02, authenticate and deliver
Global Notes that (a) shall be registered in the name of the Depository or the nominee of the Depositary and (b) shall be delivered by the Trustee to the Depositary or pursuant to the Depositary’s instructions. 

(d) Legends. 
 (i) Each Global Note shall bear the Global Securities Legend set forth in Exhibit A unless otherwise directed by the Company. 

(ii) Each Restricted Note shall bear the Restricted Securities Legend set forth in Exhibit A. Each Note that bears or is
required to bear the Restricted Securities Legend shall be subject to the restrictions on transfer set forth therein, and each holder of such Note, by such holder’s acceptance thereof, agrees to be bound by all such restrictions on transfer.

 (iii) Every stock certificate representing the shares of Common Stock issued in the circumstances described in
Section 2.06(g) hereof shall bear the Restricted Stock Legend set forth in Exhibit E unless removed in accordance with the provisions of Section 2.06(j) or otherwise at the direction of the Company. 

SECTION 2.02 Execution and Authentication. The Notes shall be executed on behalf of the Company by any Officer. The signature of
the Officer on the Notes may be manual or facsimile. If an Officer whose signature is on a Note no longer holds that office at the time the Trustee authenticates the Note, the Note shall be valid nevertheless. 

At any time on and after the original issuance of the Notes, the Company may deliver Notes executed by the Company to the Trustee for
authentication, together with a written order of the Company in the form of an Officer’s Certificate for the authentication and delivery of such Notes, and the Trustee, in accordance with such written order of the Company, shall authenticate
and deliver such Notes. 
 A Note shall not be valid until an authorized signatory of the Trustee manually signs the certificate
of authentication on the Note. The signature shall be conclusive evidence that the Note has been authenticated under this Indenture. 
 The Notes shall originally be issued only in registered form without coupons and only in denominations of $1,000 of principal amount and any integral multiple thereof. 

  
 20 

 The aggregate principal amount of Notes that may be authenticated by the Trustee under this
Indenture is initially limited to $115,000,000, subject to Section 2.14 and except for Notes authenticated and delivered upon registration or transfer of, or in exchange for, or in lieu of other Notes pursuant to Sections 2.06, 2.07, 2.09,
2.12, 9.04, 12.02 and 13.03 hereof. 
 The Trustee may appoint authenticating agents. The Trustee may at any time on and after
the original issuance of the Notes appoint an authenticating agent acceptable to the Company to authenticate Notes. An authenticating agent may authenticate Notes whenever the Trustee may do so, except any Notes issued pursuant to Section 2.07
hereof. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent. An authenticating agent shall have the same right to deal with the Company as the Trustee with respect to such matters for which it has
been appointed. 
 SECTION 2.03 Registrar Paying Agent and Conversion Agent. The Company shall maintain an office or
agency where Notes may be presented for registration of transfer or for exchange (“Registrar”), an office or agency where Notes may be presented for payment (“Paying Agent”), an office or agency where Notes may be
presented for conversion (“Conversion Agent”) and an office or agency where notices to or upon the Company in respect of the Notes and this Indenture may be served. The Registrar shall keep a register for the recording of, and shall
record, the names and addresses of holders of the Notes, the Notes held by each holder and the transfer, exchange and conversion of Notes (the “Register”). The entries in the Register shall be conclusive, and the parties may treat
each Person whose name is recorded in the Register pursuant to the terms hereof as a holder hereunder for all purposes of this Indenture. The Company may have one or more co-registrars, one or more additional paying agents and one or more additional
conversion agents. The term Paying Agent includes any additional paying agent, including any named pursuant to Section 4.02. The term Conversion Agent includes any additional conversion agent, including any named pursuant to Section 4.02.

 The Company shall enter into an appropriate agency agreement with any Registrar, Paying Agent, Conversion Agent or
co-registrar not a party to this Indenture, which shall incorporate the terms of the TIA. Any such agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall notify the Trustee of the name and address of
any such agent. If the Company fails to maintain a Registrar, Paying Agent or Conversion Agent, the Trustee may agree to act as such and shall be entitled to appropriate compensation therefor pursuant to Section 6.06. The Company or any of its
domestically incorporated wholly owned Subsidiaries may act as Paying Agent, Registrar, Conversion Agent or co-registrar. 
 The
Company initially appoints the Trustee as the Paying Agent, the Conversion Agent, and the Registrar, in connection with the Notes, and the Corporate Trust Office to be such office or agency of the Company for the aforesaid purposes. The Company may
at any time rescind the designation of the Paying Agent, Conversion Agent or the Registrar or approve a change in the location through which any of them acts. 
 SECTION 2.04 Paying Agent and Conversion Agent to Hold Money and Shares in Trust. Except as otherwise provided herein, on or prior to each due date of payment or delivery of conversion
consideration in respect of any Note, the Company shall deposit with the 

  
 21 

 
Paying Agent or Conversion Agent, as the case may be, a sum of money (in immediately available funds if deposited on the due date) and shares of Common Stock, if applicable, sufficient to make
such payments or satisfy such conversion obligations when so becoming due. The Paying Agent and Conversion Agent shall (or, if the Paying Agent or Conversion Agent is not a party hereto, the Company shall require each Paying Agent or Conversion
Agent to agree in writing that such Paying Agent or Conversion Agent shall) hold in trust for the benefit of holders or the Trustee (if the Trustee is not the Paying Agent or Conversion Agent) all money and shares of Common Stock, if any, held by
the Paying Agent or Conversion Agent for the making of payments or satisfaction of conversion obligations in respect of the Notes and shall notify the Trustee (if the Trustee is not the Paying Agent or Conversion Agent) of any default by the Company
in making any such payment or conversion obligation. At any time during the continuance of any such default, the Paying Agent or Conversion Agent (if not the Trustee) shall, upon the written request of the Trustee, forthwith pay to the Trustee all
money and shares of Common Stock, if any, so held in trust. If the Company or a wholly owned Subsidiary acts as Paying Agent or Conversion Agent, it shall segregate the money and shares of Common Stock, if any, held by it as Paying Agent or
Conversion Agent and hold it as a separate trust fund. The Company at any time may require a Paying Agent or Conversion Agent to pay all money and shares of Common Stock, if any, held by it to the Trustee and to account for any funds and shares of
Common Stock, if any, disbursed by the Paying Agent or Conversion Agent. Upon complying with this Section 2.04, the Paying Agent or Conversion Agent shall have no further liability for the money delivered to the Trustee. 

SECTION 2.05 Holder Lists. The Trustee shall preserve in as current a form as is reasonably practicable the most recent list
available to it of the names and addresses of holders. If the Trustee is not the Registrar, the Company shall furnish to the Trustee, promptly after each Record Date, and at such other times as the Trustee may request in writing, a list in such form
and as of such date as the Trustee may reasonably require of the names and addresses of holders. 
 SECTION 2.06 Transfer and
Exchange. 
 (a) Subject to Section 2.12 hereof, upon surrender for registration of transfer of any Note, together with
a written instrument of transfer satisfactory to the Registrar duly executed by the holder or such holder’s attorney-in-fact duly authorized in writing, at the office or agency of the Company-designated Registrar or co-Registrar pursuant to
Section 2.03, (i) the Company shall execute, and the Trustee (or any authenticating agent) shall authenticate and deliver, in the name of the designated transferee or transferees, one or more new Notes of any authorized denomination or
denominations, of a like aggregate principal amount and bearing such restrictive legends as may be required by this Indenture and (ii) the Registrar shall record the information required pursuant to Section 2.03 regarding the designated
transferee or transferees in the Register. The Company shall not charge a service charge for any registration of transfer or exchange, but the Company and the Trustee may require payment of a sum sufficient to pay all taxes, assessments or other
governmental charges that may be imposed in connection with the registration of, transfer or exchange of the Notes from the holder requesting such transfer or exchange. 

  
 22 

 At the option of the holder, Notes may be exchanged for other Notes of any authorized
denomination or denominations, of a like aggregate principal amount, upon surrender of the Notes to be exchanged, at such office or agency, together with a written instrument of transfer satisfactory to the Registrar duly executed by the holder or
such holder’s attorney-in-fact duly authorized in writing, and documents of identity and title satisfactory to Registrar. Whenever any Notes are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and
deliver, the Notes that the holder making the exchange is entitled to receive, bearing registration numbers not contemporaneously outstanding. 
 The Company shall not be required to make, and the Registrar need not register, transfers or exchanges of Notes in respect of which a Fundamental Change Purchase Notice has been given and not validly
withdrawn by the holder thereof in accordance with the terms of this Indenture (except, in the case of Notes to be repurchased in part, the portion of such Notes not to be repurchased). 

(b) Notwithstanding any provision to the contrary herein, so long as a Global Note remains outstanding and is held by or on behalf of the
Depositary, transfers of a Global Note, in whole or in part, shall be made only in accordance with Section 2.12 and this Section 2.06(b). Transfers of a Global Note shall be limited to transfers of such Global Note to the Depositary, to
nominees of the Depositary or to a successor of the Depositary or such successor’s nominee. 
 (c) Successive registrations
and registrations of transfers and exchanges as aforesaid may be made from time to time as desired, and each such registration shall be noted on the Register. 
 (d) Any Registrar appointed pursuant to Section 2.03 shall provide to the Trustee such information as the Trustee may reasonably require in connection with the delivery by such Registrar of Notes
upon transfer or exchange of Notes. 
 (e) No Registrar shall be required to make registrations of transfer or exchange of Notes
during any periods designated in Section 13.03 or otherwise in this Indenture as periods during which such registration of transfers and exchanges need not be made. 
 (f) Transfer Restrictions. 
 (i) Every Note that bears or is
required under this Section 2.06(f) to bear the Restricted Securities Legend required by Section 2.01(d) (the “Restricted Notes”) shall be subject to the restrictions on transfer set forth in this Section 2.06(f)
unless such restrictions on transfer shall be eliminated or otherwise waived by written consent of the Company, and the holder of each such Restricted Note, by such holder’s acceptance thereof, agrees to be bound by all such restrictions on
transfer. As used in this Section 2.06(f), and Sections 2.06(g), 2.12(b) and 2.12(c), the term “transfer” encompasses any sale, pledge, transfer, loan, hypothecation or other disposition whatsoever of any Restricted Note.
Except as otherwise provided in this Indenture with respect to any Restricted Notes (including, without limitation, Section 2.06(i) below) or as permitted under the terms of such Restricted Securities Legend, if a request is made to

  
 23 

 
remove the legend on any Restricted Note, the legend shall not be removed unless there is delivered to the Company and the Registrar such satisfactory evidence that neither the Restricted
Securities Legend nor the restrictions on transfer set forth therein are required to ensure that transfers thereof comply with the provisions of Rule 144A or Rule 144, that such Notes are not “restricted” within the meaning of
Rule 144 or that transfers thereof comply with all other applicable securities laws and regulations. In such a case, upon (i) provision of such satisfactory evidence, or (ii) notification by the Company to the Trustee and Registrar of
the sale of such Note pursuant to a registration statement that is effective at the time of such sale, the Trustee, pursuant to a Company Order, shall authenticate and deliver a Note that does not bear the Restricted Securities Legend. 

(ii) Except as provided elsewhere in this Indenture (including, without limitation, Section 2.06(i) below), until the
later of (x) the date that is one year after the last date of original issuance of the Notes and (y) the date that is three months after the holder ceases to be an Affiliate of the Company, any certificate evidencing such Notes (and all
securities issued in exchange therefor or substitution thereof, other than Common Stock, if any, issued upon conversion thereof, which shall bear the Restricted Stock Legend, if applicable) shall bear the Restricted Securities Legend unless such
Notes have been transferred (A) to the Company, (B) under a registration statement that has been declared effective under the Securities Act, (C) to a Person the seller reasonably believes is a QIB that is purchasing for its own
account or for the account of another QIB and to whom notice is given that the transfer is being made in reliance on Rule 144A, all in compliance with Rule 144A, or (D) under any other available exemption from the registration
requirements of the Securities Act. 
 (iii) No transfer of any Note prior to the Free Trade Date will be
registered by the Registrar unless the applicable box on the Form of Assignment and Transfer has been checked. 
 (g) Legends
on the Common Stock. 
 (i) Except as provided elsewhere in this Indenture (including, without limitation,
Section 2.06(j) below), until the later of (x) the date that is one year after the last date of original issuance of the Notes and (y) the date that is three months after the holder of such shares of Common Stock ceases to be an
Affiliate of the Company, any stock certificate representing shares of the Common Stock issued upon conversion of such Notes shall bear the Restricted Stock Legend unless the Notes or such Common Stock, as applicable, has been transferred
(a) to the Company; (b) under a registration statement that has been declared effective under the Securities Act; (c) to a Person the holder reasonably believes is a QIB that is purchasing for its own account or for the account of
another QIB pursuant to a valid private placement exemption under the Securities Act and to whom notice is given that the transfer is being made in reliance on such an exemption; or (d) under any other available exemption from the registration
requirements of the Securities Act. 

  
 24 

 (ii) Any such shares of Common Stock as to which such restrictions on
transfer shall have expired in accordance with their terms may, subject to applicable securities laws and regulations and upon surrender of the certificates representing such shares of Common Stock for exchange in accordance with the procedures of
the transfer agent for the Common Stock, be exchanged for a new certificate or certificates for a like aggregate number of shares of Common Stock which shall not bear the Restricted Stock Legend. 

(h) The Company shall not permit any Note that is purchased or owned by the Company or any Affiliate thereof to be resold by the Company
or such Affiliate unless registered under the Securities Act or resold pursuant to an exemption from the registration requirements of the Securities Act in a transaction that results in such Notes, as the case may be, no longer being
“restricted securities” (as defined under Rule 144). If the legend is removed from the face of a Note and the Note is subsequently held by the Company or an Affiliate of the Company, the legend shall be reinstated. 

(i) So long as and to the extent that any Notes are represented by one or more Global Notes held by or on behalf of the Depositary only,
the Company may cause the removal of the Restricted Securities Legend from such Notes at any time on or after the Free Trade Date by: 
 (i) providing to the Trustee written notice stating that the Free Trade Date has occurred and instructing the Trustee to remove the Restricted Securities Legend from such Notes; 

(ii) providing to the holders of such Notes written notice that the Restricted Securities Legend has been removed or
deemed removed; 
 (iii) providing to the Trustee and the Depositary written notice to change the CUSIP number
for the Notes to the applicable unrestricted CUSIP number; and 
 (iv) complying with any Applicable Procedures
for delegending; 
 whereupon the Restricted Securities Legend shall be deemed removed from any Global Notes without further action on the part
of holders. 
 (j) On and after the Free Trade Date, the Company shall also (i) instruct the transfer agent for the Common
Stock to remove the Restricted Stock Legend from any shares of Common Stock issued upon conversion of the Notes that bear the Restricted Stock Legend; (ii) notify the holders of any shares of Common Stock issued upon conversion of the Notes (to
the extent any shares of Common Stock have been issued upon conversion of the Notes) that such Restricted Stock Legend has been removed; (iii) if relevant, notify the transfer agent for the Common Stock to change the CUSIP number for any shares
of Common Stock issued upon conversion of the Notes to the applicable unrestricted CUSIP number; and (iv) comply with any Applicable Procedures that apply to the delegending of any shares of Common Stock issued upon conversion of a Note.

  
 25 

 SECTION 2.07 Replacement Notes. If a mutilated Note is surrendered to the Registrar
or if the holder of a Note claims that such Note has been lost, destroyed or stolen and the holder provides evidence of the loss, theft or destruction satisfactory to the Company and the Trustee, the Company shall issue, and the Trustee shall
authenticate, a replacement Note if the requirements of Section 8-405 of the Uniform Commercial Code are met and the holder satisfies any other reasonable requirements of the Trustee. If required by the Trustee or the Company, such holder shall
furnish an indemnity bond sufficient in the judgment of the Company and the Trustee to protect the Company, the Trustee, the Paying Agent, the Registrar and any co-registrar from any loss that any of them may suffer if a Note is replaced. The
Company and the Trustee may charge the holder for their expenses in replacing a Note. 
 Upon the issuance of any new Notes
under this Section 2.07, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee)
connected therewith. 
 Every new Note issued pursuant to this Section 2.07 in exchange for any mutilated Note, or in lieu
of any destroyed, lost or stolen Note, shall constitute an original additional contractual obligation of the Company and any other obligor upon the Notes, whether or not the mutilated, destroyed, lost or stolen Note shall be at any time enforceable
by anyone, and shall be entitled to all benefits of (and shall be subject to all the limitations set forth in) this Indenture equally and proportionately with any and all other Notes duly issued hereunder. 

The provisions of this Section 2.07 are exclusive and shall preclude (to the extent lawful) all other rights and remedies with
respect to the replacement or payment of mutilated , destroyed, lost or stolen Notes. 
 SECTION 2.08 Outstanding Notes.
Notes outstanding at any time include and are limited to all Notes authenticated by the Trustee except (i) those cancelled by it, (ii) those delivered to it for cancellation and (iii) those deemed not outstanding under this
Section 2.08. If the Company or an Affiliate of the Company holds the Note, a Note does not cease to be outstanding; provided, however, that for purposes of determining whether the holders of the requisite principal amount of Notes have given
or concurred in any request, demand, authorization, direction, notice, consent, waiver or other action hereunder, Notes owned by the Company or any other obligor upon the Notes or any Affiliate of the Company or such other obligor shall be
disregarded and deemed not to be outstanding. Subject to the foregoing, only Notes outstanding at the time of such determination shall be considered in any such determination (including, without limitation, determinations pursuant to Article 7).

 If a Note is replaced pursuant to Section 2.07, it ceases to be outstanding unless the Trustee and the Company receive
proof satisfactory to them that the replaced Note is held by a protected purchaser. 
 If the Paying Agent holds, in accordance
with this Indenture, on a Fundamental Change Purchase Date or on the Maturity Date, money sufficient to pay Notes payable on that date, then immediately after such Fundamental Change Purchase Date or Maturity Date, as the case may be, such Notes
shall cease to be outstanding, interest (including Additional Interest), if any, on such Notes shall cease to accrue and such Notes shall cease to be convertible. 

  
 26 

 If a Note is converted in accordance with Article 12, then from and after the time of
conversion on the Conversion Date, such Note shall cease to be outstanding and interest (including any Additional Interest), if any, shall cease to accrue on such Note. 
 SECTION 2.09 Temporary Notes. Until Certificated Notes are ready for delivery, the Company may execute and the Trustee or an authenticating agent appointed by the Trustee shall, upon written
request of the Company, authenticate and deliver temporary Notes (printed or lithographed) (“Temporary Notes”). Temporary Notes shall be issuable in any authorized denomination, and substantially in the form of Certificated Notes
but with such omissions, insertions and variations as may be appropriate for temporary Notes, all as may be determined by the Company. Every such Temporary Note shall be executed by the Company and authenticated by the Trustee or such authenticating
agent upon the same conditions and in substantially the same manner, and with the same effect, as the Certificated Notes. Without unreasonable delay the Company will prepare, execute and deliver to the Trustee or such authenticating agent
Certificated Notes (other than any Global Note) and thereupon any or all Temporary Notes (other than any Global Note) may be surrendered in exchange therefor, at each office or agency maintained by the Company pursuant to Section 4.02 and the
Trustee or such authenticating agent shall authenticate and deliver in exchange for such Temporary Notes an equal aggregate principal amount of Certificated Notes. Such exchange shall be made by the Company at its own expense and without any charge
therefor. Until so exchanged, the Temporary Notes shall in all respects be entitled to the same benefits and subject to the same limitations under this Indenture as Certificated Notes authenticated and delivered hereunder. 

SECTION 2.10 Cancellation. The Company at any time may deliver Notes to the Trustee for cancellation. The Registrar, Conversion
Agent and the Paying Agent shall forward to the Trustee any Notes surrendered to them for registration of transfer, exchange, conversion, purchase, or payment. The Trustee and no one else shall cancel all Notes surrendered for registration of
transfer, exchange, conversion, purchase, payment or cancellation and shall dispose of such Notes in its customary manner. The Company may not issue new Notes to replace Notes it has purchased, paid or delivered to the Trustee for cancellation or
that any holder has converted pursuant to Article 12. 
 SECTION 2.11 Persons Deemed Owners. Prior to due
presentment of a Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name such Note is registered in the Register as the owner of such Note for the purpose of
receiving payment of principal, interest (including Additional Interest), if any, or payment of the Fundamental Change Purchase Price, for the purpose of conversion and for all other purposes whatsoever, whether or not such Note be overdue, and
neither the Company, the Trustee nor any agent of the Company or the Trustee shall be affected by notice to the contrary. 

SECTION 2.12 Transfer of Notes. 
 (a) Notwithstanding any other provisions of this Indenture or the Notes, (A) transfers of a Global Note, in whole or in part, shall be made only in accordance with Sections 2.06 and 2.12(a)(i);
(B) transfers of a beneficial interest in a Global Note for a Certificated Note shall comply with Sections 2.06 and 2.12(a)(ii), and (C) transfers of a Certificated Note shall comply with Sections 2.06 and 2.12(a)(iii) and
(iv) below. All such transfers shall comply with the Applicable Procedures to the extent so required. 

  
 27 

 (i) Transfer of Global Note. A Global Note may not be transferred, in
whole or in part, to any Person other than the Depositary or a nominee or any successor thereof, and no transfer of a Global Note to any other Person may be registered; provided that this clause (i) shall not prohibit any transfer of a Note
that is issued in exchange for a Global Note but is not itself a Global Note. No transfer of a Note to any Person shall be effective under this Indenture or the Notes unless and until such Note has been registered in the name of such Person. Nothing
in this Section 2.12(a)(i) shall prohibit or render ineffective any transfer of a beneficial interest in a Global Note effected in accordance with the other provisions of this Section 2.12(a). 

(ii) Restrictions on Transfer of a Beneficial Interest in a Global Note for a Certificated Note. 

(A) A beneficial interest in a Global Note may not be exchanged for a Certificated Note unless: 

(1) DTC notifies the Company that it is unwilling or unable to continue as Depositary for such Global Note and a
successor Depositary is not appointed by the Company within 90 days of such notice; 
 (2) DTC ceases to be
registered as a clearing agency under the Exchange Act and a successor Depositary is not appointed by the Company within 90 days of such cessation, in which case Certificated Notes shall be issued to all owners of beneficial interests in a Global
Note in exchange for their beneficial interests; or 
 (3) An Event of Default has occurred and is continuing,
in which case, the owner of a beneficial interest in a Global Note will be entitled to receive a Certificated Note in exchange for its beneficial interest in such Global Note. 

In connection with the exchange of an entire Global Note for Certificated Notes pursuant to this
Section 2.12(a)(ii), such Global Note shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall execute, and upon Company Order the Trustee shall authenticate and deliver, to each beneficial owner identified by
DTC in exchange for its beneficial interest in such Global Note, an equal aggregate principal amount of Certificated Notes of authorized denominations. 
 (B) Upon receipt by the Registrar of instructions from the holder of a Global Note directing the Registrar to (x) issue one or more Certificated Notes in the amounts specified to the owner of a
beneficial interest in such Global Note and (y) debit or cause to be debited an equivalent amount of beneficial interest in such Global Note, subject to the Applicable Procedures: 

(1) the Registrar shall notify the Company and the Trustee of such instructions and identify the owner of and the amount
of such beneficial interest in such Global Note; 

  
 28 

 (2) the Company shall promptly execute, and upon Company Order, the Trustee
shall authenticate and deliver, to such beneficial owner Certificated Note(s) in an equivalent amount to such beneficial interest in such Global Note; and 
 (3) the Registrar shall decrease such Global Note by such amount in accordance with the foregoing. 
 (iii) Transfer and Exchange of Certificated Notes. When Certificated Notes are presented to the Registrar with a request: (x) to register the transfer of such Certificated Notes; or
(y) to exchange such Certificated Notes for an equal principal amount of Certificated Notes of other authorized denominations, the Registrar shall register the transfer or make the exchange as requested if its reasonable requirements for such
transaction are met; provided, however, that the Certificated Notes surrendered for transfer or exchange: 
 (A)
must be duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the Registrar, duly executed in writing by the holder thereof or its duly authorized attorney-in-fact; and 

(B) so long as such Notes are “restricted securities” (as defined under Rule 144), such Notes are being
transferred or exchanged pursuant to an effective registration statement under the Securities Act or pursuant to clause (1), (2) or (3) below, and are accompanied by the following additional information and documents, as applicable:

 (1) if such Certificated Notes are being delivered to the Registrar by a holder for registration in the name
of such holder, without transfer, a certification from such holder to that effect; or 
 (2) if such
Certificated Notes are being transferred to the Company, a certification from such holder to that effect; or 

(3) if such Certificated Notes are being transferred pursuant to an exemption from registration, (i) a certification
from such holder to that effect (in the form set forth in Exhibit D, if applicable) and (ii) if the Company so requests, an Opinion of Counsel in form and substance reasonably satisfactory to the Company or any other evidence as to the
compliance with the restrictions set forth in the legend thereon that is reasonably satisfactory to the Company. 

  
 29 

 (iv) Restrictions on Transfer of a Certificated Note for a Beneficial
Interest in a Global Note. (a) A Certificated Note may not be exchanged for a beneficial interest in a Global Note except upon satisfaction of the requirements set forth below. 

Upon receipt by the Trustee of a Certificated Note, duly endorsed or accompanied by appropriate instruments of transfer,
in form satisfactory to the Trustee, together with: 
 (A) so long as the Notes are Restricted Notes,
certification, in the form set forth in Exhibit D, that such Certificated Note is being transferred to a QIB in accordance with Rule 144A; and 
 (B) written instructions directing the Trustee to make, or to direct the Registrar to make, an adjustment on its books and records with respect to such Global Note to reflect an increase in the aggregate
principal amount of the Notes represented by the Global Note, such instructions to contain information regarding the Depositary account to be credited with such increase, then the Trustee shall cancel such Certificated Note and cause, or direct the
Registrar to cause, in accordance with the standing instructions and procedures existing between the Depositary and the Registrar, the aggregate principal amount of Notes represented by the Global Note to be increased by the aggregate principal
amount of the Certificated Note to be exchanged, and shall credit or cause to be credited to the account of the Person specified in such instructions a beneficial interest in the Global Note equal to the principal amount of the Certificated Note so
cancelled. If no Global Notes are then outstanding, the Company shall issue and the Trustee shall authenticate, upon written order of the Company in the form of an Officer’s Certificate, a new Global Note in the appropriate principal amount.

 (b) Subject to the succeeding Section 2.12(c), every Note shall be subject to the restrictions on transfer provided in
Section 2.06(f), including the delivery of an opinion of counsel, if so required. Whenever any Restricted Note is presented or surrendered for registration of transfer or for exchange for a Note registered in a name other than that of the
holder, such Note must be accompanied by a certificate in substantially the form set forth in Exhibit D, dated the date of such surrender and signed by the holder of such Note, as to compliance with such restrictions on transfer. The Registrar shall
not be required to accept for such registration of transfer or exchange any Note not so accompanied by a properly completed certificate. 
 (c) The restrictions imposed by Section 2.06(f) upon the transferability of any Note shall cease and terminate when such Note has been sold pursuant to an effective registration statement under the
Securities Act or transferred in compliance with Rule 144. Any Note as to which such restrictions on transfer shall have expired in accordance with their terms or shall have terminated may, upon a surrender of such Note for exchange to the
Registrar in accordance with the provisions of this Section 2.12 (accompanied, if such restrictions on transfer have terminated by reason of a transfer in compliance with Rule 144 or any successor provision, by an opinion of counsel having
substantial experience in practice under the Securities Act and otherwise reasonably acceptable in form and substance to the Company, addressed to the Company, to the effect that the transfer of such Note has been made in compliance with

  
 30 

 
Rule 144), be exchanged for a new Note, of like tenor and aggregate principal amount, which shall not bear the legends required by Section 2.01(d). The Company shall inform the Trustee
upon the occurrence of the Free Trade Date and promptly after a registration statement with respect to the Notes or any shares of Common Stock issued upon conversion of the Notes has been declared effective under the Securities Act. The Trustee
shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the aforementioned opinion of counsel or registration statement. 
 (d) The provisions of clauses (i), (ii), (iii) and (iv) below shall apply only to Global Notes: 
 (i) Notwithstanding any other provisions of this Indenture or the Notes, a Global Note shall not be exchanged in whole or in part for a Note registered in the name of any Person other than the Depositary
or one or more nominees thereof, provided that a Global Note may be exchanged for Notes registered in the name of any Person designated by the Depositary if (A) the Depositary has notified the Company that it is unwilling or unable to continue
as Depositary for such Global Note or such Depositary has ceased to be a “clearing agency” registered under the Exchange Act, and a successor Depositary is not appointed by the Company within 90 days or (B) an Event of Default has
occurred and is continuing with respect to the Notes. Any Global Note exchanged pursuant to clause (A) above shall be so exchanged in whole and not in part, and any Global Note exchanged pursuant to clause (B) above may be exchanged in
whole or, from time to time, in part as directed by the Depositary. Any Note issued in exchange for a Global Note or any portion thereof shall be a Global Note; provided that any such Note so issued that is registered in the name of a Person other
than the Depositary or a nominee thereof shall not be a Global Note. 
 (ii) Notes issued in exchange for a
Global Note or any portion thereof shall be issued in definitive, fully registered form, without interest coupons, shall have an aggregate principal amount equal to that of such Global Note or portion thereof to be so exchanged, shall be registered
in such names and be in such authorized denominations as the Depositary shall designate and shall bear the applicable legends provided for herein. Any Global Note to be exchanged in whole shall be surrendered by the Depositary to the Trustee, as
Registrar. With regard to any Global Note to be exchanged in part, either such Global Note shall be so surrendered for exchange or, if the Trustee is acting as custodian for the Depositary or its nominee with respect to such Global Note, the
principal amount thereof shall be reduced, by an amount equal to the portion thereof to be so exchanged, by means of an appropriate adjustment made on the records of the Trustee. Upon any such surrender or adjustment, the Trustee shall authenticate
and deliver the Note issuable on such exchange to or upon the order of the Depositary or an authorized representative thereof. 
 (iii) Subject to the provisions of Section 2.12(e), a holder may grant proxies and otherwise authorize any Person, including Agent Members and Persons that may hold interests through Agent Members,
to take any action which such holder is entitled to take under this Indenture or the Notes. 

  
 31 

 (iv) In the event of the occurrence of any of the events specified in
clause (i) above, the Company will promptly make available to the Trustee a reasonable supply of Certificated Notes in definitive, fully registered form, without interest coupons. 

(e) Neither any members of, or participants in, the Depositary (collectively, the “Agent Members”) nor any other Persons
on whose behalf any Agent Member may act shall have any rights under this Indenture with respect to any Global Note registered in the name of the Depositary or any nominee thereof, or under any such Global Note, and the Depositary or such nominee,
as the case may be, may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner and holder of such Global Note for all purposes whatsoever. The Trustee shall have no responsibility or obligation to
any Agent Members or any other Person on whose behalf Agent Members may act with respect to (i) any ownership interests in the Global Note, (ii) the accuracy of the records of the Depositary or its nominee (iii) any notice required
hereunder or (iv) any payments, under or with respect to, the Global Note. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to any written
certification, proxy or other authorization furnished by the Depositary or such nominee, as the case may be, or impair, as between the Depositary, its Agent Members and any other Person on whose behalf an Agent Member may act, the operation of
customary practices of such Persons governing the exercise of the rights of a holder of any Note. The registered holder of a Global Note may grant proxies and otherwise authorize any Person, including Agent Members and persons that may hold
interests through Agent Members, to take any action that a holder is entitled to take under this Indenture or the Notes. 

SECTION 2.13 CUSIP and ISIN Numbers. 
 (a) The Company, in issuing the Notes, shall use restricted CUSIP and ISIN numbers for such Notes (if then generally in use) until such time as the Restricted Securities Legend is removed pursuant to
Section 2.06(i). At such time as the legend is removed from such Notes pursuant to Section 2.06(i), the Company will use an unrestricted CUSIP number for such Note, but only with respect to the Notes where so removed. The Trustee may use
CUSIP and ISIN numbers in notices as a convenience to holders; provided, however, that neither the Company nor the Trustee shall have any responsibility for any defect in the CUSIP or ISIN number that appears on any Note, check, advice of payment or
notice, and any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice and that reliance may be placed only on the other identification numbers printed
on the Notes, and any action taken in connection with such a notice shall not be affected by any defect in or omission of such numbers. The Company shall promptly notify the Trustee in writing in the event of any change in the CUSIP or ISIN numbers.

 (b) Until such time as the Restricted Stock Legend is no longer required to be borne by any shares of Common Stock issued
upon the conversion of the Notes pursuant to Section 2.06(g) or otherwise, any shares of Common Stock issued upon conversion of the Notes shall bear a restricted CUSIP number. At such time as the Restrictive Stock Legend is no longer required
to be borne by any shares of Common Stock issued upon the conversion of the Notes pursuant to Section 2.06(g) or otherwise, any shares of Common Stock issued upon conversion of the Notes shall bear an unrestricted CUSIP number. 

  
 32 

 SECTION 2.14 Additional Notes; Repurchases. The Company may, without the consent of
the Noteholders and notwithstanding Section 2.02, reopen this Indenture and increase the principal amount of the Notes by issuing additional Notes in the future pursuant to this Indenture with the same terms and with the same CUSIP number as
the Notes initially issued hereunder in an unlimited aggregate principal amount, provided that the Company may use a temporary CUSIP number for securities law purposes and provided further that no such additional Notes may be issued
unless they will be fungible with the original Notes for United States federal income tax purposes. Prior to the issuance of any such additional Notes, the Company shall deliver to the Trustee a Company Order, an Officers’ Certificate and an
Opinion of Counsel, such Officers’ Certificate and Opinion of Counsel to cover such matters, in addition to those required by Section 14.05, as the Trustee shall reasonably request. The Company may also from time to time repurchase the
Notes in open market purchases or negotiated transactions without prior notice to Noteholders. 
 The Trustee shall have the
right to decline to authenticate and deliver any Additional Securities under this Section 2.14 if the Trustee, determines that such action may not lawfully be taken by the relevant Issuer or if the Trustee in good faith by its board of
directors or board of trustee, executive committee, or a trust committee of directors or trustees or Responsible Officers shall determine that such action would expose the Trustee to personal liability to existing Noteholders. 

ARTICLE III 

SATISFACTION AND DISCHARGE 
 SECTION 3.01 Satisfaction and Discharge. This Indenture shall upon request of the Company contained in an Officers’ Certificate cease to be of further effect, and the Trustee, at the expense
of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture, when (a) (i) all Notes theretofore authenticated and delivered (other than (x) Notes which have been destroyed, lost or
stolen and which have been replaced or paid as provided in Section 2.07 and (y) Notes for whose payment money has theretofore been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company or
discharged from such trust, as provided in Section 4.04(d)) have been delivered to the Trustee for cancellation; or (ii) the Company has deposited with the Trustee or delivered to Noteholders, as applicable, after the Notes have become due
and payable, whether at the Maturity Date, any Fundamental Change Purchase Date, upon conversion or otherwise, cash or cash and shares of Common Stock, if any (solely to satisfy the Company’s Conversion Obligation, if applicable), sufficient to
pay all of the outstanding Notes and all other sums due and payable under this Indenture by the Company; and (b) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions
precedent herein provided for relating to the satisfaction and discharge of this Indenture have been complied with. Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company to the Trustee under
Section 6.06 shall survive. 

  
 33 

 ARTICLE IV 
 PARTICULAR COVENANTS OF THE COMPANY 
 SECTION 4.01 Payment of Principal,
Interest and Additional Interest. 
 (a) The Company shall promptly make all payments on the Notes and satisfy all
conversion obligations on the dates, in the manner and as otherwise required under the Notes or this Indenture. If the Company is required to deliver any amounts of cash and/or shares of Common Stock to the Trustee, the Paying Agent or the
Conversion Agent, such amounts of cash and/or shares of Common Stock shall be deposited by the Company with the Trustee, the Paying Agent or the Conversion Agent by 10:00 a.m., New York City time, on the Business Day prior to the required date. The
Company may, at its option, make payments on any Certificated Notes by check mailed to a Noteholder’s registered address; provided, however, that if a Noteholder of more than $5,000,000 principal amount of Certificated Notes
requests in writing that the Company make payments on its Certificated Notes by wire transfer to an account in the United States, the Company shall, beginning with the interest payment corresponding to the next Record Date, make all subsequent
payments due to such Noteholder to such account until such Noteholder notifies the Registrar in writing that the Company should no longer make payments by wire transfer to such account. If the Notes are held in book-entry form, the Company shall
make all payments by wire transfer. 
 (b) The Company shall make any required interest payments (including of Additional
Interest), if any, to the Person in whose name each Note is registered at the close of business on the Record Date for such interest payment. The principal, accrued and unpaid interest (including Additional Interest), if any, or payment of the
Fundamental Change Purchase Price shall be considered paid on the applicable date due if on such date (or, in the case of a Fundamental Change Purchase Price, on the Business Day following the applicable Fundamental Change Purchase Date) the Trustee
or the Paying Agent holds, in accordance with this Indenture, cash sufficient to pay all such amounts then due. 
 (c) The
Company shall pay interest on the Notes at a rate of 3.25% per annum, payable semi-annually in arrears on each Interest Payment Date or, if any such day is not a Business Day, the immediately following Business Day. Interest on a Note shall be
paid to the holder of such Note at the Close of Business on May 1 or November 1 (each, an “Interest Record Date”), as the case may be, immediately preceding the related Interest Payment Date, and shall be computed on the
basis of a 360-day year comprised of twelve 30-day months. In the event of the maturity, conversion, or repurchase of a Note by the Company at the option of the holder, interest shall cease to accrue on such Note. If the Conversion Date for a Note
occurs after an Interest Record Date but on or before the corresponding Interest Payment Date, the interest payable on such Interest Payment Date will be paid to the holder of such Note on such Interest Record Date notwithstanding the conversion of
such Note. 

  
 34 

 (d) Any Defaulted Interest shall forthwith cease to be payable to the Noteholder on the
relevant Interest Record Date by virtue of its having been such Noteholder, and such Defaulted Interest shall be paid by the Company, at its election in each case, as provided in clause (1) or (2) below: 

(1) The Company may elect to make payment of any Defaulted Interest to the Persons in whose names the Notes (or their
respective Predecessor Notes) are registered at the close of business on a special record date for the payment of such Defaulted Interest, which shall be fixed in the following manner. The Company shall notify the Trustee in writing of the amount of
Defaulted Interest proposed to be paid on each Note and the date of the proposed payment (which shall be not less than twenty-five days after the receipt by the Trustee of such notice, unless the Trustee shall consent to an earlier date), and at the
same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such deposit on or prior to the date of
the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this clause provided. Thereupon the Company shall fix a special record date for the payment of such
Defaulted Interest which shall be not more than fifteen days and not less than ten days prior to the date of the proposed payment, and not less than ten days after the receipt by the Trustee of the notice of the proposed payment (unless the Trustee
shall consent to an earlier date). The Company shall promptly notify the Trustee of such special record date and the Trustee, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Interest and
the special record date therefor to be mailed, first-class postage prepaid, to each holder at its address as it appears in the Note Register, not less than seven days prior to such special record date. Notice of the proposed payment of such
Defaulted Interest and the special record date therefor having been so mailed, such Defaulted Interest shall be paid to the Persons in whose names the Notes (or their respective Predecessor Notes) are registered at the close of business on such
special record date and shall no longer be payable pursuant to the following clause (2) of this Section 4.01(d). 
 (2) The Company may make payment of any Defaulted Interest in any other lawful manner not inconsistent with the requirements of any securities exchange or automated quotation system on which the Notes may
be listed or designated for issuance, and upon such notice as may be required by such exchange or automated quotation system. 

SECTION 4.02 Maintenance of Office or Agency. The Company will maintain, in the continental United States, an office or agency of
the Trustee, Registrar, Paying Agent and Conversion Agent where Notes may be presented or surrendered for payment, where Notes may be surrendered for registration of transfer, exchange, repurchase, or conversion and where notices and demands to or
upon the Company in respect of the Notes and this Indenture may be served. The Corporate Trust Office of the Trustee shall initially be such office or agency for all of the aforesaid purposes. The Company shall give prompt written notice to the
Trustee of the location, and of any change in the location, of any such office or agency (other than a change in the location of the Corporate Trust Office of the Trustee). If at any time the Company shall fail to maintain any such required office
or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the address of the Corporate Trust Office. 

  
 35 

 The Company may also from time to time designate one or more other offices or agencies where
the Notes may be presented or surrendered for any or all such purposes and may from time to time rescind such designations. 

SECTION 4.03 Appointments to Fill Vacancies in Trustee’s Office. The Company, whenever necessary to avoid or fill a vacancy
in the office of Trustee, will appoint, in the manner provided in Section 6.10, a Trustee, so that there shall at all times be a Trustee hereunder. 
 SECTION 4.04 Provisions as to Paying Agent. 
 (a) If the Company shall
appoint a Paying Agent other than the Trustee, the Company will cause such Paying Agent to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this Section 4.04:

 (i) that it will hold all sums held by it as such agent for the payment of the principal of and accrued and
unpaid interest (including any Additional Interest) on the Notes in trust for the benefit of the holders of the Notes; 
 (ii) that it will give the Trustee prompt notice of any failure by the Company to make any payment of the principal of and accrued and unpaid interest (including any Additional Interest), on the Notes
when the same shall be due and payable; and 
 (iii) that at any time during the continuance of an Event of
Default, upon request of the Trustee, it will forthwith pay to the Trustee all sums so held in trust. 
 Subject to
Section 13.03, the Company shall, on or before each due date of the principal of (including the Fundamental Change Purchase Price), or accrued and unpaid interest or Additional Interest, if any, on the Notes, deposit with the Paying Agent a sum
sufficient to pay such principal (including the Fundamental Change Purchase Price), or accrued and unpaid interest or Additional Interest, if any, and (unless such Paying Agent is the Trustee) the Company will promptly notify the Trustee of any
failure to take such action, provided that if such deposit is made on the due date, such deposit must be received by the Paying Agent by 11:00 a.m., New York City time, on such date. 

(b) If the Company shall act as its own Paying Agent, it will, on or before each due date of the principal of (including the Fundamental
Change Purchase Price), accrued and unpaid interest (including any Additional Interest) on the Notes, set aside, segregate and hold in trust for the benefit of the holders of the Notes a sum sufficient to pay such principal (including the
Fundamental Change Purchase Price), accrued and unpaid interest (including any Additional Interest) so becoming due and will promptly notify the Trustee in writing of any failure to take such action and of any failure by the Company to make any
payment of the principal of (including the Fundamental Change Purchase Price), accrued and unpaid interest (including any Additional Interest) on the Notes when the same shall become due and payable. 

  
 36 

 (c) Anything in this Section 4.04 to the contrary notwithstanding, the Company may, at
any time, for the purpose of obtaining a satisfaction and discharge of this Indenture, or for any other reason, pay or cause to be paid to the Trustee all sums held in trust by the Company or any Paying Agent hereunder as required by this
Section 4.04, such sums to be held by the Trustee upon the trusts herein contained, and upon such payment by the Company or any Paying Agent to the Trustee, the Company or such Paying Agent shall be released from all further liability with
respect to such sums. 
 (d) Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for
the payment of the principal of (including the Fundamental Change Purchase Price), accrued and unpaid interest (including any Additional Interest) on any Note and remaining unclaimed for two years after such principal (including the Fundamental
Change Purchase Price), interest or Additional Interest has become due and payable shall be paid to the Company on request of the Company contained in an Officers’ Certificate, or (if then held by the Company) shall be discharged from such
trust; and the holder of such Note shall thereafter, as an unsecured general creditor, look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the
Company as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Company cause to be published once, in a newspaper
published in the English language, customarily published on each Business Day and of general circulation in The Borough of Manhattan, The City of New York, New York, notice that such money remains unclaimed and that, after a date specified therein,
which shall not be less than thirty days from the date of such publication, any unclaimed balance of such money then remaining will be repaid to the Company. 
 SECTION 4.05 Existence. Subject to Article 10, the Company will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence. 

SECTION 4.06 SEC and Other Reports; Additional Interest. 
 (a) For so long as the Notes are outstanding, the Company shall deliver to the Trustee within fifteen days after the same is required to be filed with the Commission, the Company’s annual and
quarterly reports, information, documents and other reports which the Company is required to file with the Commission pursuant to Section 13 or 15(d) of the Exchange Act (or copies of such portions of any of the foregoing as the Commission may
by rules and regulations prescribe) (giving effect to any grace period provided by Rule 12b-25 under the Exchange Act) and the Company shall otherwise comply with the requirements of TIA Section 314(a), to the extent applicable. Documents
filed by the Company with the Commission via the EDGAR filing system will be deemed to be filed with the Trustee as of the time such documents are filed via the EDGAR filing system. Delivery of such reports, information and documents to the Trustee
is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with
any of its covenants hereunder (as to which the Trustee is entitled to rely conclusively on Officers’ Certificates). 

  
 37 

 (b) If, at any time during the six-month period beginning on, and including, the date which
is six months after the last date of original issuance of the Notes and ending on the Free Trade Date, the Company fails to timely file (giving effect to any grace period provided by Rule 12b-25 under the Exchange Act) any periodic report that
the Company is required to file with the Commission pursuant to Section 13 or 15(d) of the Exchange Act, as applicable (other than current reports on Form 8-K), and the Company does not cure such failure to file within 14 calendar
days, the Company shall pay interest (such interest, and any interest payable pursuant to Section 5.03, “Additional Interest”) on the Notes, accruing from and including the due date of the first missed filing that gives rise to
such obligation (giving effect to any grace period provided by Rule 12b-25 under the Exchange Act) and continuing until the earlier of (i) the Free Trade Date and (ii) the date all such filings have been made. During the first 90 days on
which such Additional Interest is payable, such Additional Interest shall accrue at a rate of 0.25% per annum; thereafter, such Additional Interest shall accrue at a rate of 0.50% per annum. 

(c) In addition, if the Notes or any shares of the Common Stock issuable upon conversion of the Notes do not become Freely Tradable on
and at all times after the Free Trade Date (or the next succeeding Business Day if the Free Trade Date is not a Business Day), the Company will pay Additional Interest on the Notes accruing from and including the Free Trade Date and continuing until
the date on which the Notes and any shares of Common Stock issuable upon the conversion of the Notes become Freely Tradable. During the first 90 days on which such Additional Interest is payable, such Additional Interest will accrue at a rate of
0.25% per annum; thereafter, such Additional Interest will accrue at a rate of 0.50% per annum. 
 (d) Notwithstanding
anything else in this Indenture, in no event will (i) the combined rate of any Additional Interest payable under this Section 4.06 and of any Additional Interest payable under Section 5.03 exceed 0.50% per annum; or
(ii) Additional Interest accrue on any day in which (A)(1) the Company has filed a shelf registration statement for the resale of the Notes, (2) such shelf registration statement is effective and usable by Noteholders for the resale of the
Notes, and (3) the Noteholders may register the resale of their Notes under such shelf registration statement on terms customary for the resale of convertible securities offered in reliance on Rule 144A; or (B) conditions (A)(1)
through (A)(3) of this sentence have been satisfied for a period of two years. 
 (e) Whenever Additional Interest is accruing
on a Record Date, the Company will pay all accrued and unpaid Additional Interest to the Noteholders of record on such Record Date on the corresponding Interest Payment Date. If Additional Interest is not accruing on a Record Date, but has accrued
since the immediately preceding Record Date, the Company shall pay any accrued and unpaid Additional Interest on the Interest Payment Date corresponding to the latter Record Date to Noteholders of record on the latter Record Date. 

If the Company is required to pay Additional Interest to Noteholders, the Company shall provide a direction or order in the form of a
written notice to the Trustee (and if the Trustee is not the Paying Agent, to the Paying Agent) of the Company’s obligation to pay such Additional Interest no later than three Business Days prior to the date on which any such Additional
Interest is scheduled to be paid. Such notice shall set forth the amount of Additional Interest to be paid by the Company on such payment date and direct the Trustee (or, if the Trustee is not the Paying Agent, to the Paying Agent) to make payment
to the extent it receives 

  
 38 

 
funds from the Company to do so. The Trustee shall not at any time be under any duty or responsibility to any Noteholder to determine whether the Additional Interest is payable, or with respect
to the nature, extent, or calculation of the amount of the Additional Interest, or with respect to the method employed in such calculation of the Additional Interest. 
 SECTION 4.07 Stay, Extension and Usury Laws. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever claim or
take the benefit or advantage of, any stay, extension or usury law or other law that would prohibit or forgive the Company from paying all or any portion of the principal of or interest on the Notes as contemplated herein, wherever enacted, now or
at any time hereafter in force, or that may affect the covenants or the performance of this Indenture; and the Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and covenants that it will
not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted. 

SECTION 4.08 Compliance Certificate; Statements as to Defaults. The Company shall deliver to the Trustee within 120 days
after the end of each Fiscal Year (beginning with the Fiscal Year ending on December 31, 2010) an Officers’ Certificate stating whether or not the signer thereof has knowledge of any failure by the Company to comply with all conditions and
covenants then required to be performed under this Indenture and, if so, specifying each such failure and the nature thereof. 

In addition, the Company shall deliver to the Trustee, as soon as possible, and in any event within thirty days after the Company becomes
aware of the occurrence of any Event of Default or Default, an Officers’ Certificate setting forth the details of such Event of Default or Default, its status and the action that the Company proposes to take with respect thereto. 

SECTION 4.09 Further Instruments and Acts. Upon request of the Trustee, the Company will execute and deliver such further
instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purposes of this Indenture. 
 ARTICLE V 
 DEFAULTS AND REMEDIES 

SECTION 5.01 Events of Default. Each of the following shall be an “Event of Default”: 

(a) default in the payment in respect of the principal of any Note at its maturity, upon required repurchase, upon
declaration of acceleration or otherwise; 
 (b) default in the payment of any interest (including any Additional
Interest) upon any Note when it becomes due and payable, and continuance of such default for a period of 30 days; 
 (c) the Company’s failure to deliver the consideration due upon the conversion of any Notes in the manner and within the time periods described herein; 

  
 39 

 (d) the Company’s failure to timely issue a Fundamental Change Notice
as required under Section 13.01(a)(i) or a Specified Corporate Transaction Notice in accordance with Section 12.01(a)(4); 
 (e) default in the performance, or breach, of any covenant or agreement of the Company in this Indenture (other than a covenant or agreement a default in the performance or breach of which is specifically
dealt with in clauses (a), (b), (c) or (d) of this Section 5.01), and continuance of such default or breach for a period of 60 days after written notice thereof has been given to the Company by the Trustee or to the Company
and the Trustee by the holders of at least 25% in aggregate principal amount of the outstanding Notes; 
 (f) a
default or defaults under any bonds, debentures, notes or other evidences of indebtedness (other than the Notes) by the Company or any Subsidiary that is a Significant Subsidiary (or any group of Subsidiaries that, taken as a whole, would constitute
a Significant Subsidiary) having, individually or in the aggregate, a principal or similar amount outstanding of at least $15.0 million, whether such indebtedness now exists or shall hereafter be created, which default or defaults shall have
resulted in the acceleration of the maturity of such indebtedness prior to its express maturity or shall constitute a failure to pay at least $15.0 million of such indebtedness when due and payable after the expiration of any applicable grace
period with respect thereto; 
 (g) the entry against the Company or any Subsidiary that is a Significant
Subsidiary (or any group of Subsidiaries that, taken as a whole, would constitute a Significant Subsidiary) of a final judgment or final judgments for the payment of money in an aggregate amount in excess of $15.0 million, by a court or courts
of competent jurisdiction, which judgments remain undischarged, unwaived, unstayed, unbonded, unappealed or unsatisfied for a period of 60 consecutive days; 

(h) the Company, any Subsidiary that is a Significant Subsidiary or any group of Subsidiaries that, taken as a whole,
would constitute a Significant Subsidiary, pursuant to or within the meaning of any Bankruptcy Law: 
 (i)
commences a voluntary case; 
 (ii) consents to the entry of an order for relief against it in an involuntary
case; 
 (iii) consents to the appointment of a custodian of it or for all or substantially all of its property;

 (iv) makes a general assignment for the benefit of its creditors; 

(v) generally is not paying its debts as they become due; or 

  
 40 

 (vi) a court of competent jurisdiction enters an order or decree under any
Bankruptcy Law that: 
 (1) is for relief against the Company or any Subsidiary that is a Significant Subsidiary
or any group of Subsidiaries that, taken together, would constitute a Significant Subsidiary, in an involuntary case; 
 (2) appoints a Custodian of the Company or any Subsidiary that is a Significant Subsidiary or any group of Subsidiaries that, taken together, would constitute a Significant Subsidiary or for all or
substantially all of the property of the Company or any of its Subsidiaries; or 
 (3) orders the liquidation of
the Company or any Subsidiary that is a Significant Subsidiary or any group of Subsidiaries that, taken together, would constitute a Significant Subsidiary; 
 and the order or decree remains unstayed and in effect for 60 consecutive days. 
 SECTION 5.02 Acceleration. (a) In case one or more Events of Default shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or
involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body), then, and in each and every such case (other than an Event of
Default specified in Section 5.01(h), unless the principal of all of the Notes shall have already become due and payable (or waived), either the Trustee or the holders of at least 25% in aggregate principal amount of the Notes then outstanding,
determined in accordance with Section 7.04, by notice in writing to the Company (and to the Trustee if given by Noteholders), may declare 100% of the principal of and accrued and unpaid interest (including any accrued and unpaid Additional
Interest) on all the Notes to be due and payable immediately, and upon any such declaration the same shall become and shall automatically be immediately due and payable, anything in this Indenture or in the Notes contained to the contrary
notwithstanding. 
 (b) If an Event of Default specified in Section 5.01(h) occurs and is continuing, the principal of all
the Notes and accrued and unpaid interest (including any accrued and unpaid Additional Interest) shall be immediately due and payable. This provision, however, is subject to the conditions that if, at any time after the principal of the Notes shall
have been so declared due and payable, and before any judgment or decree for the payment of the monies due shall have been obtained or entered as hereinafter provided, the Company shall pay or shall deposit with the Trustee a sum sufficient to pay
installments of accrued and unpaid interest (including any accrued and unpaid Additional Interest) upon all Notes and the principal of any and all Notes that shall have become due otherwise than by acceleration (with interest on overdue installments
of accrued and unpaid interest (including any accrued and unpaid Additional Interest) (to the extent that payment of such interest is enforceable under applicable law), and on such principal at the rate borne by the Notes at such time) and amounts
due to the Trustee pursuant to Section 6.06, and if (1) rescission would not conflict with any judgment or decree of a court of competent jurisdiction and (2) any and all Events of Defaults under this Indenture, other than the

  
 41 

 
nonpayment of principal of and accrued and unpaid interest (including any accrued and unpaid Additional Interest) on Notes that shall have become due solely by such acceleration, shall have been
cured or waived pursuant to Section 5.09, then and in every such case the holders of a majority in aggregate principal amount of the Notes then outstanding, by written notice to the Company and to the Trustee, may waive all Defaults or Events
of Default with respect to the Notes (other than a Default or an Event of Default resulting from a failure to repurchase any Notes when required upon a Fundamental Change or a failure to deliver, upon conversion, cash, shares of Common Stock or a
combination of cash and shares of Common Stock, as applicable, due upon conversion) and rescind and annul such declaration and its consequences (other than a declaration or consequences, as the case may be, resulting from a failure to repurchase any
Notes when required upon a Fundamental Change or a failure to deliver, upon conversion, cash, shares of Common Stock or a combination of cash and shares of Common Stock, as applicable, due upon conversion) and such Default (other than a Default
resulting from a failure to repurchase any Notes when required upon a Fundamental Change or a failure to deliver, upon conversion, cash, shares of Common Stock or a combination of cash and shares of Common Stock, as applicable, due upon conversion)
shall cease to exist, and any Event of Default arising therefrom (other than a Default resulting from a failure to repurchase any Notes when required upon a Fundamental Change or a failure to deliver, upon conversion, cash, shares of Common Stock or
a combination of cash and shares of Common Stock, as applicable, due upon conversion) shall be deemed to have been cured for every purpose of this Indenture; but no such waiver or rescission and annulment shall extend to or shall affect any
subsequent Default or Event of Default, or shall impair any right consequent thereon. 
 SECTION 5.03 Additional
Interest. Notwithstanding anything in this Indenture or in the Notes to the contrary (except as provided in Section 4.06(d)), if the Company so elects, the sole remedy of Noteholders for an Event of Default relating to any obligation to
file reports as required under Section 4.06(a) shall, for the first 180 days after the occurrence of such an Event of Default (which will be the 60th day after written notice is provided to the Company in accordance with
Section 5.01(e)), consist exclusively of the right to receive Additional Interest on the Notes at an annual rate equal to (x) 0.25% of the outstanding principal amount of the Notes for the first 90 days an Event of Default is
continuing in such 180-day period and (y) 0.50% of the outstanding principal amount of the Notes for the remaining 90 days an Event of Default is continuing in such 180-day period. Additional Interest shall be payable in arrears on each
Interest Payment Date following the occurrence of such Event of Default in the same manner as regular interest on the Notes. The Company may elect to pay Additional Interest as the sole remedy under this Section 5.03 by giving notice to the
holders, the Trustee and Paying Agent of such election on or before the close of business on the 5th Business Day after the date on which such Event of Default otherwise would occur. If the Company fails to timely give such notice or pay Additional
Interest, the Notes will be immediately subject to acceleration as provided in Section 5.02. On the 181st day after such Event of Default (if such violation is not cured or waived prior to such 181st day), the Notes will be subject to
acceleration as provided in Section 5.02. This Section 5.03 shall not affect the rights of the Noteholders in the event of the occurrence of any other Event of Default. In the event the Company does not elect to pay Additional Interest
upon an Event of Default in accordance with this Section, the Notes will be subject to acceleration as provided in Section 5.02. Whenever in this Indenture there is mentioned, in any context, the payment of interest on, or in respect of, any
Note, such mention shall be deemed to include mention of the payment of “Additional Interest” provided for in this 

  
 42 

 
Section 5.03 and Section 4.06 to the extent that, in such context, Additional Interest is, was or would be payable in respect thereof pursuant to the provisions of such sections, and
express mention of the payment of Additional Interest (if applicable) in any provision shall not be construed as excluding Additional Interest in those provisions where such express mention is not made. 

SECTION 5.04 Payments of Notes on Default; Suit Therefor. (a) If an Event of Default under clause (a) or (b) of
Section 5.01 shall have occurred and be continuing, the Company shall, upon demand of the Trustee, pay to it, for the benefit of the holders of the Notes, the whole amount then due and payable on the Notes for principal and interest and
Additional Interest, if any, with interest on any overdue principal, interest and Additional Interest, if any, at the rate borne by the Notes at such time, and, in addition thereto, such further amount as shall be sufficient to cover any amounts due
to the Trustee under Section 6.06. If the Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, may institute a judicial proceeding for the collection of the sums so
due and unpaid, may prosecute such proceeding to judgment or final decree and may enforce the same against the Company or any other obligor upon the Notes and collect the monies adjudged or decreed to be payable in the manner provided by law out of
the property of the Company or any other obligor upon the Notes, wherever situated. 
 (b) In the event there shall be pending
proceedings for the bankruptcy or for the reorganization of the Company or any other obligor on the Notes under any Bankruptcy Law, or in case a receiver, assignee or trustee in bankruptcy or reorganization, liquidator, sequestrator or similar
official shall have been appointed for or taken possession of the Company or such other obligor, the property of the Company or such other obligor, or in the event of any other judicial proceedings relative to the Company or such other obligor upon
the Notes, or to the creditors or property of the Company or such other obligor, the Trustee, irrespective of whether the principal of the Notes shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of
whether the Trustee shall have made any demand pursuant to the provisions of this Section 5.04, shall be entitled and empowered, by intervention in such proceedings or otherwise, to file and prove a claim or claims for the whole amount of
principal and accrued and unpaid interest (including any accrued and unpaid Additional Interest) in respect of the Notes, and, in case of any judicial proceedings, to file such proofs of claim and other papers or documents and to take such other
actions as it may deem necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and of the Noteholders
allowed in such judicial proceedings relative to the Company or any other obligor on the Notes, its or their creditors, or its or their property, and to collect and receive any monies or other property payable or deliverable on any such claims, and
to distribute the same after the deduction of any amounts due the Trustee under Section 6.06; and any receiver, assignee or trustee in bankruptcy or reorganization, liquidator, custodian or similar official is hereby authorized by each of the
Noteholders to make such payments to the Trustee, as administrative expenses, and, in the event that the Trustee shall consent to the making of such payments directly to the Noteholders, to pay to the Trustee any amount due it for reasonable
compensation, expenses, advances and disbursements, including agent’s and counsel fees, and including any other amounts due to the Trustee under Section 6.06 hereof, incurred by it up to the date of such distribution. To the extent that
such payment of reasonable compensation, expenses, advances 

  
 43 

 
and disbursements out of the estate in any such proceedings shall be denied for any reason, payment of the same shall be secured by a lien on, and shall be paid out of, any and all distributions,
dividends, monies, securities and other property that the holders of the Notes may be entitled to receive in such proceedings, whether in liquidation or under any plan of reorganization or arrangement or otherwise. 

(c) Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any
Noteholder any plan of reorganization, arrangement, adjustment or composition affecting the Noteholder or the rights of any Noteholder thereof, or to authorize the Trustee to vote in respect of the claim of any Noteholder in any such proceeding.

 (d) All rights of action and of asserting claims under this Indenture, or under any of the Notes, may be enforced by the
Trustee without the possession of any of the Notes, or the production thereof at any trial or other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own name as trustee of an express
trust, and any recovery of judgment shall, after provision for the payment of the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the holders of the Notes.

 (e) In any proceedings brought by the Trustee (and in any proceedings involving the interpretation of any provision of this
Indenture to which the Trustee shall be a party) the Trustee shall be held to represent all the holders of the Notes, and it shall not be necessary to make any holders of the Notes parties to any such proceedings. 

(f) In case the Trustee shall have proceeded to enforce any right under this Indenture and such proceedings shall have been discontinued
or abandoned because of such waiver or rescission and annulment or for any other reason or shall have been determined adversely to the Trustee, then and in every such case the Company, the Noteholders, and the Trustee shall, subject to any
determination in such proceeding, be restored respectively to their several positions and rights hereunder, and all rights, remedies and powers of the Company, the Noteholders, and the Trustee shall continue as though no such proceeding had been
instituted. 
 SECTION 5.05 Application of Monies Collected by Trustee. Any monies collected by the Trustee pursuant to
this Article 5 with respect to the Notes shall be applied in the order following, at the date or dates fixed by the Trustee for the distribution of such monies, upon presentation of the several Notes, and stamping thereon the payment, if only
partially paid, and upon surrender thereof, if fully paid: 
 First, to the payment of all amounts due the Trustee under
Section 6.06; 
 Second, in case the principal of the outstanding Notes shall not have become due and be unpaid, to the
payment of interest on the Notes (including any Additional Interest) in default, in the order of the date due of the installments of such interest, with interest (to the extent that such interest has been collected by the Trustee) upon the overdue
installments of interest at the rate borne by the Notes at such time, such payments to be made ratably to the Persons entitled thereto; 

  
 44 

 Third, in case the principal of the outstanding Notes shall have become due, by declaration
or otherwise, and be unpaid to the payment of the whole amount including the payment of the Fundamental Change Purchase Price and the cash component of the Conversion Obligation, if any, then owing and unpaid upon the Notes for principal and
interest (including any Additional Interest) with interest on the overdue principal and (to the extent that such interest has been collected by the Trustee) upon overdue installments of interest at the rate borne by the Notes at such time, and in
case such monies shall be insufficient to pay in full the whole amounts so due and unpaid upon the Notes, then to the payment of such principal and interest without preference or priority of principal over interest, or of interest over principal or
of any installment of interest over any other installment of interest, or of any Note over any other Note, ratably to the aggregate of such principal and accrued and unpaid interest (including any accrued and unpaid Additional Interest); and

 Fourth, to the payment of the remainder, if any, to the Company. 

SECTION 5.06 Proceedings by Noteholders. (a) No holder of any Note shall have any right by virtue of or by availing of any
provision of this Indenture to institute any suit, action or proceeding in equity or at law upon or under or with respect to this Indenture, or for the appointment of a receiver, trustee, liquidator, custodian or other similar official, or for any
other remedy hereunder, unless such holder previously shall have given to the Trustee written notice of an Event of Default and of the continuance thereof, as hereinbefore provided, and unless also the holders of not less than 25% in aggregate
principal amount of the Notes then outstanding determined in accordance with Section 7.04 shall have made written request to the Trustee to institute such action, suit or proceeding in its own name as Trustee hereunder and shall have offered to
the Trustee such security or indemnity reasonably satisfactory to it against any loss, liability or expense to be incurred therein or thereby, and the Trustee for sixty days after its receipt of such notice, request and offer of indemnity, shall
have neglected or refused to institute any such action, suit or proceeding and no direction that, in the opinion of the Trustee, is inconsistent with such written request shall have been given to the Trustee by the holders of a majority in principal
amount of the Notes outstanding within such sixty-day period pursuant to Section 5.09; it being understood and intended, and being expressly covenanted by the taker and holder of every Note with every other taker and holder and the Trustee that
no one or more Noteholders shall have any right in any manner whatever by virtue of or by availing of any provision of this Indenture to affect, disturb or prejudice the rights of any other Noteholder, or to obtain or seek to obtain priority over or
preference to any other such holder, or to enforce any right under this Indenture, except in the manner herein provided and for the equal, ratable and common benefit of all Noteholders (except as otherwise provided herein). For the protection and
enforcement of this Section 5.06, each and every Noteholder and the Trustee shall be entitled to such relief as can be given either at law or in equity. 
 (b) Notwithstanding any other provision of this Indenture and any provision of any Note, the right of any Noteholder to receive payment of the principal of (including the consideration due upon conversion
pursuant to Article 12 and the Fundamental Change Purchase Price upon purchase pursuant to Article 11), and accrued and unpaid interest (including any accrued and unpaid Additional Interest) on such Note, on or after the respective due
dates expressed or provided for in such Note or in this Indenture, or to institute suit for the enforcement of any such payment on or after such respective dates against the Company shall not be impaired or affected without the consent of such
Noteholder. 

  
 45 

 (c) Anything in this Indenture or the Notes to the contrary notwithstanding, the holder of
any Note, without the consent of either the Trustee or the holder of any other Note, in its own behalf and for its own benefit, may enforce, and may institute and maintain any proceeding suitable to enforce, its rights of conversion as provided
herein. 
 SECTION 5.07 Proceedings by Trustee. In case of an Event of Default the Trustee may in its discretion proceed
to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as are necessary to protect and enforce any of such rights, either by suit in equity or by action at law or by proceeding in bankruptcy or
otherwise, whether for the specific enforcement of any covenant or agreement contained in this Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by this
Indenture or by law. 
 SECTION 5.08 Remedies Cumulative and Continuing. Except as provided in the second paragraph of
Section 2.07 and Section 5.03, all powers and remedies given by this Article 5 to the Trustee or to the Noteholders shall, to the extent permitted by law, be deemed cumulative and not exclusive of any thereof or of any other powers
and remedies available to the Trustee or the holders of the Notes, by judicial proceedings or otherwise, to enforce the performance or observance of the covenants and agreements contained in this Indenture, and no delay or omission of the Trustee or
of any holder of any of the Notes to exercise any right or power accruing upon any Default or Event of Default shall impair any such right or power, or shall be construed to be a waiver of any such Default or any acquiescence therein; and, subject
to the provisions of Section 5.06, every power and remedy given by this Article 5 or by law to the Trustee or to the Noteholders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the
Noteholders. 
 SECTION 5.09 Direction of Proceedings and Waiver of Defaults by Majority of Noteholders. The holders of a
majority in aggregate principal amount of the Notes at the time outstanding determined in accordance with Section 7.04 shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the
Trustee or exercising any trust or power conferred on the Trustee with respect to Notes; provided, however, that (a) such direction shall not be in conflict with any rule of law or with this Indenture, and (b) the Trustee may take any
other action deemed proper by the Trustee that is not inconsistent with such direction. The Trustee may refuse to follow any direction that it determines is unduly prejudicial to the rights of any other holder or that would involve the Trustee in
personal liability. The holders of a majority in aggregate principal amount of the Notes at the time outstanding determined in accordance with Section 7.04 may on behalf of the holders of all of the Notes waive any past Default or Event of
Default hereunder and its consequences except (i) a default in the payment of accrued and unpaid interest or accrued and unpaid Additional Interest, if any, on, or the principal (including any Fundamental Change Purchase Price) of, the Notes
when due that has not been cured pursuant to the provisions of Section 5.02, (ii) a failure by the Company to deliver any consideration due upon conversion of the Notes or (iii) a default in respect of a covenant or provision hereof
which under Article 9 cannot be modified or amended without the consent of each holder of an outstanding Note affected. Upon any such waiver the 

  
 46 

 
Company, the Trustee and the holders of the Notes shall be restored to their former positions and rights hereunder; but no such waiver shall extend to any subsequent or other Default or Event of
Default or impair any right consequent thereon. Whenever any Default or Event of Default hereunder shall have been waived as permitted by this Section 5.09, said Default or Event of Default shall for all purposes of the Notes and this Indenture
be deemed to have been cured and to be not continuing; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereon. 

SECTION 5.10 Notice of Defaults. The Trustee shall, within ninety days after the occurrence and continuance of a Default of which
a Responsible Officer has actual knowledge, mail to all Noteholders as the names and addresses of such holders appear upon the Note Register, notice of all Defaults known to a Responsible Officer, unless such Defaults shall have been cured or waived
before the giving of such notice; and provided that, except in the case of a Default in the payment of the principal of, accrued and unpaid interest or accrued and unpaid Additional Interest, if any, on any of the Notes, including without
limiting the generality of the foregoing any Default in the payment of any Fundamental Change Purchase Price, then in any such event the Trustee shall be protected in withholding such notice if and so long as a committee of Responsible Officers of
the Trustee in good faith determine that the withholding of such notice is in the interests of the Noteholders. 
 SECTION 5.11
Undertaking to Pay Costs. All parties to this Indenture agree, and each holder of any Note by its acceptance thereof shall be deemed to have agreed, that any court may, in its discretion, require, in any suit for the enforcement of any right
or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit and that such court may in its
discretion assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; provided that
the provisions of this Section 5.11 (to the extent permitted by law) shall not apply to any suit instituted by the Trustee, to any suit instituted by any Noteholder, or group of Noteholders, holding in the aggregate more than 10% in aggregate
principal amount of the Notes at the time outstanding determined in accordance with Section 7.04, or to any suit instituted by any Noteholder for the enforcement of the payment of the principal of accrued and unpaid interest or accrued and
unpaid Additional Interest, if any, on any Note (including, but not limited to, the Fundamental Change Purchase Price with respect to the Notes being repurchased as provided in this Indenture) on or after the due date expressed or provided for in
such Note or to any suit for the enforcement of the right to convert any Note in accordance with the provisions of Article 12. 
 ARTICLE VI 
 CONCERNING THE TRUSTEE 

SECTION 6.01 Duties and Responsibilities of Trustee. The Trustee, prior to the occurrence of an Event of Default and after the
curing or waiver of all Events of Default that may have occurred, undertakes to perform such duties and only such duties as are specifically set forth in this Indenture. In case an Event of Default has occurred (which has not been cured or waived)
the Trustee shall exercise such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in their exercise, as a prudent person would exercise or 

  
 47 

 
use under the circumstances in the conduct of such person’s own affairs; provided that if an Event of Default occurs and is continuing, the Trustee will be under no obligation to exercise
any of the rights or powers under this Indenture at the request or direction of any of the holders unless such holders have offered to the Trustee reasonable indemnity or security against the costs, expenses and liabilities that might be incurred by
it in compliance with such request or direction. 
 No provision of this Indenture shall be construed to relieve the Trustee
from liability for its own grossly negligent action, its own grossly negligent failure to act or its own willful misconduct, except that 
 (a) prior to the occurrence of an Event of Default and after the curing or waiving of all Events of Default that may have occurred: 

(i) the duties and obligations of the Trustee shall be determined solely by the express provisions of this Indenture and,
if applicable, after it has been qualified thereunder, the Trust Indenture Act, and the Trustee shall not be liable except for the performance of such duties and obligations as are specifically set forth in this Indenture and no implied covenants or
obligations shall be read into this Indenture and the Trust Indenture Act against the Trustee; and 
 (ii) in the
absence of bad faith or willful misconduct on the part of the Trustee, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions furnished to the
Trustee and conforming to the requirements of this Indenture; but, in the case of any such certificates or opinions that by any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine
the same to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of any mathematical calculations or other facts stated therein); 

(b) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer or Officers of the Trustee,
unless it shall be proved that the Trustee was grossly negligent in ascertaining the pertinent facts; 
 (c) the Trustee shall
not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the holders of not less than a majority in principal amount of the Notes at the time outstanding determined as provided in
Section 7.04 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this Indenture; 

(d) whether or not therein provided, every provision of this Indenture relating to the conduct or affecting the liability of, or
affording protection to, the Trustee shall be subject to the provisions of this Section 6.01; 
 (e) the Trustee shall not
be liable in respect of any payment (as to the correctness of amount, entitlement to receive or any other matters relating to payment) or notice effected by the Company or any Paying Agent or any records maintained by any co-registrar with respect
to the Notes; 

  
 48 

 (f) if any party fails to deliver a notice relating to an event the fact of which, pursuant
to this Indenture, requires notice to be sent to the Trustee, the Trustee may conclusively rely on its failure to receive such notice as reason to act as if no such event occurred, unless such Responsible Officer of the Trustee had actual knowledge
of such event; 
 (g) in the absence of written investment direction from the Company, all cash received by the Trustee shall be
placed in a non-interest bearing trust account, and in no event shall the Trustee be liable for the selection of investments or for investment losses incurred thereon or for losses incurred as a result of the liquidation of any such investment prior
to its maturity date or the failure of the party directing such investments prior to its maturity date or the failure of the party directing such investment to provide timely written investment direction, and the Trustee shall have no obligation to
invest or reinvest any amounts held hereunder in the absence of such written investment direction from the Company; and 
 (h)
in the event that the Trustee is also acting as Custodian, Note Registrar, Paying Agent, Conversion Agent or transfer agent hereunder, the rights and protections afforded to the Trustee pursuant to this Article 6 shall also be afforded to such
Custodian, Note Registrar, Paying Agent, Conversion Agent or transfer agent. 
 None of the provisions contained in this
Indenture shall require the Trustee to expend or risk its own funds or otherwise incur personal financial liability in the performance of any of its duties or in the exercise of any of its rights or powers. 

SECTION 6.02 Reliance on Documents, Opinions, Etc. Except as otherwise provided in Section 6.01: 

(a) the Trustee may conclusively rely and shall be fully protected in acting upon any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, order, bond, note, coupon or other paper or document believed by it in good faith to be genuine and to have been signed or presented by the proper party or parties; 

(b) any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by an
Officers’ Certificate (unless other evidence in respect thereof be herein specifically prescribed); and any Board Resolution may be evidenced to the Trustee by a copy thereof certified by the Secretary or an Assistant Secretary of the Company;

 (c) the Trustee may consult with counsel and require an Opinion of Counsel and any advice of such counsel or
Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken or omitted by it hereunder in good faith and in accordance with such advice or Opinion of Counsel; 

  
 49 

 (d) the Trustee shall not be bound to make any investigation into the facts
or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture or other paper or document, but the Trustee, in its discretion, may make such further inquiry or
investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled, at a reasonable time on any Business Day, to examine the books, records and premises
of the Company, personally or by agent or attorney at the expense of the Company and shall incur no liability of any kind by reason of such inquiry or investigation; 

(e) the Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or
through agents, custodians, nominees or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent, custodian, nominee or attorney appointed by it with due care hereunder; and 

(f) the permissive rights of the Trustee enumerated herein shall not be construed as duties. 

The Trustee may request that the Company deliver an Officers’ Certificate setting forth the name of the individuals and/or titles of
Officers authorized at such time to take specific actions pursuant to this Indenture, which Officers’ Certificate may be signed by any Person authorized to sign an Officers’ Certificate, including any person specified as so authorized in
any such Officers’ Certificate previously delivered and not superseded. 
 The rights, privileges, protections, immunities
and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act
hereunder. 
 In no event shall the Trustee be liable for any consequential loss or damage of any kind whatsoever (including but
not limited to lost profits), even if the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action. The Trustee shall not be charged with knowledge of any Default or Event of Default with respect to the
Notes, unless either (1) a Responsible Officer shall have actual knowledge of such Default or Event of Default or (2) written notice of such Default or Event of Default shall have been given to a Responsible Officer of the Trustee by the
Company or by any holder of the Notes. 
 SECTION 6.03 No Responsibility for Recitals, Etc. The recitals contained herein
and in the Notes (except in the Trustee’s certificate of authentication) shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness of the same. The Trustee makes no representations as to the
validity or sufficiency of this Indenture or of the Notes. The Trustee shall not be accountable for the use or application by the Company of any Notes or the proceeds of any Notes authenticated and delivered by the Trustee in conformity with the
provisions of this Indenture. 
 SECTION 6.04 Trustee, Paying Agents, Conversion Agents or Registrar May Own Notes. The
Trustee, any Paying Agent, any Conversion Agent or Note Registrar, in its individual or any other capacity, may become the owner or pledgee of Notes with the same rights it would have if it were not the Trustee, Paying Agent, Conversion Agent or
Note Registrar. 

  
 50 

 SECTION 6.05 Monies to Be Held in Trust. All monies received by the Trustee shall,
until used or applied as herein provided, be held in trust for the purposes for which they were received. Money held by the Trustee in trust hereunder need not be segregated from other funds except to the extent required by law. The Trustee shall be
under no liability for interest on any money received by it hereunder except as may be agreed from time to time by the Company and the Trustee. 
 SECTION 6.06 Compensation and Expenses of Trustee. The Company covenants and agrees to pay to the Trustee from time to time, and the Trustee shall be entitled to, reasonable compensation for all
services rendered by it hereunder in any capacity (which shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust) as mutually agreed to in writing between the Trustee and the Company, and the
Company will pay or reimburse the Trustee upon its request for all reasonable expenses, disbursements and advances reasonably incurred or made by the Trustee in accordance with any of the provisions of this Indenture in any capacity hereunder
(including the reasonable compensation and the expenses and disbursements of its agents and counsel and of all Persons not regularly in its employ) except any such expense, disbursement or advance as shall have been caused by its gross negligence,
willful misconduct or bad faith. The Company also covenants to indemnify the Trustee in any capacity under this Indenture and any other document or transaction entered into in connection herewith and its agents and any authenticating agent for, and
to hold them harmless against, any loss, claim, damage, liability or expense incurred without gross negligence, willful misconduct or bad faith on the part of the Trustee, its officers, directors, agents or employees, or such agent or authenticating
agent, as the case may be, and arising out of or in connection with the acceptance or administration of this trust or in any other capacity hereunder, including the costs and expenses of defending themselves against any claim of liability in the
premises. The obligations of the Company under this Section 6.06 to compensate or indemnify the Trustee and to pay or reimburse the Trustee for expenses, disbursements and advances shall be secured (subject to Section 14.07 below) by a
senior claim to which the Notes are hereby made subordinate on all money or property held or collected by the Trustee, except, subject to the effect of Section 5.05, funds held in trust herewith for the benefit of the holders of particular
Notes. The obligation of the Company under this Section 6.06 shall survive the satisfaction and discharge of this Indenture and the earlier resignation or removal or the Trustee. The Company need not pay for any settlement made without its
consent, which consent shall not be unreasonably withheld. The indemnification provided in this Section 6.06 shall extend to the officers, directors, agents and employees of the Trustee and shall survive the termination of this Indenture and
the resignation or removal of the Trustee. 
 Without prejudice to any other rights available to the Trustee under applicable
law, when the Trustee and its agents and any authenticating agent incur expenses or render services after an Event of Default specified in Section 5.01(h) occurs, the expenses and the compensation for the services are intended to constitute
expenses of administration under any bankruptcy, insolvency or similar laws. 
 SECTION 6.07 Officers’ Certificate as
Evidence. Except as otherwise provided in Section 6.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or omitting
any action hereunder, such matter (unless other evidence in respect thereof be herein 

  
 51 

 
specifically prescribed) may, in the absence of gross negligence, willful misconduct or bad faith on the part of the Trustee, be deemed to be conclusively proved and established by an
Officers’ Certificate delivered to the Trustee, and such Officers’ Certificate, in the absence of gross negligence, willful misconduct or bad faith on the part of the Trustee, shall be full warrant to the Trustee for any action taken or
omitted by it under the provisions of this Indenture upon the faith thereof. 
 SECTION 6.08 Conflicting Interests of
Trustee. After qualification of this Indenture under the Trust Indenture Act (if applicable), if the Trustee has or shall acquire a conflicting interest within the meaning of the Trust Indenture Act, the Trustee shall either (a) eliminate
such interest within ninety days, (b) apply to the Commission for permission to continue as Trustee or (c) resign, to the extent and in the manner provided by, and subject to the provisions of, the Trust Indenture Act and this Indenture.

 SECTION 6.09 Eligibility of Trustee. There shall at all times be a Trustee hereunder which shall be a Person that is
eligible pursuant to the Trust Indenture Act to act as such and has a combined capital and surplus of at least $50,000,000. If such Person publishes reports of condition at least annually, pursuant to law or to the requirements of any supervising or
examining authority, then for the purposes of this Section 6.09, the combined capital and surplus of such Person shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. If at any
time the Trustee shall cease to be eligible in accordance with the provisions of this Section 6.09, it shall resign immediately in the manner and with the effect hereinafter specified in this Article. 

SECTION 6.10 Resignation or Removal of Trustee. 
 (a) The Trustee may at any time resign by giving written notice of such resignation to the Company and by mailing notice thereof to the Noteholders at their addresses as they shall appear on the Note
Register. Upon receiving such notice of resignation, the Company shall promptly appoint a successor trustee by written instrument, in duplicate, executed by order of the Board of Directors, one copy of which instrument shall be delivered to the
resigning Trustee and one copy to the successor trustee. If no successor trustee shall have been so appointed and have accepted appointment within sixty days after the mailing of such notice of resignation to the Noteholders, the resigning Trustee
may, at the expense of the Company, petition any court of competent jurisdiction for the appointment of a successor trustee, or any Noteholder who has been a bona fide holder of a Note or Notes for at least six months may, subject to the
provisions of Section 5.11, on behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such court may thereupon, after such notice, if any, as it may deem proper and prescribe,
appoint a successor trustee. 
 (b) In case at any time any of the following shall occur: 

(i) the Trustee shall fail to comply with Section 6.08 within a reasonable time after written request therefor by the
Company or by any Noteholder who has been a bona fide holder of a Note or Notes for at least six months, or 

  
 52 

 (ii) the Trustee shall cease to be eligible in accordance with the
provisions of Section 6.09 and shall fail to resign after written request therefor by the Company or by any such Noteholder, or 
 (iii) the Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or a receiver of the Trustee or of its property shall be appointed, or any public officer shall take
charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation, 
 then, in any
such case, the Company may by a Board Resolution remove the Trustee and appoint a successor trustee by written instrument, in duplicate, executed by order of the Board of Directors, one copy of which instrument shall be delivered to the Trustee so
removed and one copy to the successor trustee, or, subject to the provisions of Section 5.11, any Noteholder who has been a bona fide holder of a Note or Notes for at least six months may, on behalf of himself and all others similarly
situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee. Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, remove the Trustee and
appoint a successor trustee. 
 (c) The holders of a majority in aggregate principal amount of the Notes at the time
outstanding, as determined in accordance with Section 7.04, may at any time remove the Trustee and nominate a successor trustee that shall be deemed appointed as successor trustee unless within ten days after notice to the Company of such
nomination the Company objects thereto, in which case the Trustee so removed or any Noteholder, upon the terms and conditions and otherwise as in Section 6.10(a) provided, may petition any court of competent jurisdiction for an appointment of a
successor trustee. 
 (d) Any resignation or removal of the Trustee and appointment of a successor trustee pursuant to any of
the provisions of this Section 6.10 shall become effective upon acceptance of appointment by the successor trustee as provided in Section 6.11. 
 SECTION 6.11 Acceptance by Successor Trustee. Any successor trustee appointed as provided in Section 6.10 shall execute, acknowledge and deliver to the Company and to its predecessor trustee
an instrument accepting such appointment hereunder, and thereupon the resignation or removal of the predecessor trustee shall become effective and such successor trustee, without any further act, deed or conveyance, shall become vested with all the
rights, powers, duties and obligations of its predecessor hereunder, with like effect as if originally named as trustee herein; but, nevertheless, on the written request of the Company or of the successor trustee, the trustee ceasing to act shall,
upon payment of any amounts then due it pursuant to the provisions of Section 6.06, execute and deliver an instrument transferring to such successor trustee all the rights and powers of the trustee so ceasing to act. 

Upon request of any such successor trustee, the Company shall execute any and all instruments in writing for more fully and certainly
vesting in and confirming to such successor trustee all such rights and powers. Any trustee ceasing to act shall, nevertheless, retain a senior claim to which the Notes are hereby made subordinate on all money or property held or collected by such
trustee as such, except for funds held in trust for the benefit of holders of particular Notes, to secure any amounts then due it pursuant to the provisions of Section 6.06, subject to Section 14.07 below. 

  
 53 

 No successor trustee shall accept appointment as provided in this Section 6.11 unless
at the time of such acceptance such successor trustee shall be qualified under the provisions of Section 6.08 and be eligible under the provisions of Section 6.09. 
 Upon acceptance of appointment by a successor trustee as provided in this Section 6.11, each of the Company and the successor trustee, at the written direction and at the expense of the Company,
shall mail or cause to be mailed notice of the succession of such trustee hereunder to the Noteholders at their addresses as they shall appear on the Note Register. If the Company fails to mail such notice within ten days after acceptance of
appointment by the successor trustee, the successor trustee shall cause such notice to be mailed at the expense of the Company. 

SECTION 6.12 Succession by Merger, Etc. Any corporation or other entity into which the Trustee may be merged or converted or with
which it may be consolidated, or any corporation or other entity resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation or other entity succeeding to all or substantially all of the corporate
trust business of the Trustee (including the administration of this Indenture), shall be the successor to the Trustee hereunder without the execution or filing of any paper or any further act on the part of any of the parties hereto, provided that
in the case of any corporation or other entity succeeding to all or substantially all of the corporate trust business of the Trustee, such corporation or other entity shall be qualified under the provisions of Section 6.08 and eligible under
the provisions of Section 6.09. 
 In case at the time such successor to the Trustee shall succeed to the trusts created by
this Indenture, any of the Notes shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee or authenticating agent appointed by such predecessor trustee,
and deliver such Notes so authenticated; and in case at that time any of the Notes shall not have been authenticated, any successor to the Trustee or an authenticating agent appointed by such successor trustee may authenticate such Notes either in
the name of any predecessor trustee hereunder or in the name of the successor trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Notes or in this Indenture provided that the certificate of the
Trustee shall have; provided, however, that the right to adopt the certificate of authentication of any predecessor Trustee or to authenticate Notes in the name of any predecessor Trustee shall apply only to its successor or successors by merger,
conversion or consolidation. 
 SECTION 6.13 Limitation on Rights of Trustee as Creditor. If and when the Trustee shall
be or become a creditor of the Company (or any other obligor upon the Notes), after qualification under the Trust Indenture Act (if applicable), the Trustee shall be subject to the provisions of the Trust Indenture Act regarding the collection of
the claims against the Company (or any such other obligor). 

  
 54 

 SECTION 6.14 Trustee’s Application for Instructions from the Company. Any
application by the Trustee for written instructions from the Company (other than with regard to any action proposed to be taken or omitted to be taken by the Trustee that affects the rights of the holders of the Notes under this Indenture) may, at
the option of the Trustee, set forth in writing any action proposed to be taken or omitted by the Trustee under this Indenture and the date on and/or after which such action shall be taken or such omission shall be effective. The Trustee shall not
be liable for any action taken by, or omission of, the Trustee in accordance with a proposal included in such application on or after the date specified in such application (which date shall not be less than three Business Days after the date any
officer that the Company has indicated to the Trustee should receive such application actually receives such application, unless any such officer shall have consented in writing to any earlier date), unless, prior to taking any such action (or the
effective date in the case of any omission), the Trustee shall have received written instructions in accordance with this Indenture in response to such application specifying the action to be taken or omitted. 

SECTION 6.15 Lists of Noteholders. The Company covenants and agrees that it will furnish or cause to be furnished to the Trustee,
semi-annually, not more than fifteen days after each May 1 and November 1 in each year, beginning with May 1, 2011, and at such other times as the Trustee may request in writing, within thirty days after receipt by the Company of any
such request (or such lesser time as the Trustee may reasonably request in order to enable it to timely provide any notice to be provided by it hereunder), a list in such form as the Trustee may reasonably require of the names and addresses of the
Noteholders as of a date not more than fifteen days (or such other date as the Trustee may reasonably request in order to so provide any such notices) prior to the time such information is furnished, except that no such list need be furnished so
long as the Trustee is acting as Note Registrar. 
 SECTION 6.16 Preservation and Disclosure of Lists. 

(a) The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses of the
Noteholders contained in the most recent list furnished to it as provided in Section 6.15 or maintained by the Trustee in its capacity as Note Registrar, if so acting. The Trustee may destroy any list furnished to it as provided in
Section 6.16 upon receipt of a new list so furnished. 
 (b) The rights of Noteholders to communicate with other
Noteholders with respect to their rights under this Indenture or under the Notes and the corresponding rights and duties of the Trustee, shall be as provided by the Trust Indenture Act. 

(c) Every Noteholder, by receiving and holding the same, agrees with the Company and the Trustee that neither the Company nor the Trustee
nor any agent of either of them shall be held accountable by reason of any disclosure of information as to names and addresses of Noteholders made pursuant to the Trust Indenture Act. 

SECTION 6.17 Reports by Trustee. 
 (a) The Trustee shall transmit to holders such reports concerning the Trustee and its actions under this Indenture as may be required pursuant to the Trust Indenture Act at the times and in the manner
provided pursuant thereto. If required by Section 313(a) of the Trust Indenture Act, the Trustee shall, within sixty days after each February 15 following the date of this Indenture, deliver to holders a brief report, dated as of such
February 15, that complies with the provisions of such Section 313(a). 

  
 55 

 (b) A copy of each such report shall, at the time of such transmission to Noteholders, be
filed by the Trustee with each stock exchange and automated quotation system upon which the Notes are listed and with the Company. The Company will notify the Trustee in writing within a reasonable time when the Notes are listed on any stock
exchange or automated quotation system and when any such listing is discontinued. 
 ARTICLE VII 

CONCERNING THE NOTEHOLDERS 
 SECTION 7.01 Action by Noteholders. Whenever in this Indenture it is provided that the holders of a specified percentage in aggregate principal amount of the Notes may take any action (including
the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action, the holders of such specified percentage have joined therein may be evidenced
(a) by any instrument or any number of instruments of similar tenor executed by Noteholders in person or by agent or proxy appointed in writing, or (b) by the record of the Noteholders voting in favor thereof at any meeting of Noteholders
duly called and held in accordance with the provisions of Article 8, or (c) by a combination of such instrument or instruments and any such record of such a meeting of Noteholders. Whenever the Company or the Trustee solicits the taking of
any action by the holders of the Notes, the Company or the Trustee may, but shall not be required to, fix in advance of such solicitation, a date as the record date for determining Noteholders entitled to take such action. The record date if one is
selected shall be not more than fifteen days prior to the date of commencement of solicitation of such action. 
 SECTION 7.02
Proof of Execution by Noteholders. Subject to the provisions of Section 6.01, Section 6.02 and Section 8.05, proof of the execution of any instrument by a Noteholder or its agent or proxy shall be sufficient if made in
accordance with such reasonable rules and regulations as may be prescribed by the Trustee or in such manner as shall be satisfactory to the Trustee. The holding of Notes shall be proved by the Note Register or by a certificate of the Note Registrar.
The record of any Noteholders’ meeting shall be proved in the manner provided in Section 8.06. 
 SECTION 7.03 Who
Are Deemed Absolute Owners. The Company, the Trustee, any authenticating agent, any Paying Agent, any Conversion Agent and any Note Registrar may deem the Person in whose name a Note shall be registered upon the Note Register to be, and may
treat it as, the absolute owner of such Note (whether or not such Note shall be overdue and notwithstanding any notation of ownership or other writing thereon made by any Person other than the Company or any Note Registrar) for the purpose of
receiving payment of or on account of the principal of (including the payment of the Fundamental Change Purchase Price), and (subject to Section 4.01(d)) accrued and unpaid interest (including any accrued and unpaid Additional Interest) on such
Note, for conversion of such Note and for all other purposes; and neither the Company nor the Trustee nor any Paying Agent nor any Conversion Agent nor any Note Registrar shall be affected by any notice to the contrary. All such payments so made to
any holder for the time being, or upon its order, shall be valid and, to the extent of the sum or 

  
 56 

 
sums so paid, effectual to satisfy and discharge the liability for monies payable upon any such Note. Notwithstanding anything to the contrary in this Indenture or the Notes following an Event of
Default, any holder of a beneficial interest in a Global Note may directly enforce against the Company, without the consent, solicitation, proxy, authorization or any other action of the Depositary or any other Person, such holder’s right to
exchange such beneficial interest for a Note in certificated form in accordance with the provisions of this Indenture. 

SECTION 7.04 Company-Owned Notes Disregarded. In determining whether the holders of the requisite aggregate principal amount of
Notes have concurred in any direction, consent, waiver or other action under this Indenture, Notes that are owned by the Company or by any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the
Company shall be disregarded and deemed not to be outstanding for the purpose of any such determination; provided that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, consent, waiver or other
action only Notes that a Responsible Officer knows are so owned shall be so disregarded. Notes so owned that have been pledged in good faith may be regarded as outstanding for the purposes of this Section 7.04 if the pledgee shall establish to
the satisfaction of the Trustee the pledgee’s right to so act with respect to such Notes and that the pledgee is not the Company or a Person directly or indirectly controlling or controlled by or under direct or indirect common control with the
Company. In the case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full protection to the Trustee. Upon request of the Trustee, the Company shall furnish to the Trustee promptly an
Officers’ Certificate listing and identifying all Notes, if any, known by the Company to be owned or held by or for the account of any of the above described Persons; and, subject to Section 6.01, the Trustee shall be entitled to accept
such Officers’ Certificate as conclusive evidence of the facts therein set forth and of the fact that all Notes not listed therein are outstanding for the purpose of any such determination. 

SECTION 7.05 Revocation of Consents; Future Noteholders Bound. At any time prior to (but not after) the evidencing to the Trustee,
as provided in Section 7.01, of the taking of any action by the holders of the percentage in aggregate principal amount of the Notes specified in this Indenture in connection with such action, any holder of a Note that is shown by the evidence
to be included in the Notes the holders of which have consented to such action may, by filing written notice with the Trustee at its Corporate Trust Office and upon proof of holding as provided in Section 7.02, revoke such action so far as
concerns such Note. Except as aforesaid, any such action taken by the holder of any Note shall be conclusive and binding upon such holder and upon all future holders and owners of such Note and of any Notes issued in exchange or substitution
therefor or upon registration of transfer thereof, irrespective of whether any notation in regard thereto is made upon such Note or any Note issued in exchange or substitution therefor or upon registration of transfer thereof. 

  
 57 

 ARTICLE VIII 
 NOTEHOLDERS’ MEETINGS 
 SECTION 8.01 Purpose of Meetings. A
meeting of Noteholders may be called at any time and from time to time pursuant to the provisions of this Article 8 for any of the following purposes: 
 (a) to give any notice to the Company or to the Trustee or to give any directions to the Trustee permitted under this Indenture, or to consent to the waiving of any Default or Event of Default hereunder
and its consequences, or to take any other action authorized to be taken by Noteholders pursuant to any of the provisions of Article 5; 
 (b) to remove the Trustee and nominate a successor trustee pursuant to the provisions of Article 6; 
 (c) to consent to the execution of an indenture or indentures supplemental hereto pursuant to the provisions of Section 9.02; or 

(d) to take any other action authorized to be taken by or on behalf of the holders of any specified aggregate principal
amount of the Notes under any other provision of this Indenture or under applicable law. 
 SECTION 8.02 Call of Meetings by
Trustee. The Trustee may at any time call a meeting of Noteholders to take any action specified in Section 8.01, to be held at such time and at such place as the Trustee shall determine. Notice of every meeting of the Noteholders, setting
forth the time and the place of such meeting and in general terms the action proposed to be taken at such meeting and the establishment of any record date pursuant to Section 7.01, shall be mailed to holders of such Notes at their addresses as
they shall appear on the Note Register. Such notice shall also be mailed to the Company. Such notices shall be mailed not less than twenty nor more than ninety days prior to the date fixed for the meeting. 

Any meeting of Noteholders shall be valid without notice if the holders of all Notes then outstanding are present in person or by proxy
or if notice is waived before or after the meeting by the holders of all Notes outstanding, and if the Company and the Trustee are either present by duly authorized representatives or have, before or after the meeting, waived notice. 

SECTION 8.03 Call of Meetings by Company or Noteholders. In case at any time the Company, pursuant to a Board Resolution, or the
holders of at least 10% in aggregate principal amount of the Notes then outstanding (for the avoidance of doubt, excluding those Notes identified in Section 7.04), shall have requested the Trustee to call a meeting of Noteholders, by written
request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee shall not have mailed the notice of such meeting within twenty days after receipt of such request, then the Company or such Noteholders may
determine the time and the place for such meeting and may call such meeting to take any action authorized in Section 8.01, by mailing notice thereof as provided in Section 8.02. 

SECTION 8.04 Qualifications for Voting. To be entitled to vote at any meeting of Noteholders a Person shall (a) be a holder
of one or more Notes on the record date pertaining to such meeting or (b) be a Person appointed by an instrument in writing as proxy by a holder of one or more Notes on the record date pertaining to such meeting. The only Persons who shall be
entitled to be present or to speak at any meeting of Noteholders shall be the Persons entitled to vote at such meeting and their counsel and any representatives of the Trustee and its counsel and any representatives of the Company and its counsel.

  
 58 

 SECTION 8.05 Regulations. Notwithstanding any other provisions of this Indenture, the
Trustee may make such reasonable regulations as it may deem advisable for any meeting of Noteholders, in regard to proof of the holding of Notes and of the appointment of proxies, and in regard to the appointment and duties of inspectors of votes,
the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct of the meeting as it shall think fit. 

The Trustee shall, by an instrument in writing, appoint a temporary chairman of the meeting, unless the meeting shall have been called by
the Company or by Noteholders as provided in Section 8.03, in which case the Company or the Noteholders calling the meeting, as the case may be, shall in like manner appoint a temporary chairman. A permanent chairman and a permanent secretary
of the meeting shall be elected by vote of the holders of a majority in principal amount of the Notes represented at the meeting and entitled to vote at the meeting. 
 Subject to the provisions of Section 7.04, at any meeting of Noteholders each Noteholder or proxyholder shall be entitled to one vote for each $1,000 principal amount of Notes held or represented by
him; provided, however, that no vote shall be cast or counted at any meeting in respect of any Note challenged as not outstanding and ruled by the chairman of the meeting to be not outstanding. The chairman of the meeting shall have no right to vote
other than by virtue of Notes held by it or instruments in writing as aforesaid duly designating it as the proxy to vote on behalf of other Noteholders. Any meeting of Noteholders duly called pursuant to the provisions of Section 8.02 or
Section 8.03 may be adjourned from time to time by the holders of a majority of the aggregate principal amount of Notes represented at the meeting, whether or not constituting a quorum, and the meeting may be held as so adjourned without
further notice. 
 SECTION 8.06 Voting. The vote upon any resolution submitted to any meeting of Noteholders shall be by
written ballot on which shall be subscribed the signatures of the Noteholders or of their representatives by proxy and the outstanding principal amount of the Notes held or represented by them. The permanent chairman of the meeting shall appoint two
inspectors of votes who shall count all votes cast at the meeting for or against any resolution and who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting. A record in
duplicate of the proceedings of each meeting of Noteholders shall be prepared by the secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and
affidavits by one or more Persons having knowledge of the facts setting forth a copy of the notice of the meeting and showing that said notice was mailed as provided in Section 8.02. The record shall show the principal amount of the Notes
voting in favor of or against any resolution. The record shall be signed and verified by the affidavits of the permanent chairman and secretary of the meeting and one of the duplicates shall be delivered to the Company and the other to the Trustee
to be preserved by the Trustee, the latter to have attached thereto the ballots voted at the meeting. 
 Any record so signed
and verified shall be conclusive evidence of the matters therein stated. 

  
 59 

 SECTION 8.07 No Delay of Rights by Meeting. Nothing contained in this Article 8
shall be deemed or construed to authorize or permit, by reason of any call of a meeting of Noteholders or any rights expressly or impliedly conferred hereunder to make such call, any hindrance or delay in the exercise of any right or rights
conferred upon or reserved to the Trustee or to the Noteholders under any of the provisions of this Indenture or of the Notes. 

ARTICLE IX 

SUPPLEMENTAL INDENTURES 
 SECTION 9.01 Supplemental Indentures Without Consent of Noteholders. The Company and the Trustee, at the Company’s expense, may from time to time and at any time enter into an indenture or
indentures supplemental hereto for one or more of the following purposes: 
 (a) to cure any ambiguity, omission,
defect or inconsistency in this Indenture or the Notes; 
 (b) to conform the terms of the Indenture or the Notes
to the description thereof in the Offering Memorandum; 
 (c) to provide for the assumption by a Successor
Company of the obligations of the Company under this Indenture pursuant to Article 10; 
 (d) to add
guarantees with respect to the Notes; 
 (e) to secure the Notes; 

(f) to add to the covenants of the Company further covenants, restrictions or conditions for the benefit of the
Noteholders or surrender any right or power conferred upon the Company; 
 (g) to make any change that does not
materially adversely affect the rights of any holder; 
 (h) to appoint a successor Trustee with respect to the
Notes; or 
 (i) to comply with any requirements of the Commission in connection with the qualification of this
Indenture under the Trust Indenture Act. 
 Upon the written request of the Company, the Trustee is hereby authorized to join
with the Company in the execution of any such supplemental indenture, to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to, but may in its discretion, enter into any
supplemental indenture that affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise. 

Any supplemental indenture authorized by the provisions of this Section 9.01 may be executed by the Company and the Trustee without
the consent of the holders of any of the Notes at the time outstanding, notwithstanding any of the provisions of Section 9.02. 

  
 60 

 SECTION 9.02 Supplemental Indentures With Consent of Noteholders. With the consent
(evidenced as provided in Article 7) of the holders of at least a majority in aggregate principal amount of the Notes at the time outstanding (determined in accordance with Article 7 and including, without limitation, consents obtained in
connection with a purchase of, or tender offer or exchange offer for, Notes), the Company, when authorized by the resolutions of the Board of Directors, and the Trustee, at the Company’s expense, may from time to time and at any time enter into
an indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or any supplemental indenture or of modifying in any manner the rights of the
holders of the Notes or waiving any past default; provided, however, that no such supplemental indenture shall: 
 (a) reduce the percentage in aggregate principal amount of Notes outstanding necessary to modify or amend this Indenture or to waive any past Default or Event of Default; 

(b) reduce the rate or extend the stated time for payment of interest (including any Additional Interest), on any Note;

 (c) reduce the principal amount of, or change the Maturity Date of, any Note; 

(d) make any change that impairs or adversely affects the conversion rights of any Notes; 

(e) reduce the Fundamental Change Purchase Price of any Note or amend or modify in any manner adverse to the holders of
the Notes the Company’s obligation to make such payment, whether through an amendment or waiver of provisions in the covenants, definitions or otherwise; 
 (f) make any Note payable in a currency other than that stated in the Note; 
 (g) change the ranking of the Notes; 
 (h) impair the right of any
holder to receive payment of principal of and interest (including any Additional Interest) on such holder’s Notes on or after the due dates therefor or to institute suit for the enforcement of any payment on or with respect to such
holder’s Note; 
 (i) make any change in this Article 9 that requires each holder’s consent or in
the waiver provisions in Section 5.01 or Section 5.09; or 
 (j) reduce the quorum or voting
requirements under this Indenture, 
 in each case without the consent of each holder of an outstanding Note affected. 

Upon the written request of the Company, and upon the filing with the Trustee of evidence of the consent of Noteholders as aforesaid and
subject to Section 9.05, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise,
in which case the Trustee may in its discretion, but shall not be obligated to, enter into such supplemental indenture. 

  
 61 

 It shall not be necessary for the consent of the Noteholders under this Section 9.02 to
approve the particular form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof. After an amendment under this Indenture becomes effective, the Company shall mail to the holders a
notice briefly describing such amendment. However, the failure to give such notice to all the holders, or any defect in the notice, will not impair or affect the validity of the amendment. 

SECTION 9.03 Effect of Supplemental Indentures. Any supplemental indenture executed pursuant to the provisions of this
Article 9 shall comply with the Trust Indenture Act, as then in effect; provided that this Section 9.03 shall not require such supplemental indenture to be qualified under the Trust Indenture Act prior to the time such qualification is in
fact required under the terms of the Trust Indenture Act or this Indenture has been qualified under the Trust Indenture Act, nor shall any such qualification constitute any admission or acknowledgment by any party to such supplemental indenture that
any such qualification is required prior to the time such qualification is in fact required under the terms of the Trust Indenture Act or this Indenture has been qualified under the Trust Indenture Act. Upon the execution of any supplemental
indenture pursuant to the provisions of this Article 9, this Indenture shall be and be deemed to be modified and amended in accordance therewith and the respective rights, limitation of rights, obligations, duties and immunities under this
Indenture of the Trustee, the Company and the Noteholders shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments and all the terms and conditions of any such supplemental
indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes. 
 SECTION
9.04 Notation on Notes. Notes authenticated and delivered after the execution of any supplemental indenture pursuant to the provisions of this Article 9 may, at the Company’s expense, bear a notation as to any matter provided for in
such supplemental indenture. If the Company shall so determine, new Notes so modified as to conform, in the opinion of the Board of Directors, to any modification of this Indenture contained in any such supplemental indenture may, at the
Company’s expense, be prepared and executed by the Company, authenticated by the Trustee (or an authenticating agent duly appointed by the Trustee pursuant to Section 14.11) and delivered in exchange for the Notes then outstanding, upon
surrender of such Notes then outstanding. 
 SECTION 9.05 Evidence of Compliance of Supplemental Indenture to Be Furnished to
Trustee. In addition to the documents required by Section 14.05, the Trustee shall receive an Officers’ Certificate and an Opinion of Counsel each stating that and as conclusive evidence that any supplemental indenture executed
pursuant hereto complies with the requirements of this Article 9 and is permitted or authorized by the Indenture. 

  
 62 

 ARTICLE X 
 CONSOLIDATION, MERGER, SALE, CONVEYANCE AND LEASE 
 SECTION 10.01
Company May Consolidate, Etc. on Certain Terms. Subject to the provisions of Section 10.02, the Company shall not consolidate with, merge with or into, or convey, transfer or lease all or substantially all of its properties and assets to
another Person, unless: 
 (a) the resulting, surviving or transferee Person (the “Successor
Company”), if not the Company, shall be a corporation organized and existing under the laws of the United States of America, any State thereof or the District of Columbia, and the Successor Company (if not the Company) shall expressly
assume, by supplemental indenture, executed and delivered to the Trustee, in form satisfactory to the Trustee, all the obligations of the Company under the Notes and this Indenture; and 

(b) immediately after giving effect to such transaction, no Default or Event of Default shall have occurred and be
continuing under this Indenture. 
 Upon any such consolidation, merger, conveyance, transfer or lease the Successor Company (if
not the Company) shall succeed to, and may exercise every right and power of, the Company under this Indenture. 
 For purposes
of this Section 10.01, the conveyance, transfer or lease of all or substantially all of the properties and assets of one or more Subsidiaries of the Company to another Person, which properties and assets, if held by the Company instead of such
Subsidiaries, would constitute all or substantially all of the properties and assets of the Company, shall be deemed to be the transfer of all or substantially all of the properties and assets of the Company to another Person. 

SECTION 10.02 Successor Corporation to Be Substituted. In case of any such consolidation, merger, conveyance, transfer or lease
and upon the assumption by the Successor Company, by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the due and punctual payment of the principal of (including any Fundamental Change
Purchase Price), accrued and unpaid interest (including any accrued and unpaid Additional Interest) on all of the Notes, the due and punctual delivery or payment, as the case may be, of any consideration due upon conversion of the Notes and the due
and punctual performance of all of the covenants and conditions of this Indenture to be performed by the Company, such Successor Company shall succeed to and be substituted for the Company, with the same effect as if it had been named herein as the
party of the first part. Such Successor Company thereupon may cause to be signed, and may issue in its own name any or all of the Notes issuable hereunder which theretofore shall not have been signed by the Company and delivered to the Trustee; and,
upon the order of such Successor Company instead of the Company and subject to all the terms, conditions and limitations in this Indenture prescribed, the Trustee shall authenticate and shall deliver, or cause to be authenticated and delivered, any
Notes that such Successor Company thereafter shall cause to be signed and delivered to the Trustee for that purpose. All the Notes so issued shall in all respects have the same legal rank and benefit under this Indenture as the Notes theretofore or
thereafter issued in accordance with the terms of 

  
 63 

 
this Indenture as though all of such Notes had been issued at the date of the execution hereof. In the event of any such consolidation, merger, conveyance or transfer (but not in the case of a
lease), the Person named as the “Company” in the first paragraph of this Indenture or any successor that shall thereafter have become such in the manner prescribed in this Article 10 may be dissolved, wound up and liquidated at any
time thereafter and, except in the case of a lease, such Person shall be released from its liabilities as obligor and maker of the Notes and from its obligations under this Indenture. 

In case of any such consolidation, merger, conveyance, transfer or lease, such changes in phraseology and form (but not in
substance) may be made in the Notes thereafter to be issued as may be appropriate. 
 SECTION 10.03 Opinion of Counsel to Be
Given to Trustee. The Company shall not effect any merger, consolidation, conveyance, transfer or lease referred to in Section 10.01 unless the Trustee shall receive an Officers’ Certificate and an Opinion of Counsel each stating that
and as conclusive evidence that any such consolidation, merger, conveyance, transfer or lease and any such assumption and, if a supplemental indenture is required in connection with such transaction, such supplemental indenture, complies with the
provisions of this Article 10. 
 ARTICLE XI 
 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, 
 OFFICERS AND DIRECTORS

 SECTION 11.01 Indenture and Notes Solely Corporate Obligations. No recourse for the payment of the principal of
(including any Fundamental Change Purchase Price) or accrued and unpaid interest (including any accrued and unpaid Additional Interest) on any Note, nor for any claim based thereon or otherwise in respect thereof, and no recourse under or upon any
obligation, covenant or agreement of the Company in this Indenture or in any supplemental indenture or in any Note, nor because of the creation of any indebtedness represented thereby, shall be had against any incorporator, stockholder, employee,
agent, officer or director or Subsidiary, as such, past, present or future, of the Company or of any successor corporation or entity, either directly or through the Company or any successor corporation or entity, whether by virtue of any
constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that all such liability is hereby expressly waived and released as a condition of, and as a consideration for, the
execution of this Indenture and the issuance of the Notes. 
 ARTICLE XII 

CONVERSION OF NOTES 
 SECTION 12.01 Conversion Privilege and Consideration. 
 (a) Subject to and
upon compliance with the provisions of this Indenture, a Noteholder shall have the right, at such Noteholder’s option, to convert the principal amount of its Notes, or any portion of such principal amount that is equal to $1,000 or an integral
multiple thereof, into an amount of cash and a number of shares of the Common Stock, if any, determined 

  
 64 

 
in accordance with Section 12.03, (x) prior to the close of business on the Business Day immediately preceding May 15, 2017, only upon the satisfaction of one or more of the
conditions described in clauses (i) through (iv) below, and (y) on and after May 15, 2017, at any time until the close of business on the second Scheduled Trading Day immediately preceding the Maturity Date, without regard to the
conditions described in clauses (i) through (iv) below (subject to the settlement provisions of Section 12.03, the “Conversion Obligation”): 

(i) During any fiscal quarter (and only during any such fiscal quarter) after the fiscal quarter ending April 1, 2011
if, for at least 20 Trading Days (whether or not consecutive) during the 30 consecutive Trading Day period ending on the last Trading Day of the immediately preceding fiscal quarter, the Last Reported Sale Price of the Common Stock is greater than
or equal to 130% of the Conversion Price on such Trading Day. If the Notes become convertible in accordance with this Section 12.01(a)(i), as promptly as practicable, the Company shall notify the Noteholders that the condition to conversion
described in this Section 12.01(a)(i) has been satisfied. 
 (ii) During the five consecutive Business Day
period immediately following any five consecutive Trading Day period (the “Measurement Period”) in which, for each Trading Day of such Measurement Period, the Trading Price per $1,000 principal amount of Notes, as determined
following a request by a Noteholder in accordance with the procedures set forth in this Section 12.01(a)(ii), is less than 98% of the product of (x) the Last Reported Sale Price of the Common Stock on such Trading Day and (y) the
Conversion Rate on such Trading Day (for any Trading Day, the “Trading Price Product”). 
 (A)
The Company shall have no obligation to determine the Trading Price of the Notes unless a Noteholder (x) provides the Company and the Trustee with reasonable evidence that the Trading Price per $1,000 principal amount of Notes for the
immediately following Trading Day will be less than 98% of the Trading Price Product for such Trading Day and (y) requests the Company to determine the Trading Price of the Notes on the immediately following Trading Day. 

(B) Upon receipt from a Noteholder of such evidence and such a request, the Company shall promptly determine the Trading
Price of the Notes beginning on the next Trading Day and on each successive Trading Day until a Trading Day occurs in which the Trading Price per $1,000 principal amount of Notes for such Trading Day is greater than or equal to 98% of the Trading
Price Product for such Trading Day. 
 (C) As promptly as practicable after the condition to conversion described
in this Section 12.01(a)(ii) has been met, the Company shall notify the Noteholders and the Trustee of the Noteholders’ rights to convert their Notes in accordance with this Section 12.01(a)(ii). On the first Trading Day thereafter on
which the Trading Price per $1,000 principal amount of Notes for such Trading Day is greater than or equal to 98% of the Trading Price Product for such Trading Day, as promptly as practicable, the Company shall notify the Noteholders that the
condition to conversion described in this Section 12.01(a)(ii) is no longer satisfied. 

  
 65 

 (iii) If the Company elects to: 

(A) issue to all or substantially all holders of its Common Stock rights, options or warrants that entitle them, for a
period of not more than 60 calendar days after the record date for such issuance, to subscribe for or purchase shares of the Common Stock at a price per share of Common Stock less than the average of the Last Reported Sale Prices of the Common Stock
for the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of the first public announcement of the terms of such issuance; or 

(B) distribute to all or substantially all holders of the Common Stock the Company’s assets, debt securities or
rights to purchase securities of the Company, which distribution has a per share value, as determined by the Board of Directors, exceeding 10% of the Last Reported Sale Price of the Common Stock on the Trading Day immediately preceding the
declaration date for such distribution, 
 then, in each case, at least 50 Scheduled Trading Days prior to the Ex-Dividend Date
for such issuance or distribution, the Company shall provide notice to the Noteholders and the Trustee describing such issuance or distribution, the Noteholders’ rights to convert their Notes in accordance with this Section 12.01(a)(iii),
the Conversion Rate in effect on the date the Company mails such notice, any adjustments to the Conversion Rate that must be made pursuant to Section 12.05 as a result of such issuance or distribution, and the effective date for any such
adjustments. Once the Company has given such notice, a Noteholder may surrender its Notes for conversion at any time until the earlier of (x) 5:00 p.m., New York City time, on the Business Day immediately preceding the Ex-Dividend Date for
the issuance or distribution or (y) the date of Company’s announcement that such issuance or distribution will not take place. No Noteholder may exercise this right to convert if such holder otherwise may participate in the distribution of
cash or Common Stock without conversion based upon the Conversion Rate and upon the same terms as holders of our Common Stock. 
 (iv) If a transaction or event that constitutes a Fundamental Change without giving effect to the penultimate paragraph of the definition of Fundamental Change and regardless of whether the Noteholders
have the right to require the Company to purchase their Notes pursuant to Section 13.01, or a Make-Whole Fundamental Change (a “Specified Corporate Transaction”), the Company shall provide notice (a “Specified Corporate
Transaction Notice”) of such Specified Corporate Transaction to the Noteholders as promptly as practicable after the Company first learns of the anticipated or actual effective date of such Specified Corporate Transaction; provided
that, for any Specified Corporate Transaction, the Company will use commercially reasonable efforts to deliver the Specified Corporate Transaction Notice for such Specified Corporate Transaction at least 50 Scheduled Trading Days in advance of such
anticipated effective date. The Specified Corporate Transaction Notice shall describe: 
 (A) such Specified
Corporate Transaction; 

  
 66 

 (B) the anticipated effective date of such Specified Corporate Transaction;

 (C) the Noteholders’ rights to convert their Notes in accordance with this Section 12.01(a)(iv);

 (D) the Conversion Rate in effect on the date the Company mails such notice; 

(E) any adjustments to the Conversion Rate that must be made pursuant to Section 12.05 as a result of such
transaction; 
 (F) whether such Specified Corporate Transaction also constitutes a Fundamental Change, and, if
so, the Noteholders’ rights to require the Company to purchase their Notes pursuant to Article 16; and 

(G) whether such Specified Corporate Transaction also constitutes a Make-Whole Fundamental Change, and, if so, the
Noteholders’ rights under Section 12.04 to receive Additional Shares if they convert their Notes in connection with such Make-Whole Fundamental Change. 
 Upon the Company’s delivery of a Specified Corporate Transaction Notice for a Specified Corporate Transaction, a Noteholder may surrender its Notes for conversion at any time until the close of
business on the earliest of (w) the 40th Trading Day immediately following the effective date of such Specified Corporate Transaction, (x) if such Specified Corporate Transaction constitutes a Fundamental Change, the Business Day
immediately preceding the related Fundamental Change Purchase Date, (y) if the Company announces that such Specified Corporate Transaction will not occur, the date on which the Company makes such announcement, and (z) the second Scheduled
Trading Day immediately preceding the Maturity Date. 
 SECTION 12.02 Conversion Procedure. 

(a) To convert a Note, a Noteholder must (i) in the case of a Global Note, (A) comply with the procedures of the Depositary in
effect on the date such Noteholder surrenders its Note for conversion and (B) if required, pay all funds required under Sections 12.02(e) and 12.02(f) below, and (ii) in the case of a Certificated Note, (A) complete and manually
sign the conversion notice in the form of Exhibit B hereto (a “Notice of Conversion”) or a facsimile of the Notice of Conversion, (B) deliver the Notice of Conversion, which is irrevocable, and the Certificated Note to the
Conversion Agent, (C) if required, furnish appropriate endorsements and transfer documents, (D) if required, pay all transfer or similar taxes, and (E) if required, pay all funds required under Sections 12.02(e) and 12.02(f)
below. 
 (i) On the first Business Day on which such Noteholder satisfies all of the requirements set forth in
Section 12.02(a) above with respect to a Note (and the conversion of such Note is not otherwise prohibited by Article 12 hereof), such Note will be deemed converted and such Business Day will be the conversion date (the “Conversion
Date”) for such Note. 

  
 67 

 (ii) If the last day on which a Note may be converted is not a Business Day,
the Note may be surrendered on the immediately following day that is a Business Day. Upon the conversion of a Note, the Conversion Agent, as promptly as possible, and in no event later than one Business Day immediately following the Conversion Date
for the Note, will provide the Company with notice of the conversion of the Note, and the Company, as promptly as possible, and in no event later than two Business Days after such Conversion Date, will notify the Trustee, if other than the
Conversion Agent, of the conversion of the Note. 
 (b) If a Noteholder converts the entire principal amount of a Note, such
Person will no longer be a Noteholder of such Note. 
 (c) If a Noteholder surrenders only a portion of a Certificated Note for
conversion, promptly after the Conversion Date for such portion, the Company shall execute and the Trustee shall authenticate and deliver to such Noteholder, a new Certificated Note in an authorized denomination equal to the aggregate principal
amount of the unconverted portion of the surrendered Note. Upon the conversion of an interest in a Global Note, the Trustee shall promptly make a notation on the “Schedule of Increases and Decreases of Global Note” of such Global Note as
to the reduction in the principal amount represented thereby. The Company shall notify the Trustee in writing upon any conversion of a Note effected through any Conversion Agent other than the Trustee. 

(d) If any shares of Common Stock are issuable upon the conversion of a Note, the Person in whose name the certificate or certificates
for such shares of Common Stock will be registered will become the holder of record of such shares at the close of business on the last VWAP Trading Day of the Observation Period corresponding to the Conversion Date for such Note. 

(e) If a Noteholder surrenders a Note for conversion after 5:00 p.m., New York City time, on a Record Date and prior to 9:00 a.m., New
York City time, on the corresponding Interest Payment Date, the Noteholder must accompany the Note with an amount of cash equal to the amount of interest (including any Additional Interest), that will be payable on the Note on such corresponding
Interest Payment Date; provided, however, that a Noteholder need not make such a payment (i) if the Company has specified a Fundamental Change Purchase Date that is after the Record Date and on or prior to the corresponding
Interest Payment Date, (ii) to the extent of any overdue interest on the Note, if any overdue interest exists at the time of conversion, or (iii) if the Noteholder surrenders the Note after the close of business on the last Record Date
immediately preceding the Maturity Date. 
 (f) If a Noteholder surrenders a Note for conversion, the Company shall pay all
stamp taxes and all other duties, if any, which may be imposed by the United States or any political subdivision thereof or taxing authority thereof or therein with respect to the issuance of shares of Common Stock, if any, upon the conversion.
However, if any tax is due because the Noteholder requests that any shares of Common Stock issued upon conversion be issued in a name other than that of the Noteholder, the Noteholder shall pay such tax and the Conversion

  
 68 

 
Agent, until having received a sum sufficient to pay such tax, may refuse to deliver any certificates representing shares of Common Stock being issued in a name other than that of the converting
Noteholder. Nothing herein shall preclude any tax withholding required by law or regulations. 
 SECTION 12.03 Settlement
Upon Conversion. 
 (a) (1) If a Noteholder surrenders a Note for conversion, the Company will satisfy its obligation to
convert the Note by delivering, on the third Business Day immediately following the final VWAP Trading Day of the Observation Period corresponding to the Conversion Date for such Note, cash and shares of Common Stock, if any, equal to the sum of the
Daily Settlement Amounts for each of the 40 VWAP Trading Days during the Observation Period for such Note. 
 (2)
Notwithstanding the provisions of Section 12.03(a)(1), the Company may elect to settle all or a portion of the Daily Share Amounts for each VWAP Trading Day in the Observation Period relating to a Conversion Date in cash (a “Cash
Election”). 
 (i) To make a Cash Election with respect to all or a portion of the
Daily Share Amounts for each Trading Day in the Observation Period relating to a Conversion Date, on the Business Day immediately following such Conversion Date, the Company must deliver notice (a “Cash Percentage Notice”) to all
Noteholders converting Notes on such Conversion Date. The Cash Percentage Notice for a Conversion Date must specify the single percentage of the Daily Share Amounts for each VWAP Trading Day in the Observation Period for such Conversion Date that
the Company will settle in cash (the “Cash Percentage”); provided that to make a Cash Election with respect to a Conversion Date occurring on or after the 60th Scheduled Trading Day immediately preceding the Maturity Date, the Company must (A) irrevocably specify a single
Cash Percentage that will apply to every Conversion Date occurring on or after the 60th Scheduled Trading Day immediately preceding the Maturity Date and (B) deliver a Cash Percentage Notice specifying such Cash Percentage to every Noteholder on or prior to the Scheduled Trading Day
immediately preceding the 60th Scheduled Trading Day
immediately preceding the Maturity Date. 
 (ii) If the Company timely delivers a Cash Percentage Notice for a
Conversion Date, (x) the amount of cash that the Company will deliver in lieu of the applicable portion of the shares of Common Stock comprising the Daily Share Amount for a VWAP Trading Day in the Observation Period relating to such Conversion
Date will equal the product of (A) the Cash Percentage specified in the Cash Percentage Notice for such Conversion Date, (B) the Daily Share Amount for such VWAP Trading Day (calculated as if the Company had not specified a Cash
Percentage), and (C) the Daily VWAP for such VWAP Trading Day, and (y) the number of shares of Common Stock that the Company will deliver as part of the Daily Share Amount for such VWAP Trading Day will equal the product of (A) 100%
minus the Cash Percentage for such Conversion Date and (B) the Daily Share Amount for such VWAP Trading Day (calculated as if the Company had not specified a Cash Percentage). 

  
 69 

 (iii) If, for any Conversion Date, the Company fails to deliver a Cash
Percentage Notice in accordance with Section 12.03(a)(2)(i), the Company must instead settle the Daily Share Amount for each VWAP Trading Day in the Observation Period relating to such Conversion Date by delivering a number of shares of Common
Stock determined in accordance with Section 12.03(a)(1). 
 (b) Notwithstanding the foregoing, the Company will not issue
fractional shares of Common Stock as part of the Daily Share Amount. Instead, if the Daily Share Amount for any VWAP Trading Day includes a fraction of a share of the Common Stock, the Company will, in lieu of delivering such fraction of a share of
Common Stock, pay an amount of cash equal to the product of (i) such fraction of a share and (ii) the Daily VWAP for such VWAP Trading Day of such Observation Period. 

(c) If a Noteholder surrenders more than one Note for conversion on a single day, the number of shares of Common Stock, if any, that the
Company will deliver, and the amount of cash that the Company will pay in lieu of fractional shares of Common Stock, if any, shall be determined based on the total principal amount of Notes surrendered by such Noteholder. 

(d) If a Noteholder converts a Note, the Company will not adjust the Conversion Rate to account for any accrued and unpaid interest on
the Note, and, except to the extent specified in the fourth sentence of Section 4.01(c) or in Section 4.01(d), the Company will not make any cash payment to such Noteholder for any accrued and unpaid interest on the Note. Furthermore,
except to the extent specified in the fourth sentence of Section 4.01(c) or in Section 4.01(d), the Company’s delivery to such Noteholder of the amount of cash and the number of shares of Common Stock, if any, into which such
Noteholder’s Note is convertible shall be deemed to satisfy and discharge in full the Company’s obligation to pay to such Noteholder (i) the principal amount of such converted Note and (ii) any accrued and unpaid interest
(including any Additional Interest, but not Defaulted Interest), on such converted Note. As a result, except to the extent specified in the fourth sentence of Section 4.01(c) or in Section 4.01(d)), any accrued and unpaid interest with
respect to a converted Note shall be deemed to be paid in full rather than cancelled, extinguished or forfeited. 
 (e)
Notices. 
 (i) On the second Business Day immediately following the Conversion Date for any Notes, the
Company shall deliver written notice to the Trustee stating (A) the aggregate principal amount of Notes converted on such Conversion Date, (B) whether the Company has made a Cash Election with respect to such Conversion Date, and
(C) if the Company has made a Cash Election for such Conversion Date, the Cash Percentage for such Conversion Date. 
 (ii) On the first Business Day immediately following the last VWAP Trading Day of the Observation Period for each Conversion Date, the Company shall deliver written notice to the Trustee stating
(A) the aggregate principal amount of Notes that were converted on such Conversion Date, (B) the aggregate amount of cash and the aggregate number of Shares that the Company is obligated to deliver to settle all of the Notes converted on
such Conversion Date, and (C) the Daily Share Amounts and the Daily Settlement Amounts for each VWAP Trading Day of the Observation Period for such Conversion Date. 

  
 70 

 SECTION 12.04 Increased Conversion Rate Applicable to Certain Notes Surrendered in
Connection with Make-Whole Fundamental Changes. 
 (a) Notwithstanding anything herein to the contrary, the Conversion Rate
applicable to each Note that is surrendered for conversion, in accordance with this Article 12, from, and including, the effective date (the “Effective Date”) of a Make-Whole Fundamental Change until, and including, the close
of business on the Business Day immediately preceding the related Fundamental Change Repurchase Date corresponding to such Make-Whole Fundamental Change, or the fortieth Trading Day immediately following the Effective Date of such Make-Whole
Fundamental Change (in the case of a Make-Whole Fundamental Change that does not constitute a Fundamental Change by virtue of the parenthetical in the definition of Make-Whole Fundamental Change) (such period, the “Make-Whole Fundamental
Change Period”), shall be increased to an amount equal to the Conversion Rate that would, but for this Section 12.04, otherwise apply to such Note pursuant to this Article 12, plus an amount equal to the Make-Whole Conversion Rate
Adjustment. 
 As used herein, “Make-Whole Conversion Rate Adjustment” shall mean, with respect to a Make-Whole
Fundamental Change, the amount set forth in the following table that corresponds to the Effective Date of such Make-Whole Fundamental Change and the Stock Price for such Make-Whole Fundamental Change, all as determined by the Company: 

Make-Whole Conversion Rate Adjustment 
 (per $1,000 principal amount of Notes) 
  
  

																																													
	 Stock Price
	 
	 Effective Date
	  	$26.12	 	  	$30.00	 	  	$35.00	 	  	$40.00	 	  	$45.00	 	  	$50.00	 	  	$60.00	 	  	$70.00	 	  	$80.00	 	  	$90.00	 	  	$100.00	 
	 11/19/2010
	  	 	8.8349	  	  	 	6.3895	  	  	 	4.2649	  	  	 	3.0809	  	  	 	2.3455	  	  	 	1.8655	  	  	 	1.2944	  	  	 	0.9804	  	  	 	0.7847	  	  	 	0.6445	  	  	 	0.5373	  
	 11/15/2011
	  	 	8.8349	  	  	 	6.3662	  	  	 	4.2029	  	  	 	2.9480	  	  	 	2.1879	  	  	 	1.7046	  	  	 	1.1559	  	  	 	0.8668	  	  	 	0.6923	  	  	 	0.5672	  	  	 	0.4726	  
	 11/15/2012
	  	 	8.8349	  	  	 	6.3241	  	  	 	4.0684	  	  	 	2.7519	  	  	 	1.9795	  	  	 	1.5068	  	  	 	0.9949	  	  	 	0.7418	  	  	 	0.5905	  	  	 	0.4842	  	  	 	0.4038	  
	 11/15/2013
	  	 	8.8349	  	  	 	6.2694	  	  	 	3.8441	  	  	 	2.4767	  	  	 	1.7099	  	  	 	1.2622	  	  	 	0.8063	  	  	 	0.6016	  	  	 	0.4790	  	  	 	0.3933	  	  	 	0.3281	  
	 11/15/2014
	  	 	8.8349	  	  	 	6.0833	  	  	 	3.4617	  	  	 	2.0822	  	  	 	1.3559	  	  	 	0.9630	  	  	 	0.6023	  	  	 	0.4523	  	  	 	0.3629	  	  	 	0.2991	  	  	 	0.2498	  
	 11/15/2015
	  	 	8.8349	  	  	 	5.6165	  	  	 	2.8697	  	  	 	1.5328	  	  	 	0.9085	  	  	 	0.6137	  	  	 	0.3857	  	  	 	0.2960	  	  	 	0.2394	  	  	 	0.1972	  	  	 	0.1640	  
	 11/15/2016
	  	 	8.8349	  	  	 	4.7769	  	  	 	1.9173	  	  	 	0.7770	  	  	 	0.3911	  	  	 	0.2653	  	  	 	0.1900	  	  	 	0.1522	  	  	 	0.1246	  	  	 	0.1032	  	  	 	0.0861	  
	 11/15/2017
	  	 	8.8349	  	  	 	3.8834	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  

 provided, however, that:

 (i) if the actual Stock Price of such Make-Whole Fundamental Change is between two Stock Prices listed in the
table above under the row titled “Stock Price,” or if the actual Effective Date of such Make-Whole Fundamental Change is between two Effective Dates listed in the table above in the column immediately below the title “Effective
Date,” then the Make-Whole Conversion Rate Adjustment for such Make-Whole Fundamental Change shall be determined by the Company by straight-line interpolation between the Make-Whole Conversion Rate Adjustment set forth for such higher and lower
Stock Prices, or for such earlier and later Effective Dates based on a 365 day year, as applicable; 

  
 71 

 (ii) if the actual Stock Price of such Make-Whole Fundamental Change is
greater than $100.00 per share (subject to adjustment in the same manner as the Stock Price as provided in clause (iii) below), or if the actual Stock Price of such Make-Whole Fundamental Change is less than $26.12 per share (subject to
adjustment in the same manner as the Stock Price as provided in clause (iii) below), then the Make-Whole Conversion Rate Adjustment shall be equal to zero and this Section 12.04 shall not require the Company to increase the Conversion Rate
with respect to such Make-Whole Fundamental Change; 
 (iii) if an event occurs that requires, pursuant to this
Article 12 (other than solely pursuant to this Section 12.04), an adjustment to the Conversion Rate, then, on the date and at the time such adjustment is so required to be made, each price set forth in the table above under the row titled
“Stock Price” shall be deemed to be adjusted so that such Stock Price, at and after such time, shall be equal to the product of (1) such Stock Price as in effect immediately before such adjustment to such Stock Price and (2) a
fraction whose numerator is the Conversion Rate in effect immediately before such adjustment to the Conversion Rate and whose denominator is the Conversion Rate to be in effect, in accordance with this Article 12, immediately after such
adjustment to the Conversion Rate; 
 (iv) each Make-Whole Conversion Rate Adjustment set forth in the table
above shall be adjusted in the same manner in which, at the same time and for the same events for which, the Conversion Rate is to be adjusted pursuant to Section 12.05; and 

(v) in no event will the total number of shares of Common Stock issuable upon conversion of the Notes exceed
38.2848 per $1,000 principal amount of Notes, subject to adjustment in the same manner as the Conversion Rate pursuant to Section 12.05. 
 (b) As soon as practicable after the Company determines the anticipated Effective Date of any proposed Make-Whole Fundamental Change but in any event not later than five Business Days following the
Effective Date, the Company shall provide the Trustee, the Noteholders and the Conversion Agent written notice of, and shall issue a press release indicating, the anticipated Effective Date of such proposed Make-Whole Fundamental Change. The Company
shall use commercially reasonable efforts in time to give such notice no later than fifty Business Days in advance of such anticipated Effective Date. Each such press release notice, announcement and publication shall also state that in connection
with such Make-Whole Fundamental Change, the Company shall increase, in accordance herewith, the Conversion Rate applicable to Notes entitled as provided herein to such increase (along with a description of how such increase shall be calculated and
the time periods during which Notes must be surrendered in order to be entitled to such increase). No later than five Business Days after the actual Effective Date of each Make-Whole Fundamental Change, the Company shall provide the Trustee, the
Noteholders and the Conversion Agent written notice of such Effective Date and the amount by which the Conversion Rate has been so increased. 

  
 72 

 Nothing in this Section 12.04 shall prevent an adjustment to the Conversion Rate
pursuant to Section 12.05 in respect of a Make-Whole Fundamental Change. 
 SECTION 12.05 Adjustment of Conversion
Rate. The Conversion Rate shall be adjusted from time to time by the Company as set forth below, except that the Company shall not make any adjustments to the Conversion Rate if Noteholders participate at the same time and upon the same terms as
holders of the Common Stock and solely as a result of holding the Notes, in any of the transactions described below as if such Noteholders held a number of shares of Common Stock equal to the applicable conversion rate, multiplied by the principal
amount (expressed in thousands) of Notes held by such holder, without having to convert its Notes: 
 (a) If the Company issues
solely shares of Common Stock as a dividend or distribution on all or substantially all of the shares of Common Stock, or if the Company effects a share split or share combination of the Common Stock, the applicable Conversion Rate will be adjusted
based on the following formula: 
  

					
	CR = 
CR0  x 	  	    OS    	  	
	  	    OS0	  	

  

					
	where	  		  	
			
	
CR0
	  	=	  	the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such dividend or distribution, or immediately prior to the open of business on
the effective date of such share split or share combination, as the case may be;
			
	 CR
	  	=	  	the Conversion Rate in effect immediately after the open of business on the Ex-Dividend Date for such dividend or distribution, or immediately after the open of business on the
effective date of such share split or share combination, as the case may be;
			
	
OS0
	  	=	  	the number of shares of Common Stock outstanding immediately prior to the open of business on the Ex-Dividend Date for such dividend or distribution, or immediately prior to the
open of business on the effective date of such share split or share combination, as the case may be; and
			
	 OS
	  	=	  	the number of shares of Common Stock outstanding immediately after such dividend or distribution, or immediately after the effective date of such share split or share
combination, as the case may be.

 Any adjustment made under this Section 12.05(a) shall become effective
immediately after the open of business on the Ex-Dividend Date for such dividend or distribution, or immediately after the open of business on the effective date for such share split or share combination. If any dividend or distribution of the type
described in this Section 12.05(a) 

  
 73 

 
is declared but not so paid or made, the Conversion Rate shall be immediately readjusted, effective as of the date the Board of Directors of the Company determines not to pay such dividend or
distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. 
 (b)
If the Company issues to all or substantially all holders of its Common Stock any rights, options or warrants entitling them for a period of not more than sixty calendar days after the record date for such issuance to subscribe for or purchase
shares of the Common Stock, at a price per share less than the average of the Last Reported Sale Prices of the Common Stock for the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of the
first announcement of the terms of such issuance, the Conversion Rate shall be increased based on the following formula: 
  

					
	CR = 
CR0  x 	  	OS0 + X	  	
	  	OS0 + Y	  	

  

					
	where:	  		  	
			
	
CR0
	  	=	  	the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such distribution;
			
	 CR
	  	=	  	the Conversion Rate in effect immediately after the open of business on the Ex-Dividend Date for such distribution;
			
	
OS0
	  	=	  	the number of shares of the Common Stock that are outstanding immediately prior to the open of business on the Ex-Dividend Date for such distribution;
			
	 X
	  	=	  	the total number of shares of the Common Stock issuable pursuant to such rights, options or warrants; and
			
	 Y
	  	=	  	the number of shares of the Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, divided by the average of the Last Reported Sale
Prices of Common Stock over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of the first public announcement of the terms of such issuance.

Such adjustment shall be successively made whenever any such rights, options or warrants are distributed and shall become effective immediately after the
open of business on the Ex-Dividend Date for such distribution. To the extent that shares of the Common Stock are not delivered after the expiration of such rights, options or warrants, the Conversion Rate shall be readjusted to the Conversion Rate
that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of Common Stock actually delivered. If such rights, options or warrants
are not so issued, the Conversion Rate shall again be adjusted to be the Conversion Rate that would then be in effect if such Ex-Dividend Date for such distribution had not occurred. 

  
 74 

 For purposes of this Section 12.05(b), in determining whether any rights, options or
warrants entitle the holders to subscribe for or purchase shares of the Common Stock at less than the average of the Last Reported Sale Prices of the Common Stock for each Trading Day in the applicable ten consecutive Trading Day period, there shall
be taken into account any consideration received by the Company for such rights, options or warrants and any amount payable on exercise thereof, with the value of such consideration, if other than cash, to be determined by the Board of Directors. In
no event shall the Conversion Rate be decreased pursuant to this Section 12.05(b) (other than upon a readjustment as set forth in the immediately preceding paragraph). 
 (c) If the Company shall distribute shares of its Capital Stock, evidences of its indebtedness or other of its assets or property or rights or warrants to acquire its Capital Stock or other securities to
all or substantially all holders of the Common Stock, excluding (i) dividends, distributions (including share splits), rights, options or warrants as to which an adjustment was effected pursuant to Section 12.05(a) or
Section 12.05(b), (ii) rights issued to all holders of Common Stock pursuant to a rights plan, where such rights are not presently exercisable, continue to trade with the Common Stock and Noteholders will receive such rights together with
any Common Stock upon conversion, (iii) dividends or distributions paid exclusively in cash and covered by Section 12.05(d), and (iv) Spin-offs to which the provisions set forth below in this Section 12.05(c) shall apply (any of
such shares of Capital Stock, indebtedness, or other assets or property hereinafter in this Section 12.05(c) called the “Distributed Property”), then, in each such case the Conversion Rate shall be increased based on the
following formula: 
  

					
	CR = 
CR0  x 	  	SPO	  	
	  	SP0 – FMV	  	

  

					
	where:	  		  	
			
	
CR0
	  	=	  	the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such distribution;
			
	 CR
	  	=	  	the Conversion Rate in effect immediately after the open of business on the Ex-Dividend Date for such distribution.
			
	
SP0
	  	=	  	the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the
Ex-Dividend Date for such distribution; and
			
	 FMV
	  	=	  	the fair market value (as determined by the Board of Directors) of the shares of Capital Stock, evidences of indebtedness, assets, property rights, options or warrants
distributed with respect to each outstanding share of the Common Stock as of the open of business on the Ex-Dividend Date for such distribution.

 Such adjustment shall become effective immediately after the open of business on the Ex-Dividend Date for such distribution; provided that if “FMV” as set forth above is equal to or greater than
“SP0” as set forth above, in lieu of the foregoing
adjustment, each Noteholder shall have the right to receive, for each $1,000 principal amount of the Notes held by such holder, at 

  
 75 

 
the same time and upon the same terms as holders of Common Stock, the amount and kind of Distributed Property such holder would have received had such holder already owned a number of shares of
Common Stock equal to the Conversion Rate immediately prior to the Ex-Dividend Date for such distribution. If such distribution is not so paid or made, the Conversion Rate shall be decreased to be the Conversion Rate that would then be in effect if
such distribution had not been declared. If the Board of Directors determines “FMV” for purposes of this Section 12.05(c) by reference to the actual or when-issued trading market for any securities, it shall in doing so consider the
prices in such market over the same period used in computing the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the Ex-Dividend Date for such
distribution. 
 With respect to an adjustment pursuant to this Section 12.05(c) where there has been a payment of a
dividend or other distribution on the Common Stock of shares of Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or other business unit of the Company and such dividend or distribution is listed for
trading or quoted (or will be so listed or quoted upon consummation of the Spin-off) on a United States national or regional securities exchange (a “Spin-off”), the Conversion Rate will be increased based on the following formula:

  

					
	CR  =
 CR0  x 	 	FMV + MP0	  	
	 	MP0 	  	

  

					
	where	  		  	
			
	
CR0
	  	=	  	the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for the Spin-off;
			
	 CR
	  	=	  	the Conversion Rate in effect immediately after the open of business on the Ex-Dividend Date for the Spin-off;
			
	 FMV
	  	=	  	the average of the Last Reported Sale Prices of the Capital Stock or similar equity interest distributed to holders of the Common Stock applicable to one share of the Common
Stock (determined for purposes of the definition of Last Reported Sale Price as if such capital stock or similar equity interest were the Common Stock) over the first ten consecutive Trading Day period commencing on, and including, the Ex-Dividend
Date for the Spin-off (the “Valuation Period”), and
			
	
MP0
	  	=	  	the average of the Last Reported Sale Prices of the Common Stock over the Valuation Period.

 Any adjustment to the applicable conversion rate under the preceding paragraph of this Section 12.05(c) will be determined on the last Trading Day of the Valuation Period but will be given effect
immediately after the opening of business on the Ex-Dividend Date for the Spin-off. If such Spin-off is subsequently cancelled and does not become effective, the Conversion Rate shall be readjusted to be the Conversion Rate that would have been in
effect if such Spin-off had not been declared. 

  
 76 

 Notwithstanding the foregoing, (i) if the last VWAP Trading Day of the Observation Period for any
conversion occurs on or after the effective date for the Spin-off, but less than ten Trading Days immediately following, and including the Effective Date for the Spin-off, references to ten Trading Days in the portion of this Section 12.05(c)
relating to Spin-offs shall be deemed replaced, for purposes of calculating the affected Daily Settlement Amounts in respect of that conversion, with such lesser number of Trading Days as have elapsed from, and including, the Effective Date for the
Spin-off to, and including, the last VWAP Trading Day of such Observation Period, and (ii) for the purposes of determining the Conversion Rate applicable to any conversion for which the Conversion Date occurs during the ten Trading Days
commencing on the Effective Date for any Spin-off, references to ten Trading Days in the portion of this Section 12.05(c) relating to Spin-offs shall be deemed replaced with such lesser number of Trading Days as have elapsed from, and
including, the Effective Date for such Spin-off to, but excluding, the relevant Conversion Date. 
 In no event shall the
Conversion Rate be decreased pursuant to this Section 12.05(c) (other than upon a readjustment if a distribution of Distributed Property is not made as set forth above in this Section 12.05(c)). 

(d) If the Company pays any cash dividend or distribution to all or substantially all holders of the Common Stock other than a regular,
quarterly cash dividend that does not exceed $0.14 per share of the Common Stock (the “Initial Dividend Threshold”), the Conversion Rate will be adjusted based on the following formula: 

 

					
	CR = 
CR0  x 	 	SP0 – T	  	
	 	SP0      C	  	

 where 
  

					
	
CR0
	  	=	  	the applicable Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such dividend or distribution;
			
	 CR
	  	=	  	the Conversion Rate in effect immediately after the open of business on the Ex-Dividend Date for such dividend or distribution;
			
	
SP0
	  	=	  	the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the
Ex-Dividend Date for such dividend or distribution;
			
	 T
	  	=	  	the Initial Dividend Threshold; provided that if the dividend or distribution in question is not a regular quarterly cash dividend, the Initial Distribution Threshold will
be deemed to be zero; and
			
	 C
	  	=	  	the amount in cash per share the Company distributes to holders of its Common Stock in excess of the Initial Dividend Threshold.

The Initial Dividend Threshold is subject to concurrent adjustment in a manner inversely proportional to adjustments to the Conversion
Rate; provided that no adjustment will be made to the Initial Dividend Threshold for any adjustment to the Conversion Rate under this Section 11.05(d). 

  
 77 

 Such increase shall become effective immediately after the open of business on the
Ex-Dividend Date for such dividend or distribution. If such dividend or distribution is not so paid, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared.

 Notwithstanding the foregoing, if C (as defined above) is equal to or greater than SP0 (as defined above), in lieu of the foregoing increase, each holder of a
note shall receive, for each $1,000 principal amount of the Notes, at the same time and upon the same terms as holders of shares of the Common Stock, the amount of cash that such holder would have received if such holder owned a number of shares of
the Common Stock equal to the Conversion Rate on the Ex-Dividend Date for such cash dividend or distribution. 
 In no event
shall the Conversion Rate be decreased pursuant to this Section 12.05(d) (other than upon a readjustment if a regular, quarterly cash dividend or distribution is not made as set forth above in this Section 12.05(d)). 

(e) If the Company or any of its Subsidiaries makes a payment in respect of a tender offer or exchange offer for the Common Stock and if
the cash and value of any other consideration included in the payment per share of the Common Stock exceeds the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading-Day period commencing on, and including,
the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer (the “Expiration Date”), the Conversion Rate shall be increased based on the following formula:

  

					
	CR = 
CR0  x 	 	AC + (SP x OS)	  	
	 	OS0 x SP	  	

 where 
  

					
	
CR0
	  	=	  	the Conversion Rate in effect immediately prior to the open of business on the Trading Day next succeeding the Expiration Date;
			
	 CR
	  	=	  	the Conversion Rate in effect immediately after the open of business on the Trading Day next succeeding the Expiration Date;
			
	 AC
	  	=	  	the aggregate value of all cash and any other consideration (as determined by the Board of Directors) paid or payable for shares of Common Stock purchased in such tender or
exchange offer;
			
	
OS0
	  	=	  	the number of shares of Common Stock outstanding immediately prior to the time (the “Expiration Time”) such tender or exchange offer expires (prior to giving
effect to such tender offer or exchange offer);

  
 78 

					
			
	 OS
	  	=	  	the number of shares of Common Stock outstanding immediately after the Expiration Time (after giving effect to the purchase of all shares accepted for purchase or exchange in
such tender offer or exchange offer); and
			
	 SP
	  	=	  	the average of the Last Reported Sale Prices of Common Stock over the ten consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the
Expiration Date.

 Such adjustment under this Section 12.05(e) shall be determined at the close of business
on the last Trading Day of the ten consecutive Trading Day period commencing on, and including, the Expiration Date but will be given effect immediately after the open of business on the Trading Day next succeeding the Expiration Date. If the
Trading Day next succeeding the Expiration Date is less than ten Trading Days prior to, and including, the last VWAP Trading Day of the Observation Period in respect of any conversion, references within this Section 12.05(e) to ten Trading Days
shall be deemed replaced, for purposes of calculating the affected Daily Settlement Amounts in respect of that conversion, with such lesser number of Trading Days as have elapsed from, and including, the Trading Day next succeeding the Expiration
Date to, and including, the last VWAP Trading Day of such Observation Period. If the Company is obligated to purchase shares pursuant to any such tender or exchange offer, but the Company is ultimately prevented by applicable law from effecting any
or all or any portion of such purchases or all such purchases are rescinded, the Conversion Rate shall again be adjusted to be the Conversion Rate that would then be in effect if such tender or exchange offer had not been made or had been made only
in respect of the purchases that had been effected. In no event shall the Conversion Rate be decreased pursuant to this Section 12.05(e) (other than upon a readjustment if a self-tender offer is not made as set forth above in this
Section 12.05(e)). 
 (f) Adjustments Not Yet Effective. 

If a Noteholder converts a Note and, on any VWAP Trading Day during the Observation Period corresponding to the Conversion Date for such
Note: 
 (A) shares of Common Stock are deliverable as part of the Daily Settlement Amount for such VWAP Trading
Day; 
 (B) any event that requires an adjustment to the Conversion Rate pursuant to Sections 12.05(a), (b),
(c), (d), or (e) has occurred, but will not result in an adjustment to the Conversion Rate for such VWAP Trading Day for such Noteholder; and 
 (C) the shares of Common Stock (or the cash value thereof) that the Noteholder shall receive as part of the Daily Settlement Amount for such VWAP Trading Day will not be entitled to participate in the
distribution or transaction requiring the adjustment (because such shares were not held by such Noteholder on the record date corresponding to such distribution or transaction or otherwise), 
 then the Company shall adjust the number of shares of Common Stock (or the cash value thereof) deliverable to such Noteholder as part of the Daily Settlement Amount for such VWAP Trading Day in a manner
that appropriately reflects the relevant distribution or transaction requiring adjustment. 

  
 79 

 (g) Noteholder Participation in Adjustment Events. Notwithstanding the foregoing, if
pursuant to this Section 12.05, an adjustment to the Conversion Rate becomes effective on any Ex-Dividend Date or effective date and a Noteholder that has converted its Notes would (i) receive shares of Common Stock based on an adjusted
Conversion Rate and (ii) be a record holder of the shares of Common Stock on the record date for the dividend, distribution or event giving rise to the adjustment pursuant to this Section 12.05, then, in lieu of receiving shares of Common
Stock at such an adjusted Conversion Rate, such Noteholder will participate in the related dividend, distribution or other event giving rise to such adjustment and shall receive a number of shares of Common Stock, if any, upon conversion based on an
unadjusted Conversion Rate. 
 (h) Other Adjustments. Whenever any provision of this Indenture requires the calculation
of the Last Reported Sale Price, the Daily VWAP or any functions thereof over a span of multiple days, the Board of Directors will make appropriate adjustments to such prices, functions of such prices, the Conversion Rate, or the amount of cash and
the number of shares of the Common Stock, if any (subject to the Company’s right under Section 12.02 to pay cash in lieu of all or a portion of any shares of Common Stock deliverable as part of a Daily Settlement Amount), due upon
conversion to account for any adjustment to the Conversion Rate that becomes effective, or any event requiring an adjustment to the Conversion Rate in which the Ex-Dividend Date of the event occurs, at any time prior to or during the period during
which such calculation is to be made. 
 (i) In addition to those required by clauses (a), (b), (c), (d), (e) and
(f) of this Section 12.05, and to the extent permitted by applicable law and subject to the applicable rules of the NASDAQ Global Select Market or such other principal exchange on which the Common Stock is then traded, the Company from
time to time may increase the Conversion Rate by any amount for a period of at least twenty Business Days if the Board of Directors determines that such increase would be in the Company’s best interest. In addition, the Company may also (but is
not required to) increase the Conversion Rate to avoid or diminish any income tax to holders of Common Stock or rights to purchase shares of Common Stock in connection with any dividend or distribution of shares (or rights to acquire shares) or
similar event. Whenever the Conversion Rate is increased pursuant to the preceding sentence, the Company shall provide notice to the Noteholders and the Trustee at least fifteen days prior to the date the increased Conversion Rate takes effect, and
such notice shall state the increased Conversion Rate and the period during which it will be in effect. 
 (j) The Company shall
not take any action that would result in adjustment of the Conversion Rate, pursuant to this Article 12, in such a manner as to result in the reduction of the Conversion Price to less than the par value per share of the Common Stock.

 (k) Except as specifically described in this Section 12.05, the Conversion Rate will not be subject to adjustment as a
result of any issuance of shares of Common Stock, securities convertible into or exchangeable for shares of Common Stock or rights, options or warrants to purchase shares of Common Stock or securities convertible into or exchangeable for

  
 80 

 
shares of Common Stock. In addition, if the application of the formulas in Sections 12.05(a) through 12.05(e) would result in a decrease in the Conversion Rate, no adjustment to the
Conversion Rate will be made (other than as a result of a reverse share split or share combination); provided that, for the avoidance of doubt, if the Company adjusts the Conversion Rate pursuant to Section 12.05(a), 12.05(b), 12.05(c),
12.05(d) or 12.05(e) and the event that gave rise to the adjustment is not paid or made, delivered or issued or fails to become effective, as applicable, the Company may readjust the Conversion Rate as expressly contemplated in the applicable
section. Without limiting the foregoing, the Conversion Rate will not be adjusted upon the following events: 

(i) the issuance of any shares of the Common Stock pursuant to any present or future plan providing for the reinvestment
of dividends or interest payable on the Company’s securities and the investment of additional optional amounts in shares of the Common Stock under any plan; 

(ii) the issuance of any shares of the Common Stock or options or rights to purchase those shares pursuant to any present
or future employee, director or consultant benefit plan or program of, or assumed by, the Company or any of the Company’s Subsidiaries; 
 (iii) the issuance of any shares of the Common Stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security not described in clause (ii) of this subsection and
outstanding as of the date the Notes were first issued including the hedge warrants issued in connection with the offering of the Notes; 
 (iv) the issuance of any shares of Common Stock or options or rights to purchase those shares pursuant to any plan of acquisition of the stock or assets of another entity, whether by asset purchase, stock
purchase, merger or other combination (except as provided in Section 12.04); 
 (v) for a change in the par
value of the Common Stock; or 
 (vi) for accrued and unpaid interest (including any Additional Interest).

 (l) All calculations and other determinations under this Article 12 shall be made to the nearest one-ten thousandth
(1/10,000) of a share. 
 (m) The Company shall not be required to make an adjustment in the Conversion Rate unless the
adjustment would require a change of at least 1% in the Conversion Rate. However, the Company shall carry forward any adjustments that are less than 1% of the Conversion Rate and make such carried forward adjustments with respect to a Note,
regardless of whether the aggregate adjustment is less than 1%, on the first VWAP Trading Day in the Observation Period for such Note and, on each subsequent VWAP Trading Day of such Observation Period for such Note, shall be required to make
adjustments to the Conversion Rate regardless of whether such adjustments could otherwise be carried forward pursuant to the immediately preceding sentence. 

  
 81 

 (n) In the event of an increase in the Conversion Rate above that which would result in the
Notes, in the aggregate, becoming potentially convertible into shares in excess of 19.9% of the shares outstanding at the time of the initial offering of the Notes, the Company shall, at its option, either obtain stockholder approval of such
issuances or, in accordance with the terms of the Notes, deliver cash in lieu of any shares otherwise deliverable upon conversions in excess of such limitation. 
 (o) Whenever the Conversion Rate is adjusted as herein provided, the Company shall promptly file with the Trustee and any Conversion Agent other than the Trustee an Officers’ Certificate setting
forth the Conversion Rate after such adjustment and setting forth a brief statement of the facts requiring such adjustment. Unless and until a Responsible Officer of the Trustee shall have received such Officers’ Certificate, the Trustee shall
not be deemed to have knowledge of any adjustment of the Conversion Rate and may assume without inquiry that the last Conversion Rate of which it has knowledge is still in effect. Promptly after delivery of such certificate, the Company shall
prepare a notice of such adjustment of the Conversion Rate setting forth the adjusted Conversion Rate and the date on which each adjustment becomes effective and shall mail such notice of such adjustment of the Conversion Rate to the holder of each
Note at its registered address, within ten days of the effective date of such adjustment. Failure to deliver such notice shall not affect the legality or validity of any such adjustment. 

(p) For purposes of this Section 12.05, the number of shares of Common Stock at any time outstanding shall not include shares held
in the treasury of the Company but shall include shares issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock. The Company will not pay any dividend or make any distribution on shares of Common Stock held in
the treasury of the Company. 
 SECTION 12.06 Shares to Be Fully Paid. The Company shall provide, free from preemptive
rights, out of its authorized but unissued shares or shares held in treasury, sufficient shares of Common Stock to provide for conversion of the Notes from time to time as such Notes are presented for conversion. 

SECTION 12.07 Effect of Reclassification, Consolidation, Merger or Sale. 

(a) Upon the occurrence of: 
 (i) any recapitalization, reclassification or change of the Common Stock (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a
subdivision or combination for which an adjustment is provided pursuant to Section 12.05); 
 (ii) any sale
or conveyance to another person of all or substantially all of the property and assets of the Company; 
 (iii)
any sale, lease or other transfer to another Person of substantially all of the consolidated assets of the Company and its Subsidiaries; 
 (iv) a consolidation, merger, or combination involving the Company; or 

  
 82 

 (v) any statutory share exchange, 

and, in each case, as a result of which the Common Stock will be converted into, or exchanged for, stock, other securities, other property or assets
(including cash or any combination including cash) (any such event, a “Merger Event,” such stock, securities, other property or assets, “Reference Property,” and the kind and amount of such stock, securities, other
property or assets that a holder of one share of the Common Stock immediately prior to the effective date of such Merger Event would have been entitled to receive upon the occurrence of such transaction, a “Unit of Reference
Property,” provided that if a Merger Event causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of election by holders
of the Common Stock), then each Unit of Reference Property will be deemed to be the Weighted Average Consideration), then: 
 (A) on or prior to the effective date of such Merger Event, the Company or the successor or purchasing Person, as the case may be, shall execute with the Trustee a supplemental indenture (which shall
comply with the TIA as in force at the date of execution of such supplemental indenture if such supplemental indenture is then required to so comply) providing for the conversion and settlement of the Notes as set forth in this Indenture and for
adjustments to the Conversion Rate that shall be as nearly equivalent as may be practicable to the adjustments provided for in this Article 12. If, in the case of any Merger Event, the Reference Property includes shares of stock or other
securities and assets of a corporation other than the successor or purchasing corporation, as the case may be, then such supplemental indenture shall also be executed by such other corporation and shall contain such additional provisions to protect
the interests of the Noteholders as the Board of Directors shall reasonably consider necessary by reason of the foregoing, including to the extent required by the Board of Directors and practicable the provisions providing for the repurchase rights
set forth in Article 13 herein; 
 (B) subject to the provisions of Sections 12.01 and 12.04, at and
after the effective date of such Merger Event, the right of Noteholders to convert each $1,000 principal amount of Notes into cash and shares of Common Stock, if any (subject to the Company’s right to pay cash in lieu of all or any portion of
the shares of Common Stock), shall be changed into a right to convert each $1,000 principal amount of Notes into cash and Units of Reference Property, if any (subject to the Company’s right to pay cash in lieu of all or any portion of the Units
of Reference Property) so that on or after the effective date of such Merger Event, 
 (1) references in
Section 12.01 to the Last Reported Sale Price of the Common Stock shall be deemed to be references to the Last Reported Sale Price of a Unit of Reference Property; 

(2) the Daily VWAP for a VWAP Trading Day (and any functions thereof) will be calculated based on the value of a Unit of
Reference Property on such VWAP Trading Day; 

  
 83 

 (3) instead of delivering shares of Common Stock to converting Noteholders
as part of the Daily Share Amount for a VWAP Trading Day, the Company shall deliver a number of Units of Reference Property equal to such number of shares of Common Stock (subject to the Company’s right to pay cash in lieu of all or a portion
of the Daily Share Amount); and 
 (4) instead of delivering an amount of cash in lieu of fractional shares of
Common Stock based on the Daily VWAP of the Common Stock, the Company will deliver an amount of cash in lieu of fractional Units of Reference Property, with the amount of cash calculated in accordance with Section 12.02 (except using the Daily
VWAP computed in accordance with clause (2) above). 
 (C) For the purposes of this Section 12.07, if a
Merger Event causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of election by holders of the Common Stock), the “Weighted
Average Consideration” for such Merger Event means the weighted average, per share of Common Stock, of the types and amounts of consideration received by the holders of the Common Stock that affirmatively make an election receive in such
Merger Event. 
 (b) Notices. 
 (i) As soon as practicable after it determines the Weighted Average Consideration, the Company shall notify the Noteholders of the Weighted Average Consideration. 

(ii) As soon as practicable upon learning the anticipated or actual effective date of a Merger Event, the Company shall
deliver written notice to the Noteholders stating: 
 (1) a brief description of such Merger Event; 

(2) the Conversion Rate in effect on the date the Company delivers such notice; 

(3) the anticipated effective date for the Merger Event; 

(4) that the Notes will be convertible into Reference Property in lieu of shares of Common Stock on and after the
effective date for the Merger Event; and 
 (5) the composition of a Unit of Reference Property for such Merger
Event. 

  
 84 

 provided, however, that the Company will use commercially reasonable efforts to deliver such
written notice at least 45 Scheduled Trading Days immediately prior to the effective date for such Merger Event. 
 (c) If the
Company executes a supplemental indenture pursuant to this Section 12.07, as promptly as practicable, the Company shall file with the Trustee an Officers’ Certificate briefly describing such Merger Event, the composition of a Unit of
Reference Property for such Merger Event, any adjustment to be made with respect thereto and that all conditions precedent to such Merger Event under this Indenture have been complied with. Any failure to deliver such Officers’ Certificate
shall not affect the legality or validity of such supplemental indenture. 
 (d) The provisions of this Section 12.07 shall
apply successively to successive Merger Events. 
 (e) The Company covenants that it will not become party to any transaction
that would constitute a Merger Event unless the terms thereof are consistent with this Section 12.07. 
 SECTION 12.08
Certain Covenants. 
 (a) The Company covenants that all shares of Common Stock issued upon conversion of Notes will be
fully paid and non-assessable by the Company and free from all taxes, liens and charges with respect to the issue thereof. 

(b) The Company covenants that, if any shares of Common Stock to be provided for the purpose of conversion of Notes hereunder require
registration with or approval of any governmental authority under any federal or state law before such shares may be validly issued upon conversion, the Company will, to the extent then permitted by the rules and interpretations of the Commission,
secure such registration or approval, as the case may be. 
 (c) The Company further covenants that if at any time the Common
Stock shall be listed on any national securities exchange or automated quotation system, the Company will list and keep listed, so long as the Common Stock shall be so listed on such exchange or automated quotation system, any Common Stock issuable
upon conversion of the Notes. 
 SECTION 12.09 Responsibility of Trustee. The Trustee and any other Conversion Agent
shall not at any time be under any duty or responsibility to any Noteholder to determine the Conversion Rate (or any adjustment thereto) or whether any facts exist that may require any adjustment (including any increase) of the Conversion Rate, or
with respect to the nature or extent or calculation of any such adjustment when made, or with respect to the method employed, or herein or in any supplemental indenture provided to be employed, in making the same. The Trustee and any other
Conversion Agent shall not be accountable with respect to the validity or value (or the kind or amount) of any shares of Common Stock, or of any securities, property or cash that may at any time be issued or delivered upon the conversion of any
Note; and the Trustee and any other Conversion Agent make no representations with respect thereto. Neither the Trustee nor any Conversion Agent shall be responsible for any failure of the Company to issue, transfer or deliver any shares of Common
Stock or stock certificates or other 

  
 85 

 
securities or property or cash upon the surrender of any Note for the purpose of conversion or to comply with any of the duties, responsibilities or covenants of the Company contained in this
Article. Without limiting the generality of the foregoing, neither the Trustee nor any Conversion Agent shall be under any responsibility to determine the correctness of any provisions contained in any supplemental indenture entered into pursuant to
Section 12.07 relating either to the kind or amount of shares of stock or securities or property (including cash) receivable by Noteholders upon the conversion of their Notes after any event referred to in such Section 12.07 or to any
adjustment to be made with respect thereto, but, subject to the provisions of Section 6.01, may accept (without any independent investigation) as conclusive evidence of the correctness of any such provisions, and shall be protected in relying
upon, the Officers’ Certificate (which the Company shall be obligated to file with the Trustee prior to the execution of any such supplemental indenture) with respect thereto. Neither the Trustee nor any other Conversion Agent shall at any time
be under any duty or responsibility to any Noteholder to determine whether any facts exist that may require Additional Interest to be paid by the Company, or the determination of the amount thereof, if any. 

SECTION 12.10 Notice to Noteholders Prior to Certain Actions. In case: 

(a) the Company shall declare a dividend (or any other distribution) on its Common Stock that would require an adjustment in the
Conversion Rate pursuant to Section 12.05; or 
 (b) the Company shall authorize the granting to all of the holders of its
Common Stock of rights, options or warrants to subscribe for or purchase any share of any class or any other rights, options or warrants; or 
 (c) of any reclassification of the Common Stock of the Company (other than a subdivision or combination of its outstanding Common Stock, or a change in par value, or from par value to no par value, or
from no par value to par value), or of any consolidation or merger to which the Company is a party and for which approval of any stockholders of the Company is required, or of the sale or transfer of all or substantially all of the assets of the
Company; or 
 (d) of the voluntary or involuntary dissolution, liquidation or winding-up of the Company; 

the Company shall provide notice to the Trustee and the Noteholders as promptly as possible but in any event at least twenty days prior to the applicable
date hereinafter specified, a notice stating (i) the date on which a record is to be taken for the purpose of such dividend, distribution or rights, options or warrants, or, if a record is not to be taken, the date as of which the holders of
Common Stock of record to be entitled to such dividend, distribution or rights are to be determined, or (ii) the date on which such reclassification, consolidation, merger, sale, transfer, dissolution, liquidation or winding-up is expected to
become effective or occur, and the date as of which it is expected that holders of Common Stock of record shall be entitled to exchange their Common Stock for securities or other property deliverable upon such reclassification, consolidation,
merger, binding share exchange, sale, transfer, dissolution, liquidation or winding-up. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such dividend, distribution, reclassification, consolidation,
merger, sale, transfer, dissolution, liquidation or winding-up. 

  
 86 

 SECTION 12.11 Stockholder Rights Plans. To the extent that the Company has a
stockholder rights plan or other “poison pill” in effect upon conversion of the Notes, each share of Common Stock, if any, issued upon such conversion shall be entitled to receive the appropriate number of rights, if any, and the
certificates representing the Common Stock issued upon such conversion shall bear such legends, if any, in each case as may be provided by the terms of any such stockholder rights plan or poison pill, as the same may be amended from time to time. If
prior to the time of conversion, however, the rights have separated from the shares of Common Stock in accordance with the provisions of the applicable stockholder rights agreement so that the holders of the Notes would not be entitled to receive
any rights in respect of Common Stock, if any, issuable upon conversion of the Notes, the Conversion Rate will be adjusted at the time of separation as if the Company had distributed to all holders of Common Stock, shares of Capital Stock of the
Company, evidence of indebtedness or assets as provided in Section 12.05(c), subject to readjustment in the event of the expiration, termination or redemption of such rights. 

ARTICLE XIII 
 REPURCHASE OF NOTES AT OPTION OF HOLDERS 
 SECTION 13.01 Repurchase at
Option of Noteholders upon a Fundamental Change. (a) If there shall occur a Fundamental Change at any time prior to the Maturity Date, then each Noteholder shall have the right, at such holder’s option, to require the Company to
repurchase for cash all of such holder’s Notes, or any portion thereof that is an integral multiple of $1,000 principal amount, on the date (the “Fundamental Change Purchase Date”) specified by the Company that is not less than
twenty Business Days and not more than thirty-five Business Days after the date of the Fundamental Change Company Notice (as defined below) at a repurchase price equal to 100% of the principal amount thereof, together with accrued and unpaid
interest (including any Additional Interest), thereon to, but excluding, the Fundamental Change Purchase Date (the “Fundamental Change Purchase Price”), unless the Fundamental Change Purchase Date is after an Interest Record Date
and on or prior to the related Interest Payment Date, in which case interest accrued to the Interest Payment Date will be paid to holders of the Notes as of the preceding Interest Record Date and the Fundamental Change Purchase Price payable to the
holder surrendering the Note for repurchase pursuant to this Section 13.01 shall be equal to 100% of the principal amount of the Notes subject to repurchase and will not include any accrued and unpaid interest (including any Additional
Interest). Repurchases of Notes under this Section 13.01 shall be made, at the option of the holder thereof, upon: 
 (i) delivery to the Paying Agent by a holder of a duly completed notice (the “Fundamental Change Purchase Notice”) in the form of Exhibit C hereto on or prior to the Business Day
immediately preceding the Fundamental Change Purchase Date; and 
 (ii) delivery or book-entry transfer of the
Notes to the Paying Agent at any time after delivery of the Fundamental Change Purchase Notice (together with all necessary endorsements) at the office of the Paying Agent, such delivery being a condition to receipt by the holder of the Fundamental
Change Purchase Price therefor; 

  
 87 

 
provided that such Fundamental Change Purchase Price shall be so paid pursuant to this Section 13.01 only if the Note so delivered to the Paying Agent shall conform in all respects to
the description thereof in the related Fundamental Change Purchase Notice. 
 The Fundamental Change Purchase Notice shall
state: 
 (A) if certificated, the certificate numbers of Notes to be delivered for repurchase; 

(B) the portion of the principal amount of Notes to be repurchased, which must be $1,000 or an integral multiple thereof;
and 
 (C) that the Notes are to be repurchased by the Company pursuant to the applicable provisions of the Notes
and this Indenture; 
 provided, however, that if the Notes are not in certificated form, the Fundamental Change Purchase Notice
must comply with appropriate Depositary procedures. 
 Any repurchase by the Company contemplated pursuant to the provisions of
this Section 13.01 shall be consummated by the payment of the Fundamental Change Purchase Price pursuant to Section 13.03(a). 
 Notwithstanding anything herein to the contrary, any holder delivering to the Paying Agent the Fundamental Change Purchase Notice contemplated by this Section 13.01 shall have the right to withdraw,
in whole or in part, such Fundamental Change Purchase Notice at any time prior to the close of business on the Business Day immediately preceding the Fundamental Change Purchase Date in accordance with Section 13.02 below. 

The Paying Agent shall promptly notify the Company of the receipt by it of any Fundamental Change Purchase Notice or written notice of
withdrawal thereof. 
 (b) On or before the twentieth calendar day after the occurrence of a Fundamental Change, the Company
shall provide notice to holders of record of the Notes (and to beneficial owners if required by applicable law) (the “Fundamental Change Company Notice”) of the occurrence of the Fundamental Change and of the repurchase right at the
option of the holders arising as a result thereof. The Company shall also deliver a copy of the Fundamental Change Company Notice to the Trustee, the Paying Agent and the Conversion Agent within five Business Days after the effective date of the
Fundamental Change. Each Fundamental Change Company Notice shall specify: 
 (i) the events causing the
Fundamental Change; 
 (ii) the effective date of the Fundamental Change, and, whether the Fundamental Change is
a Make-Whole Fundamental Change, in which case the effective date of the Make-Whole Fundamental Change; 
 (iii)
the last date on which a holder may exercise the repurchase right pursuant to this Section 13.01; 

  
 88 

 (iv) the Fundamental Change Purchase Price; 

(v) the Fundamental Change Purchase Date; 

(vi) if applicable, the name and address of the Paying Agent and the Conversion Agent; 

(vii) if applicable, the applicable Conversion Rate, and any adjustments to the applicable Conversion Rate; 

(viii) if applicable, that the Notes with respect to which a Fundamental Change Purchase Notice has been delivered by a
holder may be converted only if the holder withdraws the Fundamental Change Purchase Notice in accordance with the terms of this Indenture; 
 (ix) that the holder must exercise the repurchase right on or prior to the close of business on the Business Day immediately preceding the Fundamental Change Purchase Date (the “Fundamental Change
Expiration Time”); 
 (x) that the holder shall have the right to withdraw any Notes surrendered prior
to the Fundamental Change Expiration Time; and 
 (xi) the procedures that holders must follow to require the
Company to repurchase their Notes. 
 No failure of the Company to give a Fundamental Change Company Notice and no defect
therein shall limit the Noteholders’ repurchase rights or affect the validity of the proceedings for the repurchase of the Notes pursuant to this Section 13.01. 
 (c) Notwithstanding the foregoing, no Notes may be repurchased by the Company at the option of the holders upon a Fundamental Change if the principal amount of the Notes has been accelerated, and such
acceleration has not been rescinded, on or prior to the Fundamental Change Purchase Date (except in the case of an acceleration resulting from a default by the Company in the payment of the Fundamental Change Purchase Price with respect to such
Notes). 
 (d) In connection with any purchase offer, the Company will: 

(i) comply with the provisions of Rule 13e-4, Rule 14e-1 and any other tender offer rules under the Exchange
Act, if required under the Exchange Act, 
 (ii) file a Schedule TO or any successor or similar schedule, if
required under the Exchange Act, and 
 (iii) otherwise comply with all federal and state securities laws in
connection with any offer by the Company to purchase the Notes. 

  
 89 

 Notwithstanding anything to the contrary provided in this Indenture, compliance by the
Company with Rule 13e-4, Rule 14e-1 and any other tender offer rule under the Exchange Act in accordance with clause (i) above, to the extent inconsistent with any other provision of this Indenture, will not, standing alone,
constitute an Event of Default solely as a result of compliance by the Company with such rules. 
 Notwithstanding the foregoing
the Company shall not be required to repurchase the Notes in accordance with this Section 13.01 if a third party makes an offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Section 13.01
and purchases all Notes validly tendered and not withdrawn under such purchase offer. 
 SECTION 13.02 Withdrawal of
Fundamental Change Purchase Notice. 
 (a) A Fundamental Change Purchase Notice may be withdrawn by means of a written
notice of withdrawal delivered to the Corporate Trust Office of the Paying Agent in accordance with this Section 13.02 at any time prior to the close of business on the Business Day immediately preceding the Fundamental Change Purchase Date
specifying: 
 (i) the certificate number, if any, of the Note in respect of which such notice of withdrawal is
being submitted, 
 (ii) the principal amount of the Note with respect to which such notice of withdrawal is
being submitted, and 
 (iii) the principal amount, if any, of such Note that remains subject to the original
Fundamental Change Purchase Notice, which portion must be in principal amounts of $1,000 or an integral multiple of $1,000; 
 provided,
however, that if the Notes are not in certificated form, the withdrawal notice must comply with appropriate procedures of the Depositary. 
 SECTION 13.03 Deposit of Fundamental Change Purchase Price. 
 (a) The
Company will deposit with the Trustee (or other Paying Agent appointed by the Company, or if the Company is acting as its own Paying Agent, set aside, segregate and hold in trust as provided in Section 4.04) on or prior to 11:00 a.m., New
York City time, on the Business Day prior to the Fundamental Change Purchase Date, as applicable, an amount of money sufficient to repurchase all of the Notes to be repurchased at the appropriate Fundamental Change Purchase Price, as the case may
be. Subject to receipt of funds and/or Notes by the Trustee (or other Paying Agent appointed by the Company), payment for Notes surrendered for repurchase (and not withdrawn prior to the Fundamental Change Expiration Time, if applicable) will be
made on the later of (i) the Fundamental Change Purchase Date with respect to such Note (provided the holder has satisfied the conditions in Section 13.01) and (ii) the time of book-entry transfer or the delivery of such Note to the
Trustee (or other Paying Agent appointed by the Company) by the holder thereof in the manner required by Section 13.01 by mailing checks for the amount payable to the holders of such Notes entitled thereto as they shall appear in the Note
Register, provided, however, that payments to the Depositary shall be made by wire transfer of immediately available funds to the account of the Depositary or its nominee. The Trustee shall, promptly after such payment and upon written
demand by the Company, return to the Company any funds in excess of the Fundamental Change Purchase Price, as applicable. 

  
 90 

 (b) If by 11:00 a.m., New York City time, on the Fundamental Change Purchase Date the
Trustee (or other Paying Agent appointed by the Company) holds money sufficient to make payment on all the Notes or portions thereof that are to be repurchased as a result of the corresponding Fundamental Change, then (i) such Notes will cease
to be outstanding, (ii) interest, including Additional Interest, if any, will cease to accrue on such Notes, and (iii) all other rights of the holders of such Notes will terminate (other than the right to receive the Fundamental Change
Purchase Price, as applicable, and previously accrued but unpaid interest, including Additional Interest, if any, upon book-entry transfer or delivery of the Notes), in each case, whether or not book-entry transfer of the Notes has been made or the
Notes have been delivered to the Trustee or Paying Agent. 
 (c) The Registrar need not transfer or exchange any Notes in
respect of which a Fundamental Change Purchase Notice has been given and not withdrawn (except, in the case of a Note to be purchased in part, the portion of the Note not to be repurchased). Upon surrender of a Note that is to be repurchased in part
pursuant to Section 13.01, the Company shall execute and the Trustee shall authenticate and deliver to the holder a new Note in an authorized denomination equal in principal amount to the unrepurchased portion of the Note surrendered.

 ARTICLE XIV 
 MISCELLANEOUS PROVISIONS 
 SECTION 14.01 Provisions Binding on
Company’s Successors. All the covenants, stipulations, promises and agreements of the Company contained in this Indenture shall bind its successors and assigns whether so expressed or not. 

SECTION 14.02 Official Acts by Successor Corporation. Any act or proceeding by any provision of this Indenture authorized or
required to be done or performed by any board, committee or officer of the Company shall and may be done and performed with like force and effect by the like board, committee or officer of any corporation or other entity that shall at the time be
the lawful successor of the Company. 
 SECTION 14.03 Addresses for Notices, Etc. Any notice or demand that by any
provision of this Indenture is required or permitted to be given or served by the Trustee or by the Noteholders on the Company shall be deemed to have been sufficiently given or made, for all purposes if given or served by being deposited postage
prepaid by registered or certified mail in a post office letter box addressed (until another address is filed by the Company with the Trustee) to Kaman Corporation, 1332 Blue Hills Avenue, Bloomfield, Connecticut 06002, Attention: Robert Starr, Vice
President and Treasurer, with a copy to Candace Clark, Senior Vice President & Chief Legal Counsel, and to Crowell & Moring LLP, 1001 Pennsylvania Avenue, NW, Washington, D.C. 20004, Attention: Morris DeFeo. Any notice, direction,
request or demand hereunder to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or served by being deposited postage prepaid by registered or certified mail in a post office letter box addressed
to the Corporate Trust Office. 

  
 91 

 The Trustee, by notice to the Company, may designate additional or different addresses for
subsequent notices or communications. 
 Any notice or communication mailed to a Noteholder shall be mailed to it by first class
mail, postage prepaid, at its address as it appears on the Note Register and shall be deemed to have been sufficiently given to it if so mailed within the time prescribed. 
 Failure to mail a notice or communication to a Noteholder or any defect in it shall not affect its sufficiency with respect to other Noteholders. Except as otherwise provided herein, if a notice or
communication is mailed in the manner provided above, it is duly given, whether or not the addressee receives it. 
 In case by
reason of the suspension of regular mail service or by reason of any other cause it shall be impracticable to give such notice to holders by mail, then such notification as shall be made with the approval of the Trustee shall constitute a sufficient
notification for every purpose hereunder. 
 Except as otherwise provided in this Indenture or any Note, where this Indenture or
any Note provides for notice of any event to a holder of a Global Note (whether by mail or otherwise), such notice shall be sufficiently given if given to the Depositary for such Note (or its designee), pursuant to customary procedures of such
Depositary. 
 The Trustee may rely upon and comply with instructions or directions sent via unsecured facsimile or email
transmission provided they are via a Company Order and the Trustee shall not be liable for any loss, liability or expense of any kind incurred by the Company or the holders due to the Trustee’s reliance upon and compliance with instructions or
directions given by unsecured facsimile or email transmission, provided, however, that such losses have not arisen from the negligence or willful misconduct of the Trustee, it being understood that the failure of the Trustee to verify or confirm
that the person providing the instructions or directions, is, in fact, an authorized person does not constitute negligence or willful misconduct. 
 SECTION 14.04 Governing Law. THIS INDENTURE AND EACH NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF NEW YORK, AND FOR ALL PURPOSES SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAWS OF
NEW YORK. 
 SECTION 14.05 Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to
Trustee. 
 (a) Upon any request or application by the Company to the Trustee to take any action under this Indenture, the
Company shall furnish to the Trustee: 
 (i) an Officers’ Certificate stating that, in the opinion of the
signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and 
 (ii) an Opinion of Counsel stating that, in the opinion of such counsel, all such conditions precedent have been complied with. 

  
 92 

 (b) Each certificate or opinion with respect to compliance with a condition or covenant
provided for in this Indenture shall include: 
 (i) a statement that each person signing such certificate or
opinion has read such covenant or condition and the definitions herein relating thereto; 
 (ii) a brief
statement as to the nature and scope of the examination or investigation upon which the statement or opinion contained in such certificate or opinion is based; 
 (iii) a statement that, in the opinion of each such person, the person has made such examination or investigation as is necessary to enable the person to express an informed opinion as to whether or not
such covenant or condition has been complied with; and 
 (iv) a statement as to whether or not, in the opinion
of each such person, such condition or covenant has been complied with; provided, however, that, with respect to matters of fact, an Opinion of Counsel may rely on an Officers’ Certificate or certificates of public officials. 

SECTION 14.06 Legal Holidays. In any case where any Interest Payment Date, Fundamental Change Purchase Date, Conversion Date or
Maturity Date is not a Business Day, then any action to be taken on such date need not be taken on such date, but may be taken on the next succeeding Business Day with the same force and effect as if taken on such date, and no interest shall accrue
for the period from and after such date. 
 SECTION 14.07 No Security Interest Created. Nothing in this Indenture or in
the Notes, expressed or implied, shall be construed to constitute a security interest under the Uniform Commercial Code or similar legislation, as now or hereafter enacted and in effect, in any jurisdiction. 

SECTION 14.08 Trust Indenture Act. This Indenture is hereby made subject to, and shall be governed by, the provisions of the Trust
Indenture Act required to be part of and to govern indentures qualified under the Trust Indenture Act upon such qualification; provided that this Section 14.08 shall not require that this Indenture or the Trustee be qualified under the Trust
Indenture Act prior to the time such qualification is in fact required under the terms of the Trust Indenture Act, nor shall it constitute any admission or acknowledgment by any party hereto that any such qualification is required prior to the time
such qualification is in fact required under the terms of the Trust Indenture Act. If any provision hereof limits, qualifies or conflicts with another provision hereof that is required to be included in an indenture qualified under the Trust
Indenture Act, such required provision shall control. 
 SECTION 14.09 Benefits of Indenture. Nothing in this Indenture
or in the Notes, expressed or implied, shall give to any Person, other than the parties hereto, any Paying Agent, any Conversion Agent, any authenticating agent, any Note Registrar and their successors hereunder or the Noteholders, any benefit or
any legal or equitable right, remedy or claim under this Indenture. 

  
 93 

 SECTION 14.10 Table of Contents, Headings, Etc. The table of contents and the titles
and headings of the articles and sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof. 

SECTION 14.11 Authenticating Agent. The Trustee may appoint an authenticating agent that shall be authorized to act on its behalf
and subject to its direction in the authentication and delivery of Notes in connection with the original issuance thereof and transfers and exchanges of Notes hereunder, including under Section 2.02, Section 2.05, Section 2.06,
Section 2.07, Section 2.09, Section 9.04, Section 12.02 and Section 13.04 as fully to all intents and purposes as though the authenticating agent had been expressly authorized by this Indenture and those Sections to
authenticate and deliver Notes. For all purposes of this Indenture, the authentication and delivery of Notes by the authenticating agent shall be deemed to be authentication and delivery of such Notes “by the Trustee” and a certificate of
authentication executed on behalf of the Trustee by an authenticating agent shall be deemed to satisfy any requirement hereunder or in the Notes for the Trustee’s certificate of authentication. Such authenticating agent shall at all times be a
Person eligible to serve as trustee hereunder pursuant to Section 6.09. 
 Any corporation or other entity into which any
authenticating agent may be merged or converted or with which it may be consolidated, or any corporation or other entity resulting from any merger, consolidation or conversion to which any authenticating agent shall be a party, or any corporation or
other entity succeeding to the corporate trust business of any authenticating agent, shall be the successor of the authenticating agent hereunder, if such successor corporation or other entity is otherwise eligible under this section, without the
execution or filing of any paper or any further act on the part of the parties hereto or the authenticating agent or such successor corporation or other entity. 
 Any authenticating agent may at any time resign by giving written notice of resignation to the Trustee and to the Company. The Trustee may at any time terminate the agency of any authenticating agent by
giving written notice of termination to such authenticating agent and to the Company. Upon receiving such a notice of resignation or upon such a termination, or in case at any time any authenticating agent shall cease to be eligible under this
Section, the Trustee may appoint a successor authenticating agent (which may be the Trustee), shall give written notice of such appointment to the Company and shall mail notice of such appointment to all Noteholders as the names and addresses of
such holders appear on the Note Register. 
 The Company agrees to pay to the authenticating agent from time to time reasonable
compensation for its services although the Company may terminate the authenticating agent, if it determines such agent’s fees to be unreasonable. 
 The provisions of Section 6.02, Section 6.03, Section 6.04, Section 7.03 and this Section 14.11 shall be applicable to any authenticating agent. 

  
 94 

 If an authenticating agent is appointed pursuant to this Section 14.11, the Notes may
have endorsed thereon, in addition to the Trustee’s certificate of authentication, an alternative certificate of authentication in the following form: 

	
	
	  
	as Authenticating Agent, certifies that this is one of the Notes described in the within-named Indenture.

			
		
	By:	 	 
		 	Authorized Officer

 SECTION 14.12
Execution in Counterparts. This Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument. 

SECTION 14.13 Severability. In the event any provision of this Indenture or in the Notes shall be invalid, illegal or
unenforceable, then (to the extent permitted by law) the validity, legality or enforceability of the remaining provisions shall not in any way be affected or impaired. 
 SECTION 14.14 Waiver of Jury Trial. EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED HEREBY. 
 SECTION 14.15
Force Majeure. In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without
limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and
hardware) services; it being understood that the Trustee shall use reasonable efforts that are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. 

SECTION 14.16 Calculations in Respect of the Notes. Except as otherwise provided herein, the Company shall make all calculations
and determinations under this Indenture and the Notes (including, without limitation, the Last Reported Sale Price, Daily VWAPs, accrued interest payable and the Conversion Rate). All calculations under this Indenture and the Notes shall be made in
good faith. In the absence of manifest error, such calculations shall be final and binding on all holders. The Company shall provide a copy of any such calculation it has made to the Trustee and the Conversion Agent as required hereunder, and both
of the Trustee and Conversion Agent shall be entitled to rely conclusively on the accuracy of any such calculation without independent verification. The Trustee and any other Conversion Agent shall forward the Company’s calculations or any
calculations by the Trustee or such other Conversion Agent, as applicable, to any Noteholder upon the written request of that Noteholder. 

  
 95 

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of
the date first written above. 
  

			
	KAMAN CORPORATION
		
	By:	 	/s/ William C. Denninger
		 	Name: William C. Denninger
		 	Title: Sr. Vice President and CFO
	
	 THE BANK OF NEW YORK MELLON
 TRUST COMPANY, N.A., as Trustee

		
	By:	 	/s/ Beth Mellinger
		 	Name: Beth Mellinger
		 	Title: Senior Associate

 EXHIBIT A 
 [FORM OF FACE OF NOTE] 
 [Include the following legend for Global Notes only (the
“Global Securities Legend”):] 
 THIS IS A GLOBAL NOTE WITHIN THE
MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS CONVERTIBLE NOTE FOR
ALL PURPOSES. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE
ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY
(AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 TRANSFERS OF THIS GLOBAL NOTE SHALL
BE LIMITED TO TRANSFERS TO NOMINEES OF THE DEPOSITORY TRUST COMPANY, OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET
FORTH IN ARTICLE TWO OF THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 
 [Include the following legend on all Notes that are Restricted
Notes (the “Restricted Securities Legend”):] 
 THE SALE OF THIS NOTE HAS NOT BEEN REGISTERED UNDER THE U.S.
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND, ACCORDINGLY, PRIOR TO THE RESALE RESTRICTION TERMINATION DATE (AS DEFINED BELOW), THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON CONVERSION OF THIS
NOTE (AND ANY BENEFICIAL INTEREST HEREIN OR THEREIN) MAY NOT BE OFFERED, RESOLD OR OTHERWISE TRANSFERRED, EXCEPT: 
 (A) TO THE COMPANY OR ANY
SUBSIDIARY THEREOF; 
 (B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT; 

(C) TO A PERSON THAT YOU REASONABLY BELIEVE TO BE A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT; OR

 (D) UNDER ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (INCLUDING, IF AVAILABLE, THE EXEMPTION
PROVIDED BY RULE 144 UNDER THE SECURITIES ACT). 
 THE “RESALE RESTRICTION TERMINATION DATE” MEANS THE DATE: (A) THAT IS AT
LEAST ONE YEAR AFTER THE LAST DATE OF ORIGINAL ISSUANCE OF THE NOTES; AND (B) ON WHICH THE COMPANY HAS INSTRUCTED THE TRUSTEE THAT THIS LEGEND WILL NO LONGER APPLY IN ACCORDANCE WITH THE PROCEDURES DESCRIBED IN THE INDENTURE. 

PRIOR TO ANY TRANSFER PURSUANT TO THE FOREGOING CLAUSE (D), THE COMPANY AND THE TRUSTEE RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH
CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION AS THEY MAY REASONABLY REQUIRE AND MAY RELY UPON TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT. 
 NO AFFILIATE OF THE COMPANY MAY PURCHASE OR OTHERWISE ACQUIRE NOTES. 

  
 A-1

 KAMAN CORPORATION 
 3.25% Convertible Senior Note due 2017 
  

			
	 No. [            ]
	  	$[      ]

CUSIP No. [        ] 

Kaman Corporation, a corporation duly organized and validly existing under the laws of the State of Connecticut
(herein called the “Company,” which term includes any successor corporation or other entity under the Indenture referred to on the reverse hereof), for value received hereby promises to pay to [CEDE & CO., or its registered
assigns,]1 the principal sum of
[            ] million Dollars, [as revised by the Schedule of Increases and Decreases in Global Note attached hereto,]2 on November 15, 2017, interest thereon as set forth below and Additional Interest in the manner, at the rates and
to the Persons set forth in Sections 4.06 and 5.03, as applicable, of the Indenture. 
 The Company promises to pay
interest on the principal amount of this Note at the rate of 3.25% per annum (subject to increase pursuant to Sections 4.06 and 5.03, as applicable, of the Indenture) from November 19, 2010 semiannually in arrears on May 15 and
November 15 of each year, commencing on May 15, 2011, to holders of record at the close of business on the preceding November 1 and May 1 (whether or not such day is a Business Day), respectively, until the maturity or earlier
conversion or repurchase. Interest on the Note will accrue from the most recent date to which interest has been paid, or, if no interest has been paid on the Note, from November 19, 2010. 

Payment of the principal of and accrued and unpaid interest (including any accrued and unpaid Additional Interest) on this Note shall be
made at the office or agency of the Company maintained for that purpose in the Borough of Manhattan, The City of New York, in such lawful money of the United States of America as at the time of payment shall be legal tender for the payment of public
and private debts; provided, however, that any payment to the Depositary or its nominee shall be paid by wire transfer in immediately available funds in accordance with the wire transfer instruction supplied by the Depositary or its
nominee from time to time to the Trustee and Paying Agent (if different from Trustee). 
 Reference is made to the further
provisions of this Note set forth on the reverse hereof, including, without limitation, provisions giving the holder of this Note the right to convert this Note into cash or a combination of cash and shares of Common Stock of the Company, as
applicable, on the terms and subject to the limitations set forth in the Indenture. Such further provisions shall for all purposes have the same effect as though fully set forth at this place. 

 

	1	 Use bracketed language for a Global Note. 

	2	 Use bracketed language for a Global Note. 

  
 A-2

 This Note shall be deemed to be a contract made under the laws of the State of New York, and
for all purposes shall be construed in accordance with and governed by the laws of said State. 
 This Note shall not be valid
or become obligatory for any purpose until the certificate of authentication hereon shall have been manually signed by the Trustee or a duly authorized authenticating agent under the Indenture. 

[Remainder of page intentionally left blank] 

  
 A-3

 IN WITNESS WHEREOF, the Company has caused this Note to be duly executed. 

 

			
	KAMAN CORPORATION
		
	By:	 	 
		 	Name:
		 	Title:

 Dated: 

TRUSTEE’S CERTIFICATE OF AUTHENTICATION 
 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., 
 as Trustee, certifies that this is one of
the Notes described 
 in the within-named Indenture. 

			
		
	By:	 	 
		 	Authorized Officer

  
 A-4

 [FORM OF REVERSE OF NOTE] 

KAMAN CORPORATION 

3.25% Convertible Senior Note due 2017 
 This Note is one of a duly authorized issue of Notes of the Company, designated as its 3.25% Convertible Senior Notes due 2017 (the “Notes”), limited to the aggregate principal amount of
$115,000,000 all issued or to be issued under and pursuant to an Indenture dated as of November 19, 2010 (as such may be amended from time to time, the “Indenture”), between the Company and The Bank of New York Mellon Trust
Company, N.A. (the “Trustee”), to which Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee,
the Company and the holders of the Notes. Additional Notes may be issued in an unlimited aggregate principal amount, subject to certain conditions specified in the Indenture. 
 In case an Event of Default, as defined in the Indenture, shall have occurred and be continuing, the principal of and interest, including Additional Interest, if any, on all Notes may be declared, by
either the Trustee or the holders of not less than 25% in aggregate principal amount of Notes then outstanding, and upon said declaration shall become, due and payable, in the manner, with the effect and subject to the conditions and certain
exceptions set forth in the Indenture. 
 Subject to the terms and conditions of the Indenture, the Company will make all
payments and deliveries in respect of the principal amount on the Maturity Date to the holder who surrenders a Note to a Paying Agent to collect such payments in respect of the Note. The Company will pay cash amounts in money of the United States
that at the time of payment is legal tender for payment of public and private debts. 
 The Indenture contains provisions
permitting the Company and the Trustee in certain circumstances, without the consent of the holders of the Notes, and in other circumstances, with the consent of the holders of not less than a majority in aggregate principal amount of the Notes at
the time outstanding, evidenced as in the Indenture provided, to execute supplemental indentures modifying the terms of the Indenture and the Notes as described therein. It is also provided in the Indenture that, subject to certain exceptions, the
holders of a majority in aggregate principal amount of the Notes at the time outstanding may on behalf of the holders of all of the Notes waive any past Default or Event of Default under the Indenture and its consequences. 

No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of and accrued and unpaid interest (including any Additional Interest) on this Note at the place, at the respective times, at the rate and in the lawful money herein prescribed.

 The Notes are issuable in registered form without coupons in denominations of $1,000 principal amount and integral
multiples thereof. At the office or agency of the Company referred to on the face hereof, and in the manner and subject to the limitations provided in the 

  
 A-5

 
Indenture, Notes may be exchanged for a like aggregate principal amount of Notes of other authorized denominations, without payment of any service charge but, if required by the Company or
Trustee, with payment of a sum sufficient to cover any tax, assessments or other governmental charges that may be imposed in connection therewith as a result of the name of the holder of the new Notes issued upon such exchange of Notes being
different from the name of the holder of the old Notes surrendered for such exchange. 
 Subject to the provisions of the
Indenture, upon the occurrence of a Fundamental Change, the holder has the right, at such holder’s option, to require the Company to repurchase for cash all of such holder’s Notes or any portion thereof (in principal amounts of $1,000 or
integral multiples thereof) on the Fundamental Change Purchase Date at a price equal to the Fundamental Change Purchase Price. 

Subject to the provisions of the Indenture, the holder hereof has the right, at its option, during certain periods and upon the
occurrence of certain conditions specified in the Indenture, prior to the close of business on the second Scheduled Trading Day immediately preceding the Maturity Date, to convert any Notes into cash or a combination of cash and shares of Common
Stock, as applicable, at a Conversion Rate specified in the Indenture, as adjusted from time to time as provided in the Indenture. 
 Terms used in this Note and defined in the Indenture are used herein as therein defined. 

  
 A-6

 ABBREVIATIONS 
 The following abbreviations, when used in the inscription of the face of this Note, shall be construed as though they were written out in full according to applicable laws or regulations: 

					
			
	 TEN COM -as tenants in common
	  	UNIF GIFT MIN ACT	  	
			
		  	 	  	Custodian
		  	(Cust)	  	
			
	 TEN ENT as tenants by the entireties
	  	 	  	
		  	(Minor)	  	
	 JT TEN -as joint tenants with right of

survivorship and not as tenants in common
	  	Uniform Gifts to Minors Act	  	
			
		  	 	  	(State)

 Additional abbreviations may also
be used 
 though not in the above list. 

  
 A-7

 SCHEDULE OF INCREASES AND DECREASES IN GLOBAL NOTE3 

KAMAN CORPORATION 

3.25% Convertible Senior Notes due 2017 
 The initial principal amount of this Global Note is $[    ]. The following increases or decreases in this Global Note have been made: 

 

																			
	            Date:     
       	 	  	Amount of decrease in
Principal Amount of this
Date Global Note	 	  	Amount of increase in
Principal Amount of this
Global
Note	 	  	Principal Amount of this
Global Note following
such decrease or
increase	 	  	Signature of authorized
signatory of Trustee or
Custodian	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 
				  				  				  				  			
	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 

  

	3	For Global Notes only. 

  
 A-8

 EXHIBIT B 
 [FORM OF NOTICE OF CONVERSION] 
 To: KAMAN CORPORATION 

The undersigned registered owner of this Note hereby exercises the option to convert this Note, or the portion hereof (that is $1,000
principal amount or an integral multiple thereof) below designated, into cash or a combination of cash and shares of Common Stock, as applicable, in accordance with the terms of the Indenture referred to in this Note, and directs that an amount of a
cash, together with a number of shares of Common Stock issuable and deliverable upon such conversion, if any, payable upon conversion, be issued and delivered to the registered holder hereof unless a different name has been indicated below. If any
shares of Common Stock or any portion of this Note not converted are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto. Any amount required to be paid to the
undersigned on account of interest accompanies this Note. 
  

							
	Dated:	 	 	 		 	 
	 	 	 	 		 	  
		 		 		 	Signature(s)

 Signature Guarantee 

Signature(s) must be guaranteed by an eligible 

Guarantor Institution (banks, stock brokers, 

savings and loan associations and credit unions) 

with membership in an approved signature 

guarantee medallion program pursuant to 

Securities and Exchange Commission 

Rule 17Ad-15 if shares of Common Stock are to 
 be issued, or Notes to be delivered, other than to 
 and in the name of the registered holder.

  
 B-1

	
	 Fill in for registration of shares if to be issued, and Notes if

to be delivered, other than to and in the name of the
 registered holder:
  

	 (Name)

 

	 (Street Address)

 

	 (City, State and Zip Code)

Please print name and address

  

	
	 Principal amount to be converted

(if less than all): $        ,000

	
	 NOTICE: The above signature(s) of the
 holder(s) hereof must correspond with the
 name as written upon the face of the Note in

every particular without alteration or

enlargement or any change whatever.

	
	 
	Social Security or Other Taxpayer Identification Number

  
 B-2

 EXHIBIT C 
 [FORM OF FUNDAMENTAL CHANGE PURCHASE NOTICE] 
 To: KAMAN CORPORATION 

The undersigned registered owner of this Note hereby acknowledges receipt of a notice from Kaman Corporation (the “Company”) as to the
occurrence of a Fundamental Change with respect to the Company and specifying the Fundamental Change Purchase Date and requests and instructs the Company to repay to the registered holder hereof in accordance with the applicable provisions of the
Indenture referred to in this Note (1) the entire principal amount of this Note, or the portion thereof (that is $1,000 principal amount or an integral multiple thereof) below designated, and (2) if such Fundamental Change Purchase Date
does not fall during the period after an Interest Record Date and on or prior to the corresponding Interest Payment Date, accrued and unpaid interest (including any Additional Interest) thereon to, but excluding, such Fundamental Change Purchase
Date. 
 In the case of Certificated Notes, the certificate numbers of the Notes to be repurchased are as set forth below: 

 

							
	Dated:	 	 	 		 	
				
	 	 	 	 		 	  
		 		 		 	Signature(s)
				
		 		 		 	 
		 		 		 	Social Security or Other Taxpayer Identification Number
				
		 		 		 	Principal amount to be repaid (if less than all): $__,000
				
		 		 		 	NOTICE: The above signature(s) of the holder(s) hereof must correspond with the name as written upon the face of the Note in every particular without alteration or enlargement or
any change whatever.

  
 C-1

 EXHIBIT D 
 [FORM OF ASSIGNMENT AND TRANSFER] 
 For value received
             hereby sell(s), assign(s) and transfer(s) unto              (Please insert social security or Taxpayer
Identification Number of assignee) the within Note, and hereby irrevocably constitutes and appoints              attorney to transfer the said Note on the books of the Company, with
full power of substitution in the premises. 
 In connection with any transfer of the within Note occurring prior to the Resale Restriction
Termination Date, as defined in the Indenture governing such Note, the undersigned confirms that such Note is being transferred: 
  ̈ To Kaman Corporation or a subsidiary thereof; or 

 ̈ For so long as the Notes are eligible for resale pursuant to Rule 144A under the Securities Act of
1933, as amended, to a person it reasonably believes is a qualified institutional buyer (as defined in Rule 144A) that purchases for its own account or for the account of a qualified institutional buyer to which notice is given that the transfer is
being made in reliance on Rule 144A; or 
  ̈ Pursuant to a registration statement that has
become or been declared effective under the Securities Act of 1933, as amended; or 
  ̈ Pursuant
to any other available exemption from the registration requirements of the Securities Act of 1933, as amended, if available. 

  
 D-1

			
	
		
	Dated:	 	 
	
	 
	
	 
	Signature(s)
	
	 
	Signature Guarantee
	
	Signature(s) must be guaranteed by an eligible Guarantor Institution (banks, stock brokers, savings and loan associations and credit unions) with membership in an
approved signature guarantee medallion program pursuant to Securities and Exchange Commission Rule l7Ad-15 Notes are to be delivered, other than to and in the name of the registered holder.

NOTICE: The signature on the assignment must correspond with the name as written upon the face of the Note in every particular without alteration or
enlargement or any change whatever. 

  
 D-2

 EXHIBIT E 
 RESTRICTED STOCK LEGEND 
 THE SALE OF THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE U.S.
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND, ACCORDINGLY, PRIOR TO THE RESALE RESTRICTION TERMINATION DATE (AS DEFINED BELOW), THIS SECURITY (AND ANY BENEFICIAL INTEREST HEREIN OR THEREIN)
MAY NOT BE OFFERED, RESOLD OR OTHERWISE TRANSFERRED, EXCEPT: 
 (A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF; 

(B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT; OR 
 (C) UNDER ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (INCLUDING, IF AVAILABLE, THE EXEMPTION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT). 

THE “RESALE RESTRICTION TERMINATION DATE” MEANS THE DATE: (A) THAT IS AT LEAST ONE YEAR AFTER THE LAST DATE OF ORIGINAL ISSUANCE OF THE
COMPANY’S 3.25% CONVERTIBLE SENIOR NOTES DUE 2017; AND (B) ON WHICH THE COMPANY HAS INSTRUCTED THE TRANSFER AGENT THAT THIS LEGEND WILL NO LONGER APPLY, IN ACCORDANCE WITH THE PROCEDURES DESCRIBED IN THE INDENTURE FOR THE NOTES.

 PRIOR TO ANY TRANSFER PURSUANT TO THE FOREGOING CLAUSE (C), THE COMPANY AND THE COMPANY’S TRANSFER AGENT RESERVE THE RIGHT TO
REQUIRE THE DELIVERY OF SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION AS THEY MAY REASONABLY REQUIRE AND MAY RELY UPON TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. 

  
 E-1Exhibit 10.1

 EXHIBIT 10.1 

 
  

 
 KAMAN CORPORATION 

(a Connecticut corporation) 
 $100,000,000 
 3.25% Convertible Senior Notes due 2017 

PURCHASE AGREEMENT 

November 15, 2010 
  

 
  

 EXECUTION VERSION 

KAMAN CORPORATION 

(a Connecticut corporation) 
 $100,000,000 
 3.25% Convertible Senior Notes due 2017 

PURCHASE AGREEMENT 
 November 15, 2010 
 Merrill Lynch, Pierce, Fenner & Smith Incorporated 

RBS Securities Inc. 
 as Representatives of the
several Initial Purchasers 
 c/o Merrill Lynch, Pierce, Fenner & Smith Incorporated 

One Bryant Park 
 New York, 

New York 10036 
 Ladies and Gentlemen:

 KAMAN CORPORATION, a Connecticut corporation (the “Company”), confirms its agreement with Merrill Lynch, Pierce,
Fenner & Smith Incorporated (“Merrill Lynch”) and each of the other Initial Purchasers named in Schedule A hereto (collectively, the “Initial Purchasers,” which term shall also include any initial purchaser substituted
as hereinafter provided in Section 10 hereof), for whom Merrill Lynch and RBS Securities Inc. are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase
by the Initial Purchasers, acting severally and not jointly, of the respective principal amounts set forth in said Schedule A of $100,000,000 aggregate principal amount of the Company’s 3.25% Convertible Senior Notes due 2017 (the
“Initial Securities”) and (ii) the grant by the Company to the Initial Purchasers, acting severally and not jointly, of the option to purchase all or any part of an additional $15,000,000 aggregate principal amount of its 3.25%
Convertible Senior Notes due 2017 (the “Option Securities” and, together with the Initial Securities, the “Securities”) to cover overallotments. The Securities are to be issued pursuant to an indenture dated as of
November 19, 2010 (the “Indenture”) between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”). 
 The Company understands that the Initial Purchasers propose to make an offering of the Securities on the terms and in the manner set forth in this Purchase Agreement (this “Agreement”) and
agrees that the Initial Purchasers may resell, subject to the conditions set forth herein, all or a portion of the Securities to purchasers (“Subsequent Purchasers”) at any time after this Agreement has been executed and delivered. The
Securities are to be offered and sold through the Initial Purchasers without being registered under the Securities Act of 1933, as amended (the “1933 Act”), in reliance upon exemptions therefrom. Pursuant to the terms of the
Securities and the Indenture, investors that acquire Securities may only resell or otherwise transfer such Securities if such Securities are hereafter registered under the 1933 Act or if an exemption from the registration requirements of the
1933 Act is available (including the exemption afforded by Rule 144A (“Rule 144A”) of the rules and regulations promulgated under the 1933 Act (the “1933 Act Regulations”) by the Securities and Exchange
Commission (the “Commission”)). 

 The Company has prepared and delivered to each Initial Purchaser copies of a preliminary
offering memorandum dated November 15, 2010 (the “Preliminary Offering Memorandum”) and has prepared and will deliver to each Initial Purchaser, on the date hereof or the next succeeding day, copies of a final offering memorandum
dated November 15, 2010 (the “Final Offering Memorandum”), each for use by such Initial Purchaser in connection with its solicitation of purchases of, or offering of, the Securities. “Offering Memorandum” means, with respect
to any date or time referred to in this Agreement, the most recent offering memorandum (whether the Preliminary Offering Memorandum or the Final Offering Memorandum, or any amendment or supplement to either such document), including exhibits thereto
and any documents incorporated therein by reference, which has been prepared and delivered by the Company to the Initial Purchasers in connection with their solicitation of purchases of, or offering of, the Securities. The Company will prepare a
final term sheet reflecting the final terms of the Securities, in the form set forth in Schedule B hereto (the “Final Term Sheet”), and will deliver such Final Term Sheet to the Initial Purchasers in connection with their solicitation of
purchases of, or offering of, the Securities. The Company agrees that, unless it obtains the prior written consent of the Representatives, it will not make any offer relating to the Securities by any written materials other than the Offering
Memorandum and the Issuer Written Information. “Issuer Written Information” means (i) any writing intended for general distribution to investors as evidenced by its being specified in Schedule C hereto, including the Final Term Sheet,
and (ii) any “road show” that is a “written communication” within the meaning of the 1933 Act and that has been previously reviewed and approved for distribution by the Company. “General Disclosure Package” means
the Preliminary Offering Memorandum and any Issuer Written Information specified on Schedule C hereto and issued at or prior to 4:00 P.M., New York City time, on November 15, 2010 or such other time as agreed by the Company and Merrill Lynch
(such date and time, the “Applicable Time”). 
 All references in this Agreement to financial statements and schedules
and other information which is “contained,” “included” or “stated” in the Offering Memorandum (or other references of like import) shall be deemed to mean and include all such financial statements and schedules and
other information which are incorporated by reference in the Offering Memorandum; and all references in this Agreement to amendments or supplements to the Offering Memorandum shall be deemed to mean and include the filing of any document under the
Securities Exchange Act of 1934 (the “1934 Act”) which is incorporated by reference in the Offering Memorandum. 

SECTION 1. Representations and Warranties. 
 (a) Representations and Warranties by the Company. The Company represents and warrants to each Initial Purchaser as of the date hereof, the Applicable Time, the Closing Time (as defined below) and
any Date of Delivery (as defined below), except in the case of representations and warranties that by their terms speak as of a specified date, in which instance the Company represents and warrants as of such specified date, and agrees with each
Initial Purchaser, as follows: 
 (i) General Disclosure Package; Rule 144A Eligibility. The Company
hereby confirms that it has authorized the use of the General Disclosure Package, including the Preliminary Offering Memorandum and the Final Term Sheet, and the Final Offering Memorandum in connection with the offer and sale of the Securities by
the Initial Purchasers. The Securities are eligible for resale pursuant to Rule 144A and will not be, at the Closing Time, of the same class as securities listed on a national securities exchange registered under Section 6 of the
1934 Act, or quoted in a U.S. automated interdealer quotation system. 
 (ii) No Registration Required;
No General Solicitation. Subject to compliance by the Initial Purchasers with the representations and warranties of the Initial Purchasers and the procedures set forth in Section 6 hereof, it is not necessary in connection with the offer,
sale and 

  
 2 

 
delivery of the offered Securities to the Initial Purchasers and to each Subsequent Purchaser in the manner contemplated by this Agreement and the Offering Memorandum to register the Securities
under the 1933 Act or to qualify the Indenture under the Trust Indenture Act of 1939, as amended (the “1939 Act”). None of the Company, its affiliates controlled by the Company or any person acting on its or any of their behalf (other
than the Initial Purchasers, as to whom the Company makes no representation) has engaged, in connection with the offering of the offered Securities, in any form of general solicitation or general advertising within the meaning of Rule 502(c)
under the 1933 Act Regulations. 
 (iii) Accurate Disclosure. As of the Applicable Time, neither
(A) the General Disclosure Package nor (B) any Issuer Written Information, when considered together with the General Disclosure Package, included, includes or will include an untrue statement of a material fact or omitted, omits or will
omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Final Offering Memorandum, as of its date, at the Closing Time or at any Date of
Delivery, did not, does not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The documents incorporated or deemed to be incorporated by reference in the General Disclosure Package and the Final Offering Memorandum, when such documents incorporated by reference were filed with the Commission, when read together with the other
information in the General Disclosure Package or the Final Offering Memorandum, as the case may be, did not, does not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. 
 The
representations and warranties in this subsection shall not apply to statements in or omissions from the General Disclosure Package or the Final Offering Memorandum made in reliance upon and in conformity with written information furnished to the
Company by any Initial Purchaser through Merrill Lynch expressly for use therein. For purposes of this Agreement, the only information so furnished shall be the information in the first paragraph under the heading “Plan of
Distribution–Price Stabilization, Short Positions” in the Offering Memorandum (collectively, the “Initial Purchaser Information”). 
 (iv) Incorporation of Documents by Reference. The documents incorporated or deemed to be incorporated by reference in the Offering Memorandum, when they became effective or at the time they were or
hereafter are filed with the Commission, complied and will comply in all material respects with the requirements of the 1934 Act and the rules and regulations of the Commission under the 1934 Act (the “1934 Act Regulations”). 

(v) Independent Accountants. The accountants who certified the financial statements and supporting schedules
included in the Offering Memorandum are independent public accountants as required by the 1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act Regulations and the Public Company Accounting Oversight Board. 

(vi) Financial Statements; Non-GAAP Financial Measures. The financial statements included or incorporated by
reference in the General Disclosure Package and the Final Offering Memorandum, together with the related schedules and notes, present fairly the financial position of the Company and its consolidated subsidiaries at the dates indicated and the
statement of operations, stockholders’ equity and cash flows of the Company and its consolidated subsidiaries for the periods specified; said financial statements have been prepared in conformity with U.S. generally accepted accounting
principles (“GAAP”) applied on a consistent basis throughout the 

  
 3 

 
periods involved. The supporting schedules, if any, present fairly in accordance with GAAP the information required to be stated therein. The selected financial data and the summary financial
information included in the Offering Memorandum present fairly the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included therein. Except as included therein, no historical or
pro forma financial statements or supporting schedules are required to be included or incorporated by reference in the Offering Memorandum under the 1933 Act or the 1933 Act Regulations. All disclosures contained in the General Disclosure Package or
the Final Offering Memorandum, or incorporated by reference therein, regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission) comply with Regulation G of the 1934 Act and Item 10
of Regulation S-K of the 1933 Act, to the extent applicable. 
 (vii) No Material Adverse Change in
Business. Except as otherwise stated therein, since the respective dates as of which information is given in the General Disclosure Package or the Final Offering Memorandum, (A) there has been no material adverse change in the condition,
financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business (a “Material Adverse Effect”),
(B) there have been no transactions entered into by the Company or any of its subsidiaries, other than those in the ordinary course of business, which are material with respect to the Company and its subsidiaries considered as one enterprise,
and (C) except for regular quarterly dividends on the Company’s common stock, par value $1.00 per share (the “Common Stock”), in amounts per share that are consistent with past practice, there has been no dividend or distribution
of any kind declared, paid or made by the Company on any class of its capital stock. 
 (viii) Good Standing
of the Company. The Company has been duly organized and is validly existing as a corporation in good standing under the laws of the State of Connecticut and has corporate power and authority to own, lease and operate its properties and to
conduct its business as described in the General Disclosure Package and the Final Offering Memorandum and to enter into and perform its obligations under this Agreement; and the Company is duly qualified as a foreign corporation to transact business
and is in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would
not result in a Material Adverse Effect. 
 (ix) Good Standing of Subsidiaries. Each “significant
subsidiary” of the Company (as such term is defined in Rule 1-02 of Regulation S-X) (each, a “Significant Subsidiary” and, collectively, the “Significant Subsidiaries”) has been duly organized and is validly existing in good
standing under the laws of the jurisdiction of its incorporation or organization, has corporate or similar power and authority to own, lease and operate its properties and to conduct its business as described in the General Disclosure Package and
the Final Offering Memorandum and is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business,
except where the failure to so qualify or to be in good standing would not result in a Material Adverse Effect. Except as otherwise disclosed in the General Disclosure Package and the Final Offering Memorandum, all of the issued and outstanding
capital stock of each Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable and is owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien,
encumbrance, claim or equity, except for the security interest granted in favor of the collateral agent under that certain Amended and Restated Security Agreement, dated as of September 20, 2010, among the Company, certain of its subsidiaries
and Bank of America, 

  
 4 

 
N.A. None of the outstanding shares of capital stock of any Subsidiary was issued in violation of the preemptive or similar rights of any securityholder of such Subsidiary. The Company does not
own or control, directly or indirectly, any subsidiary (as defined in Rule 405 under the Securities Act) other than (i) the subsidiaries listed in Schedule D hereto (each a “Subsidiary” and, collectively, the
“Subsidiaries”) and (ii) subsidiaries that, if considered in the aggregate as a single subsidiary, would not constitute a Significant Subsidiary. 
 (x) Capitalization. The authorized, issued and outstanding shares of capital stock of the Company are as set forth in the General Disclosure Package and the Final Offering Memorandum in the column
entitled “Actual” under the caption “Capitalization” (except for subsequent issuances, if any, pursuant to this Agreement, pursuant to reservations, agreements or employee benefit plans referred to in the General Disclosure
Package and the Final Offering Memorandum or pursuant to the exercise of convertible securities or options referred to in the General Disclosure Package and the Final Offering Memorandum). 

(xi) Authorization of Agreement. This Agreement has been duly authorized, executed and delivered by the Company.

 (xii) Hedge and Warrant Confirmations. The confirmations (the “Convertible Note Hedge
Confirmations”) among the Company and the counterparties thereto (the “Note Hedge Counterparties”) relating to the OTC convertible note hedge as described in the General Disclosure Package and Final Offering Memorandum and the
confirmations (the “Warrant Transaction Confirmations”) among the Company and the counterparties thereto (the “Warrant Counterparties” and, together with the Note Hedge Counterparties, the “Counterparties”) relating to
the OTC warrant transaction described in the General Disclosure Package and Final Offering Memorandum have been duly authorized and, assuming due authorization, execution and delivery by each Counterparty, when executed and delivered by the Company,
will constitute valid and binding instruments of the Company, enforceable in accordance with their terms, subject, as to enforcement, to bankruptcy, insolvency, reorganization and other laws of general applicability relating to or affecting
creditors’ rights and to general equity principles. 
 (xiii) Authorization of the Indenture. The
Indenture has been duly authorized by the Company and, when duly executed and delivered by the Company and the Trustee, will constitute a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms,
except as the enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all laws relating to fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights
generally and except as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at law). 

(xiv) Authorization of the Securities and the Common Stock. The Securities have been duly authorized and, at the
Closing Time, will have been duly executed by the Company and, when authenticated, issued and delivered in the manner provided for in the Indenture and delivered against payment of the purchase price therefor as provided in this Agreement, will
constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all laws relating to
fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights generally and except as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered
in a proceeding in equity or at law), and will be in the form contemplated by, and entitled to the benefits of, the Indenture. The shares of Common Stock issuable upon conversion 

  
 5 

 
of the Securities have been duly authorized and reserved for issuance upon such conversion by all necessary corporate action and such shares, when issued upon such conversion, will be validly
issued and will be fully paid and non-assessable; no holder of such shares will be subject to personal liability by reason of being such a holder; and the issuance of such shares upon such conversion will not be subject to the preemptive or other
similar rights of any securityholder of the Company. 
 (xv) Description of the Securities, the Common Stock
and the Indenture. The Securities and the Indenture will conform in all material respects to the respective statements relating thereto contained in the General Disclosure Package and the Final Offering Memorandum. The Common Stock conforms to
all statements relating thereto contained or incorporated by reference in the General Disclosure Package and the Final Offering Memorandum and such description conforms to the rights set forth in the instruments defining the same. 

(xvi) Registration Rights. There are no persons with registration rights or other similar rights to have any
securities registered for sale by the Company under the 1933 Act. 
 (xvii) Absence of Violations, Defaults
and Conflicts. Neither the Company nor any of its Subsidiaries is (A) in violation of its charter, by-laws or similar organizational document, (B) in default in the performance or observance of any obligation, agreement, covenant or
condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company or any of its Subsidiaries is a party or by which it or any of them may be bound or
to which any of the properties or assets of the Company or any Subsidiary is subject (collectively, “Agreements and Instruments”), except for such defaults that would not, singly or in the aggregate, result in a Material Adverse Effect, or
(C) in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency having jurisdiction over the Company
or any of its Subsidiaries or any of their respective properties, assets or operations (each, a “Governmental Entity”), except for such violations that would not, singly or in the aggregate, result in a Material Adverse Effect. The
execution, delivery and performance of the Convertible Note Hedge Confirmations, the Warrant Transaction Confirmations and this Agreement and the consummation of the transactions contemplated herein, therein and in the General Disclosure Package and
the Final Offering Memorandum (including the issuance and sale of the Securities and the use of the proceeds from the sale of the Securities as described therein under the caption “Use of Proceeds”) and compliance by the Company with its
obligations under the Convertible Note Hedge Confirmations, the Warrant Transaction Confirmations and this Agreement have been duly authorized by all necessary corporate action and do not and will not, whether with or without the giving of notice or
passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Company or any
Subsidiary pursuant to, the Agreements and Instruments (except for such conflicts, breaches, defaults or Repayment Events or liens, charges or encumbrances that would not, singly or in the aggregate, result in a Material Adverse Effect), nor will
such action result in any violation of the provisions of the charter, by-laws or similar organizational document of the Company or any of its Subsidiaries or any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental
Entity (except for such violation of any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity that would not, singly or in the aggregate, result in a Material Adverse Effect). As used herein, a “Repayment
Event” means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a
portion of such indebtedness by the Company or any of its Subsidiaries. 

  
 6 

 (xviii) Absence of Labor Dispute. No labor dispute with the employees
of the Company or any of its Subsidiaries exists or, to the knowledge of the Company, is imminent, which would result in a Material Adverse Effect. 
 (xix) Absence of Proceedings. Except as disclosed in the General Disclosure Package and the Final Offering Memorandum, there is no action, suit, proceeding, inquiry or investigation before or
brought by any Governmental Entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any of its Subsidiaries, which would reasonably be expected to result in a Material Adverse Effect, or which would
reasonably be expected to materially and adversely affect their respective properties or assets or the consummation of the transactions contemplated in the Convertible Note Hedge Confirmations, the Warrant Transaction Confirmations or this Agreement
or the performance by the Company of its obligations under the Convertible Note Hedge Confirmations, the Warrant Transaction Confirmations or this Agreement; and the aggregate of all pending legal or governmental proceedings to which the Company or
any such Subsidiary is a party or of which any of their respective properties or assets is the subject which are not described in the General Disclosure Package and the Final Offering Memorandum, including ordinary routine litigation incidental to
the business, would not reasonably be expected to result in a Material Adverse Effect. 
 (xx) Absence of
Further Requirements. No filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any Governmental Entity is necessary or required for the performance by the Company of its obligations
hereunder, in connection with the offering, issuance or sale of the Securities hereunder by the Company or the consummation by the Company of the transactions contemplated by this Agreement or for the due execution, delivery and performance by the
Company of the Indenture, except such as have been already obtained. 
 (xxi) Possession of Licenses and
Permits. The Company and its Subsidiaries possess such permits, licenses, approvals, consents and other authorizations (collectively, “Governmental Licenses”) issued by the appropriate Governmental Entities necessary to conduct the
business now operated by them, except where the failure so to possess would not, singly or in the aggregate, result in a Material Adverse Effect. The Company and its Subsidiaries are in compliance with the terms and conditions of all Governmental
Licenses, except where the failure so to comply would not, singly or in the aggregate, result in a Material Adverse Effect. All of the Governmental Licenses are valid and in full force and effect, except when the invalidity of such Governmental
Licenses or the failure of such Governmental Licenses to be in full force and effect would not, singly or in the aggregate, result in a Material Adverse Effect. Neither the Company nor any of its Subsidiaries has received any notice of proceedings
relating to the revocation or modification of any Governmental Licenses which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse Effect. 

(xxii) Title to Property. The Company and its Subsidiaries have good and marketable title to all real property
owned by them and good title to all other properties owned by them, in each case, free and clear of all mortgages, pledges, liens, security interests, claims, restrictions or encumbrances of any kind except such as (A) are described in the
General Disclosure Package and the Final Offering Memorandum, (B) liens for Taxes or governmental assessments, charges or claims, the payment of which is not yet due or (C) do not, singly or in the aggregate, materially affect the value of
such property and do not interfere with the use made and proposed to be made 

  
 7 

 
of such property by the Company or any of its Subsidiaries; and all of the leases and subleases material to the business of the Company and its Subsidiaries, considered as one enterprise, and
under which the Company or any of its Subsidiaries holds properties described in the General Disclosure Package and the Final Offering Memorandum, are in full force and effect (except where the failure of such leases and subleases to be in full
force and effect would not, singly or in the aggregate, result in a Material Adverse Effect), and neither the Company nor any such Subsidiary has any notice of any material claim of any sort that has been asserted by anyone adverse to the rights of
the Company or any subsidiary under any of the leases or subleases mentioned above, or affecting or questioning the rights of the Company or such subsidiary to the continued possession of the leased or subleased premises under any such lease or
sublease. 
 (xxiii) Possession of Intellectual Property. The Company and its Subsidiaries own or possess,
or can acquire on reasonable terms, adequate patents, patent rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures),
trademarks, service marks, trade names or other intellectual property (collectively, “Intellectual Property”) necessary to carry on the business now operated by them, and neither the Company nor any of its Subsidiaries has received any
notice or is otherwise aware of any infringement of or conflict with asserted rights of others with respect to any Intellectual Property or of any facts or circumstances which would render any Intellectual Property invalid or inadequate to protect
the interest of the Company or any of its Subsidiaries therein, and which infringement or conflict (if the subject of any unfavorable decision, ruling or finding) or invalidity or inadequacy, singly or in the aggregate, would result in a Material
Adverse Effect. 
 (xxiv) Environmental Laws. Except as described in the General Disclosure Package and
the Final Offering Memorandum or would not, singly or in the aggregate, result in a Material Adverse Effect, (A) neither the Company nor any of its Subsidiaries is in violation of any federal, state, local or foreign statute, law, rule,
regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the
environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release of chemicals,
pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively, “Hazardous Materials”) or to the manufacture, processing, distribution, use,
treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, “Environmental Laws”) (except for such violation of Environmental Laws that would not, singly or in the aggregate, result in a Material Adverse
Effect) (B) the Company and its Subsidiaries have all permits, authorizations and approvals required under any applicable Environmental Laws and are each in compliance with their requirements (except where the lack of such permit, authorization
or approval or non-compliance would not, singly or in the aggregate, result in a Material Adverse Effect), (C) there are no pending or, to the Company’s knowledge, threatened administrative, regulatory or judicial actions, suits, demands,
demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries and (D) there are no events or circumstances that would
reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or proceeding by any private party or Governmental Entity, against or affecting the Company or any of its subsidiaries relating to Hazardous
Materials or any Environmental Laws that would reasonably be expected to result in a Material Adverse Effect. 

  
 8 

 (xxv) Accounting Controls and Disclosure Controls. The Company and
each of its Subsidiaries maintain effective internal control over financial reporting (as defined under Rule 13-a15 and 15d-15 under the 1934 Act Regulations) and a system of internal accounting controls sufficient to provide reasonable assurances
that (A) transactions are executed in accordance with management’s general or specific authorization; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
accountability for assets; (C) access to assets is permitted only in accordance with management’s general or specific authorization; and (D) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. Except as described in the General Disclosure Package and the Final Offering Memorandum, since the end of the Company’s most recent audited fiscal year, there has been
(1) no material weakness in the Company’s internal control over financial reporting (whether or not remediated) and (2) no change in the Company’s internal control over financial reporting that has materially affected, or is
reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company and each of its Subsidiaries maintain an effective system of disclosure controls and procedures (as defined in Rule 13a-15 and Rule
15d-15 under the 1934 Act Regulations) that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported, within the time
periods specified in the Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to
allow timely decisions regarding disclosure. 
 (xxvi) Compliance with the Sarbanes-Oxley Act. There is
and has been no failure on the part of the Company or any of the Company’s directors or officers, in their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated in connection therewith, including Section 402 related to loans and Sections 302 and 906 related to certifications. 
 (xxvii) Payment of Taxes. All United States federal income tax returns of the Company and its Subsidiaries required by law to be filed have been filed and all taxes shown by such returns or
otherwise assessed, which are due and payable, have been paid, except assessments against which appeals have been or will be promptly taken and as to which adequate reserves have been provided. No assessment has been made against the Company in
respect of United States federal income tax returns of the Company through the fiscal year ended December 31, 2009. The Company and its subsidiaries have filed all other tax returns that are required to have been filed by them pursuant to
applicable foreign, state, local or other law except insofar as the failure to file such returns would not result in a Material Adverse Effect, and has paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company
and its subsidiaries, except for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been established by the Company. The charges, accruals and reserves on the books of the Company in respect of any income
and corporation tax liability for any years not finally determined are adequate to meet any assessments or re-assessments for additional income tax for any years not finally determined, except to the extent of any inadequacy that would not result in
a Material Adverse Effect. 
 (xxviii) Insurance. The Company and its subsidiaries carry or are entitled
to the benefits of insurance, with financially sound and reputable insurers, in such amounts and covering such risks as is sufficient for the Company’s business as now conducted, and all such insurance is in full force and effect. To the
Company’s knowledge, neither the Company nor any of its Subsidiaries will be unable (A) to renew its existing insurance coverage as and when such policies expire or (B) to obtain comparable coverage from similar institutions as may be
necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse Effect. 

  
 9 

 (xxix) Investment Company Act. The Company is not required, and upon
the issuance and sale of the Securities as herein contemplated and the application of the net proceeds therefrom as described in the General Disclosure Package and the Final Offering Memorandum will not be required, to register as an
“investment company” under the Investment Company Act of 1940, as amended (the “1940 Act”). 

(xxx) Absence of Manipulation. Neither the Company nor any affiliate controlled by the Company has taken, nor will
the Company or any affiliate of the Company take, directly or indirectly, any action which is designed, or would be expected, to cause or result in, or which has constitutes, the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of the Securities. 
 (xxxi) Foreign Corrupt Practices Act. None
of the Company, any of its Subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee, affiliate controlled by the Company or other person acting on behalf of the Company or any of its subsidiaries (excluding the
Initial Purchasers, in their capacity as such, as to which no representation or warranty is made) is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of
1977, as amended, and the rules and regulations thereunder (the “FCPA”), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise
to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political
party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company and, to the knowledge of the Company, its affiliates controlled by the Company have conducted their businesses in compliance with
the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith. 

(xxxii) Money Laundering Laws. The operations of the Company and its Subsidiaries are and have been conducted at
all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the “Money Laundering Laws”); and no action, suit or proceeding by or before any
Governmental Entity involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened. 

(xxxiii) OFAC. None of the Company, any of its Subsidiaries or, to the knowledge of the Company, any director,
officer, agent, employee, affiliate controlled by the Company or other person acting on behalf of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S.
Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds of the sale of the Securities, or lend, contribute or otherwise make available such proceeds to any of its subsidiaries, joint venture partners
or other person, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. 

  
 10 

 (xxxiv) Statistical and Market-Related Data. Any statistical and
market-related data included in the General Disclosure Package or the Final Offering Memorandum are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate and, to the extent required, the
Company has obtained the written consent to the use of such data from such sources. 
 (b) Officer’s Certificates.
Any certificate signed by any officer of the Company or any of its subsidiaries delivered to the Representatives or to counsel for the Initial Purchasers shall be deemed a representation and warranty by the Company to each Initial Purchaser as to
the matters covered thereby. 
 SECTION 2. Sale and Delivery to Initial Purchasers; Closing. 

(a) Initial Securities. On the basis of the representations and warranties herein contained and subject to the terms and
conditions herein set forth, the Company agrees to sell to each Initial Purchaser, severally and not jointly, and each Initial Purchaser, severally and not jointly, agrees to purchase from the Company, at the price set forth in Schedule A, the
aggregate principal amount of Initial Securities set forth in Schedule A, plus any additional principal amount of Initial Securities which such Initial Purchaser may become obligated to purchase pursuant to the provisions of Section 11 hereof,
subject to such adjustments as Merrill Lynch in its discretion shall make to ensure that any sales or purchases are in authorized denominations. 
 (b) Option Securities. In addition, on the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, the Company hereby grants an option
to the Initial Purchasers, severally and not jointly, to purchase the Option Securities, at the price set forth in Schedule A. The option hereby granted will expire 30 days after the date hereof and may be exercised in whole or in part from
time to time only for the purpose of covering overallotments made in connection with the offering and distribution of the Initial Securities upon notice by the Representatives to the Company setting forth the amount of Option Securities as to which
the several Initial Purchasers are then exercising the option and the time and date of payment and delivery for such Option Securities. Any such time and date of delivery (a “Date of Delivery”) shall be determined by the Representatives,
but shall not be later than seven full business days after the exercise of said option, nor in any event prior to the Closing Time. If the option is exercised as to all or any portion of the Option Securities, each of the Initial Purchasers, acting
severally and not jointly, will purchase that proportion of the total principal amount of Option Securities then being purchased which the number of Initial Securities set forth in Schedule A opposite the name of such Initial Purchaser bears to the
total principal amount of Initial Securities, subject in each case to such adjustments as Merrill Lynch in its discretion shall make to ensure that any sales or purchases are in authorized denominations. 

(c) Payment. Payment of the purchase price for, and delivery of certificates for, the Initial Securities shall be made at the
offices of Shearman & Sterling LLP, 599 Lexington Avenue, New York, New York 10022, or at such other place as shall be agreed upon by the Representatives and the Company, at 9:00 A.M. (New York City time) on the third (fourth, if the
pricing occurs after 4:30 P.M. (New York City time) on any given day) business day after the date hereof (unless postponed in accordance with the provisions of Section 11), or such other time not later than ten business days after such date as
shall be agreed upon by the Representatives and the Company (such time and date of payment and delivery being herein called “Closing Time”). 
 In addition, in the event that any or all of the Option Securities are purchased by the Initial Purchasers, payment of the purchase price for, and delivery of certificates for, such Option Securities
shall be made at the above-mentioned offices, or at such other place as shall be agreed upon by the Representatives and the Company, on each Date of Delivery as specified in the notice from the Representatives to the Company. 

  
 11 

 Payment shall be made to the Company by wire transfer of immediately available funds to a
bank account designated by the Company, against delivery to the Representatives for the respective accounts of the Initial Purchasers of certificates for the Securities to be purchased by them. It is understood that each Initial Purchaser has
authorized the Representatives, for its account, to accept delivery of, receipt for, and make payment of the purchase price for, the Initial Securities and the Option Securities, if any, which it has agreed to purchase. Merrill Lynch, individually
and not as representative of the Initial Purchasers, may (but shall not be obligated to) make payment of the purchase price for the Initial Securities or the Option Securities, if any, to be purchased by any Initial Purchaser whose funds have not
been received by the Closing Time or the relevant Date of Delivery, as the case may be, but such payment shall not relieve such Initial Purchaser from its obligations hereunder. 

(d) Denominations; Registration. Certificates for the Initial Securities and the Option Securities, if any, shall be in such
denominations ($1,000 or integral multiples thereof) and registered in such names as the Representatives may request in writing at least one full business day before the Closing Time or the relevant Date of Delivery, as the case may be. The Initial
Securities and the Option Securities, if any, will be made available for examination and packaging by the Representatives in The City of New York not later than 10:00 A.M. (New York City time) on the business day prior to the Closing Time or
the relevant Date of Delivery, as the case may be. 
 SECTION 3. Covenants of the Company. The Company covenants with
each Initial Purchaser as follows: 
 (a) Delivery of Offering Memorandum. The Company has delivered to each Initial
Purchaser, without charge, as many copies of the Preliminary Offering Memorandum (as amended or supplemented) thereto and documents incorporated by reference therein as such Initial Purchaser reasonably requested, and the Company hereby consents to
the use of such copies in connection with the transactions contemplated by this Agreement. The Company will furnish to each Initial Purchaser, without charge, such number of copies of the Final Offering Memorandum thereto and documents incorporated
by reference therein as such Initial Purchaser may reasonably request. 
 (b) Notice and Effect of Material Events. If at
any time prior to the completion of resales of the Securities by the Initial Purchasers, any event shall occur or condition shall exist as a result of which it is necessary, in the opinion of counsel for the Initial Purchasers or for the Company, to
amend or supplement the General Disclosure Package or the Final Offering Memorandum in order that the General Disclosure Package or the Final Offering Memorandum, as the case may be, will not include any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time it is delivered to a Subsequent Purchaser, the Company will promptly (A) give the Representatives
notice of such event and (B) prepare any amendment or supplement as may be necessary to correct such statement or omission and, a reasonable amount of time prior to any proposed use or distribution, furnish the Representatives with copies of
any such amendment or supplement; provided that the Company shall not use or distribute any such amendment or supplement to which the Representatives or counsel for the Initial Purchasers shall object. The Company will furnish to the Initial
Purchasers such number of copies of such amendment or supplement as the Initial Purchasers may reasonably request. 
 (c)
Reporting Requirements. Until the completion of resales of the Securities by the Initial Purchasers, the Company will file all documents required to be filed with the Commission pursuant to the 1934 Act within the time periods required by the
1934 Act and the 1934 Act Regulations. The Company 

  
 12 

 
has given the Representatives notice of any filings made pursuant to the 1934 Act or 1934 Act Regulations within 48 hours prior to the Applicable Time; the Company will give the Representatives
notice of its intention to make any such filing from the Applicable Time to the Closing Time and will furnish the Representatives with copies of any such documents a reasonable amount of time prior to such proposed filing, as the case may be, and
will not file or use any such document to which the Representatives or counsel for the Initial Purchasers shall reasonably object. 
 (d) Blue Sky Qualifications. The Company will use its best efforts, in cooperation with the Initial Purchasers, to qualify the Securities for offering and sale under the applicable securities laws
of such states and other jurisdictions (domestic or foreign) as the Representatives may designate and to maintain such qualifications in effect so long as required to complete the distribution of the Securities; provided, however, that the Company
shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing
business in any jurisdiction in which it is not otherwise so subject. 
 (e) Use of Proceeds. The Company will use the
net proceeds received by it from the sale of the Securities in the manner specified in the General Disclosure Package and the Final Offering Memorandum under “Use of Proceeds.” 

(f) DTCC. The Company will cooperate with the Initial Purchasers and use its best efforts to permit the offered Securities to be
eligible for clearance and settlement through the facilities of The Depository Trust & Clearing Corporation (“DTCC”). 
 (g) Listing. The Company will use its best efforts to effect and maintain the listing of the Common Stock issuable upon conversion of the Securities on the Nasdaq Global Market or New York Stock
Exchange. 
 (h) Restriction on Sale of Securities. During a period of 90 days from the date of the Final Offering
Memorandum, the Company will not, without the prior written consent of Merrill Lynch, (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or file any registration statement under the 1933 Act with respect
to any of the foregoing or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Common Stock, whether any such swap or
transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing sentence shall not apply to (A) the Securities to be sold hereunder,
(B) any shares of Common Stock issued by the Company upon the exercise of an option or warrant or the conversion of a security outstanding on the date hereof and referred to in the General Disclosure Package and the Final Offering Memorandum,
(C) any shares of Common Stock issued or options to purchase Common Stock granted pursuant to existing employee benefit plans of the Company referred to in the General Disclosure Package and the Final Offering Memorandum or as inducement grants
pursuant to the rules of the NASDAQ Stock Market, provided such grants are subject to restrictions substantially similar to those set forth above (D) any shares of Common Stock issued pursuant to any non-employee director stock plan or dividend
reinvestment plan referred to in the General Disclosure Package and the Final Offering Memorandum, (E) the filing of any registration statement on Form S-8 to register shares of common stock reserved for issuance under the Company’s
existing employee benefit plans or (F) during the last 60 days of such 90 day period, the issuance of shares of Common Stock which the Company may issue or agree to issue in connection with the acquisition of one or more businesses,
products or technologies (whether by means of merger, stock purchase or asset 

  
 13 

 
purchase), provided that such shares of common stock are subject to restrictions substantially similar to those set forth above and provided, further, that the aggregate number of
shares of Common Stock issued or agreed to be issued in such transactions in the aggregate shall not exceed five percent (5%) of the Company’s outstanding Common Stock as of the Closing Time. 

SECTION 4. Payment of Expenses. 
 (a) Expenses. The Company will pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including (i) preparation, issuance and delivery of the
Securities to the Initial Purchasers and the Common Stock issuable upon conversion thereof and any charges of DTCC in connection therewith, (ii) the fees and disbursements of the Company’s counsel, accountants and other advisors,
(iii) the qualification of the Securities under securities laws in accordance with the provisions of Section 3(d) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Initial Purchasers in connection
therewith and in connection with the preparation of the Blue Sky Survey and any supplement thereto, (iv) the preparation, printing and delivery to the Initial Purchasers of copies of each Preliminary Offering Memorandum, any Issuer Written
Information, the Final Term Sheet and the Final Offering Memorandum and any amendments or supplements thereto and any costs associated with electronic delivery of any of the foregoing by the Initial Purchasers to investors, (v) all fees and
expenses of the Trustee and any expenses of any transfer agent or registrar for the Securities or the Common Stock issuable upon conversion of the Securities, (vi) the costs and expenses of the Company relating to investor presentations on any
“road show” undertaken in connection with the marketing of the Securities, including without limitation, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection
with the road show presentations, travel and lodging expenses of the representatives and officers of the Company and any such consultants, and the cost of aircraft and other transportation chartered in connection with the road show, (vii) the
fees and expenses incurred in connection with the listing of the Common Stock issuable upon conversion of the Securities on the Nasdaq Global Market and (viii) the costs and expenses (including, without limitation, any damages or other amounts
payable in connection with legal or contractual liability) associated with the reforming of any contracts for sale of the Securities made by the Initial Purchasers caused by a breach of the representation contained in the first sentence of
Section 1(a)(iii). 
 (b) Termination of Agreement. If this Agreement is terminated by the Representatives in
accordance with the provisions of Section 5, Section 10(a)(i) or (iii) or Section 11 hereof, the Company shall reimburse the Initial Purchasers for all of their reasonable out-of-pocket expenses, including the reasonable fees and
disbursements of counsel for the Initial Purchasers. In the case of termination by the Representatives in accordance with the provisions of Section 11, the Company shall have no obligation to reimburse a defaulting Initial Purchaser pursuant to
this Section 4(b). 
 SECTION 5. Conditions of Initial Purchasers’ Obligations. The obligations of the several
Initial Purchasers hereunder are subject to the accuracy of the representations and warranties of the Company contained herein or in certificates of any officer of the Company or any of its subsidiaries, to the performance by the Company of its
covenants and other obligations hereunder, and to the following further conditions: 
 (a) Opinion of Counsel for
Company. At the Closing Time, the Representatives shall have received an opinion, dated the Closing Time, of Crowell & Moring LLP, counsel for the Company, in form and substance satisfactory to counsel for the Initial Purchasers,
together with signed or reproduced copies of such letter for each of the other Initial Purchasers to the effect set forth in Exhibit A - 1 hereto. In giving such opinion, such counsel may rely, as to all matters governed by the laws of jurisdictions
other than the law of the State of New York and the federal securities laws of the United States, upon the opinions of counsel satisfactory to the Representatives. 

  
 14 

 (b) Opinion of Local Counsel for Company. At the Closing Time, the Representatives
shall have received an opinion, dated the Closing Time, of Murtha Cullina LLP, counsel for the Company, in form and substance satisfactory to counsel for the Initial Purchasers, together with signed or reproduced copies of such letter for each of
the other Initial Purchasers to the effect set forth in Exhibit A - 2 hereto. In giving such opinion, such counsel may rely, as to all matters governed by the laws of jurisdictions other than the law of the State of Connecticut and the federal
securities laws of the United States, upon the opinions of counsel satisfactory to the Representatives. 
 (c) Opinion of
Chief Legal Counsel of Company. At the Closing Time, the Representatives shall have received an opinion, dated the Closing Time, of Candace Clark, Senior Vice President and Chief Legal Counsel of the Company, in form and substance satisfactory
to counsel for the Initial Purchasers, together with signed or reproduced copies of such letter for each of the other Initial Purchasers to the effect set forth in Exhibit A - 3 hereto. 

(d) Opinion of Counsel for Initial Purchasers. At the Closing Time, the Representatives shall have received an opinion, dated the
Closing Time, of Shearman & Sterling LLP, counsel for the Initial Purchasers, together with signed or reproduced copies of such letter for each of the other Initial Purchasers in form and substance satisfactory to the Representatives. In
giving such opinion such counsel may rely, as to all matters governed by the laws of jurisdictions other than the law of the State of New York and the federal securities laws of the United States, upon the opinions of counsel satisfactory to the
Representatives. Such counsel may also state that, insofar as such opinion involves factual matters, they have relied, to the extent they deem proper, upon certificates of officers and other representatives of the Company and its subsidiaries and
certificates of public officials. 
 (e) Officers’ Certificate. At the Closing Time, there shall not have been,
since the date hereof or since the respective dates as of which information is given in the General Disclosure Package or the Final Offering Memorandum, any material adverse change in the condition, financial or otherwise, or in the earnings,
business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business, and the Representatives shall have received a certificate of the Chief Executive
Officer/President of the Company and of the chief financial or chief accounting officer of the Company, dated the Closing Time, to the effect that (i) there has been no such material adverse change, (ii) the representations and warranties
of the Company in this Agreement are true and correct with the same force and effect as though expressly made at and as of the Closing Time and (iii) the Company has complied with all agreements and satisfied all conditions on its part to be
performed or satisfied at or prior to the Closing Time. 
 (f) Accountant’s Comfort Letter. At the time of the
execution of this Agreement, the Representatives shall have received from KPMG LLP a letter, dated such date, in form and substance satisfactory to the Representatives, together with signed or reproduced copies of such letter for each of the other
Initial Purchasers containing statements and information of the type ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information contained in the
Offering Memorandum. 
 (g) Bring-down Comfort Letter. At the Closing Time, the Representatives shall have received from
KPMG LLP a letter, dated as of the Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (f) of this Section, except that the specified date referred to shall be a date not more than
three business days prior to the Closing Time. 

  
 15 

 (h) Approval of Listing. At the Closing Time, the Common Stock issuable upon
conversion of the Securities shall have been approved for listing on the Nasdaq Global Market, subject only to official notice of issuance. 
 (i) Lock-up Agreements. At the date of this Agreement, the Representatives shall have received an agreement substantially in the form of Exhibit B hereto signed by the persons listed on
Schedule E hereto. 
 (j) Maintenance of Rating. Since the execution of this Agreement, there shall not have been any
decrease in or withdrawal of the rating of any securities of the Company or any of its subsidiaries by any “nationally recognized statistical rating organization” (as such term is defined in Section 3(a)(62) of the 1934 Act) or any
notice given of any intended or potential decrease in or withdrawal of any such rating or of a possible change in any such rating that does not indicate the direction of the possible change. 

(k) Execution and Delivery of Certain Transaction Documents. At or prior to the Closing Time, the Company shall have executed and
delivered the Convertible Note Hedge Confirmations and the Warrant Transaction Confirmations, each in a form satisfactory to the Representatives. 
 (l) Conditions to Purchase of Option Securities. In the event that the Initial Purchasers exercise their option provided in Section 2(b) hereof to purchase all or any portion of the Option
Securities, the representations and warranties of the Company contained herein and the statements in any certificates furnished by the Company and any of its subsidiaries hereunder shall be true and correct as of each Date of Delivery and, at the
relevant Date of Delivery, the Representatives shall have received: 
 (i) Officers’ Certificate. A
certificate, dated such Date of Delivery, of the President or a Vice President of the Company and of the chief financial or chief accounting officer of the Company confirming that the certificate delivered at the Closing Time pursuant to
Section 5(d) hereof remains true and correct as of such Date of Delivery. 
 (ii) Opinion of Counsel for
Company. If requested by the Representatives, an opinion of Crowell & Moring LLP, counsel for the Company, in form and substance satisfactory to counsel for the Initial Purchasers, dated such Date of Delivery, relating to the Option
Securities to be purchased on such Date of Delivery and otherwise to the same effect as the opinion required by Section 5(a) hereof. 
 (iii) Opinion of Local Counsel for Company. If requested by the Representatives, an opinion of Murtha Cullina LLP, counsel for the Company, in form and substance satisfactory to counsel for the
Initial Purchasers, dated such Date of Delivery, relating to the Option Securities to be purchased on such Date of Delivery and otherwise to the same effect as the opinion required by Section 5(b) hereof. 

(iv) Opinion of Chief Legal Counsel of Company. If requested by the Representatives, an opinion of Candace Clark,
Senior Vice President and Chief Legal Counsel of the Company, in form and substance satisfactory to counsel for the Initial Purchasers, dated such Date of Delivery, relating to the Option Securities to be purchased on such Date of Delivery and
otherwise to the same effect as the opinion required by Section 5(c) hereof. 
 (v) Opinion of Counsel
for Initial Purchasers. If requested by the Representatives, an opinion of Shearman & Sterling LLP, counsel for the Initial Purchasers, dated such Date of Delivery, relating to the Option Securities to be purchased on such Date of
Delivery and otherwise to the same effect as the opinion required by Section 5(d) hereof. 

  
 16 

 (vi) Bring-down Comfort Letter. If requested by the Representatives,
a letter from KPMG LLP, in form and substance satisfactory to the Representatives and dated such Date of Delivery, substantially in the same form and substance as the letter furnished to the Representatives pursuant to Section 5(g) hereof,
except that the “specified date” in the letter furnished pursuant to this paragraph shall be a date not more than three business days prior to such Date of Delivery. 
 (m) Additional Documents. At the Closing Time and at each Date of Delivery (if any), counsel for the Initial Purchasers shall have been furnished with such documents and opinions as they may
require for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions,
herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Securities as herein contemplated shall be satisfactory in form and substance to the Representatives and counsel for the Initial Purchasers.

 (n) Termination of Agreement. If any condition specified in this Section shall not have been fulfilled when and as
required to be fulfilled, this Agreement, or, in the case of any condition to the purchase of Option Securities on a Date of Delivery which is after the Closing Time, the obligations of the several Initial Purchasers to purchase the relevant Option
Securities, may be terminated by the Representatives by notice to the Company at any time at or prior to Closing Time or such Date of Delivery, as the case may be, and such termination shall be without liability of any party to any other party
except as provided in Section 4 and except that Sections 1, 7, 8, 9, 14, 15 and 16 shall survive any such termination and remain in full force and effect. 
 SECTION 6. Subsequent Offers and Resales of the Securities. 
 (a) Offer
and Sale Procedures. Each of the Initial Purchasers and the Company hereby establish and agree to observe the following procedures in connection with the offer and sale of the Securities: 

(i) Offers and Sales. Offers and sales of the Securities shall be made to such persons and in such manner as is
contemplated by the Offering Memorandum. Each Initial Purchaser severally agrees that it will not offer, sell or deliver any of the Securities in any jurisdiction outside the United States except under circumstances that will result in compliance
with the applicable laws thereof, and that it will take at its own expense whatever action is required to permit its purchase and resale of the Securities in such jurisdictions. The Company has not entered into any contractual arrangement, other
than this Agreement, with respect to the offering and sale of the Securities or the Common Stock issuable upon conversion of the Securities and the Company will not enter into any such arrangement except as contemplated thereby. 

(ii) No General Solicitation. No general solicitation or general advertising (within the meaning of
Rule 502(c) under the 1933 Act Regulations) will be used in the United States in connection with the offering or sale of the Securities. 
 (iii) Legends. Each of the Securities will bear, to the extent applicable, the legend contained in “Notice to Investors” in the General Disclosure Package and the Final Offering
Memorandum for the time period and upon the other terms stated therein. 

  
 17 

 (iv) Minimum Principal Amount. No sale of the Securities to any one
Subsequent Purchaser will be for less than U.S. $1,000 principal amount and no Security will be issued in a smaller principal amount. If the Subsequent Purchaser is a non-bank fiduciary acting on behalf of others, each person for whom it is acting
must purchase at least U.S. $1,000 principal amount of the Securities. 
 (b) Covenants of the Company. The Company
covenants with each Initial Purchaser as follows: 
 (i) Integration. The Company agrees that it will not
and will cause its affiliates controlled by the Company not to, directly or indirectly, solicit any offer to buy, sell or make any offer or sale of, or otherwise negotiate in respect of, securities of the Company of any class if, as a result of the
doctrine of “integration” referred to in Rule 502 under the 1933 Act Regulations, such offer or sale would render invalid (for the purpose of (i) the sale of the offered Securities by the Company to the Initial Purchasers,
(ii) the resale of the offered Securities by the Initial Purchasers to Subsequent Purchasers or (iii) the resale of the offered Securities by such Subsequent Purchasers to others) the exemption from the registration requirements of the
1933 Act provided by Section 4(2) thereof or by Rule 144A thereunder or otherwise. 
 (ii) Rule
144A Information. The Company agrees that, in order to render the offered Securities eligible for resale pursuant to Rule 144A, while any of the offered Securities remain outstanding, it will make available, upon request, to any holder of
offered Securities or prospective purchasers of Securities the information specified in Rule 144A(d)(4), unless the Company furnishes information to the Commission pursuant to Section 13 or 15(d) of the 1934 Act. 

(iii) Restriction on Repurchases. Until the expiration of one year after the original issuance of the offered
Securities, the Company will not, and will cause its affiliates controlled by the Company not to, resell any offered Securities which are “restricted securities” (as such term is defined under Rule 144(a)(3)), whether as beneficial
owner or otherwise (except as agent acting as a securities broker on behalf of and for the account of customers in the ordinary course of business in unsolicited broker’s transactions). 

(c) Representations, Warranties and Agreements of the Initial Purchasers. Each Initial Purchaser severally and not jointly
represents and warrants to, and agrees with, the Company that it is a “Qualified Institutional Buyer” within the meaning of Rule 144A under the 1933 Act Regulations and an “accredited investor” within the meaning of
Rule 501(a) under the 1933 Act Regulations. Each Initial Purchaser understands that the offered Securities have not been and will not be registered under the 1933 Act and may not be offered or sold within the United States except
pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the 1933 Act. Each Initial Purchaser severally represents and agrees that it has not offered or sold, and will not offer or sell, any offered
Securities constituting part of its allotment within the United States except in accordance with Rule 144A or another applicable exemption from the registration requirements of the 1933 Act. Accordingly, neither it nor any person acting on
its behalf has made or will make offers or sales of the Securities in the United States by means of any form of general solicitation or general advertising (within the meaning of Regulation D) in the United States. Each Initial Purchaser will take
reasonable steps to inform, and cause each of its affiliates (as such term is defined in Rule 501(b) under the 1933 Act Regulations (each, an “Affiliate”)) to take reasonable steps to inform, persons acquiring Securities from such Initial
Purchaser or Affiliate, as the case may be, in the United States that the Securities (A) have not been and will not be registered under the 1933 Act, (B) are being sold to them without registration under the 1933 Act in reliance
on Rule 144A or in accordance with another exemption from registration under the 1933 Act, as the case may be, and (C) may not be offered, sold or otherwise transferred except (1) to the Company,

  
 18 

 
(2) outside the United States in accordance with Regulation S or (3) inside the United States in accordance with (x) Rule 144A to a person whom the seller reasonably
believes is a Qualified Institutional Buyer that is purchasing such Securities for its own account or for the account of a Qualified Institutional Buyer to whom notice is given that the offer, sale or transfer is being made in reliance on
Rule 144A or (y) pursuant to another available exemption from registration under the 1933 Act. 
 SECTION 7.
Indemnification. 
 (a) Indemnification of Initial Purchasers. The Company agrees to indemnify and hold harmless
each Initial Purchaser, its Affiliates, its selling agents and each person, if any, who controls any Initial Purchaser within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act as follows: 

(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue
statement or alleged untrue statement of a material fact included in any Preliminary Offering Memorandum, the Final Offering Memorandum, the information contained in the Final Term Sheet, any Issuer Written Information or any other written
information used by or on behalf of the Company that has been previously reviewed and approved for distribution by the Company in connection with the offer or sale of the Securities (or any amendment or supplement to the foregoing) or the omission
or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; 

(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the
aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged
untrue statement or omission; provided that (subject to Section 7(d) below) any such settlement is effected with the written consent of the Company; 
 (iii) against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel chosen by Merrill Lynch), reasonably incurred in investigating, preparing or defending against
any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent
that any such expense is not paid under (i) or (ii) above; 
 provided, however, that this indemnity agreement shall not apply to any
loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made in any Preliminary Offering Memorandum, the Final Offering Memorandum or the information contained
in the Final Term Sheet (or any amendment or supplement to the foregoing) in reliance upon and in conformity with the Initial Purchaser Information. 
 (b) Indemnification of Company, Directors and Officers. Each Initial Purchaser severally and not jointly agrees to indemnify and hold harmless the Company, its directors, its officers and each
person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, against any and all loss, liability, claim, damage and expense described in the indemnity contained in subsection
(a) of this Section, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in any Preliminary Offering Memorandum, the Final Offering Memorandum or the information contained in the
Final Term Sheet (or any amendment or supplement to the foregoing) in reliance upon and in conformity with the Initial Purchaser Information. 

  
 19 

 (c) Actions against Parties; Notification. Each indemnified party shall give notice
as promptly as reasonably practicable to each indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from
any liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. In the case of parties
indemnified pursuant to Section 7(a) above, counsel to the indemnified parties shall be selected by Merrill Lynch, and, in the case of parties indemnified pursuant to Section 7(b) above, counsel to the indemnified parties shall be selected
by the Company. An indemnifying party may participate at its own expense in the defense of any such action; provided, however, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the
indemnified party. In no event shall the indemnifying parties be liable for fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for all indemnified parties in connection with any one action
or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or
consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of which indemnification or contribution could be
sought under this Section 7 or Section 8 hereof (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified
party from all liability arising out of such litigation, investigation, proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.

 (d) Settlement without Consent if Failure to Reimburse. If at any time an indemnified party shall have requested an
indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 7(a)(ii) effected without its written
consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days
prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement. 

SECTION 8. Contribution. If the indemnification provided for in Section 7 hereof is for any reason unavailable to or
insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims,
damages and expenses incurred by such indemnified party, as incurred, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Initial Purchasers, on the other hand, from the
offering of the Securities pursuant to this Agreement or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause
(i) above but also the relative fault of the Company, on the one hand, and of the Initial Purchasers, on the other hand, in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as
well as any other relevant equitable considerations. 
 The relative benefits received by the Company, on the one hand, and the
Initial Purchasers, on the other hand, in connection with the offering of the Securities pursuant to this Agreement shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Securities pursuant to
this Agreement (before deducting expenses) received by the Company, on the one hand, and the total underwriting discount received by the Initial Purchasers, on the other hand, bear to the aggregate initial offering price of the Securities as set
forth on the cover of the Final Offering Memorandum. 

  
 20 

 The relative fault of the Company, on the one hand, and the Initial Purchasers, on the other
hand, shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or by the
Initial Purchasers and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
 The Company and the Initial Purchasers agree that it would not be just and equitable if contribution pursuant to this Section 8 were determined by pro rata allocation (even if the Initial Purchasers
were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 8. The aggregate amount of losses, liabilities, claims, damages and
expenses incurred by an indemnified party and referred to above in this Section 8 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any
litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission. 

Notwithstanding the provisions of this Section 8, no Initial Purchaser shall be required to contribute any amount in excess of the
amount by which the total price at which the Securities purchased and sold by it hereunder exceeds the amount of any damages which such Initial Purchaser has otherwise been required to pay by reason of such untrue or alleged untrue statement or
omission or alleged omission. 
 No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the 1933 Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 
 For
purposes of this Section 8, each person, if any, who controls an Initial Purchaser within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act and each Initial Purchaser’s Affiliates and selling agents shall
have the same rights to contribution as such Initial Purchaser, and each director of the Company, each officer of the Company, and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20
of the 1934 Act shall have the same rights to contribution as the Company. The Initial Purchasers’ respective obligations to contribute pursuant to this Section 8 are several in proportion to the aggregate principal amount of Initial
Securities set forth opposite their respective names in Schedule A hereto and not joint. 
 SECTION 9. Representations,
Warranties and Agreements to Survive. All representations, warranties and agreements contained in this Agreement or in certificates of officers of the Company or any of its subsidiaries submitted pursuant hereto, shall remain operative and in
full force and effect regardless of (i) any investigation made by or on behalf of any Initial Purchaser or its Affiliates or selling agents, any person controlling any Initial Purchaser, its officers or directors or any person controlling the
Company and (ii) delivery of and payment for the Securities. 
 SECTION 10. Termination of Agreement. 

(a) Termination. The Representatives, in their absolute discretion, may terminate this Agreement without liability to the Company,
by notice to the Company, at any time at or prior to the Closing Time (i) if there has been, since the time of execution of this Agreement or since the respective dates as of which information is given in the General Disclosure Package or the
Final Offering Memorandum, any material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in
the ordinary course of business, or (ii) if there has occurred any material adverse 

  
 21 

 
change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or
development involving a prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Representatives, impracticable or inadvisable to
proceed with the completion of the offering or to enforce contracts for the sale of the Securities, or (iii) if trading in any securities of the Company has been suspended or materially limited by the Commission or the Nasdaq Global Market, or
(iv) if trading generally on the New York Stock Exchange or in the Nasdaq Global Market has been suspended or materially limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any
of said exchanges or by order of the Commission, the Financial Industry Regulatory Authority (FINRA) or any other governmental authority, or (v) a material disruption has occurred in commercial banking or securities settlement or clearance
services in the United States, or (vi) if a banking moratorium has been declared by either Federal or New York authorities. 
 (b) Liabilities. If this Agreement is terminated pursuant to this Section, such termination shall be without liability of any party to any other party except as provided in Section 4 hereof,
and provided further that Sections 1, 6(c), 7, 8, 9, 14, 15 and 16 shall survive such termination and remain in full force and effect. 
 SECTION 11. Default by One or More of the Initial Purchasers. If one or more of the Initial Purchasers shall fail at the Closing Time or a Date of Delivery to purchase the Securities which it or
they are obligated to purchase under this Agreement (the “Defaulted Securities”), the Representatives shall have the right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting Initial Purchasers, or
any other initial purchasers, to purchase all, but not less than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the Representatives shall not have completed such arrangements
within such 24-hour period, then: 
 (i) if the number of Defaulted Securities does not exceed 10% of the
aggregate principal amount of the Securities to be purchased on such date, each of the non-defaulting Initial Purchasers shall be obligated, severally and not jointly, to purchase the full amount thereof in the proportions that their respective
underwriting obligations hereunder bear to the underwriting obligations of all non-defaulting Initial Purchasers, or 
 (ii) if the number of Defaulted Securities exceeds 10% of the aggregate principal amount of the Securities to be purchased on such date, this Agreement or, with respect to any Date of Delivery which
occurs after the Closing Time, the obligation of the Initial Purchasers to purchase, and the Company to sell, the Option Securities to be purchased and sold on such Date of Delivery, shall terminate without liability on the part of any
non-defaulting Initial Purchaser. 
 No action taken pursuant to this Section shall relieve any defaulting Initial Purchaser
from liability in respect of its default. 
 In the event of any such default which does not result in a termination of this
Agreement or, in the case of a Date of Delivery which is after the Closing Time, which does not result in a termination of the obligation of the Initial Purchasers to purchase and the Company to sell the relevant Option Securities, as the case may
be, either the (i) Representatives or (ii) the Company shall have the right to postpone Closing Time or the relevant Date of Delivery, as the case may be, for a period not exceeding seven days in order to effect any required changes in the
General Disclosure Package or the Final Offering Memorandum or in any other documents or arrangements. As used herein, the term “Initial Purchaser” includes any person substituted for an Initial Purchaser under this Section 11.

  
 22 

 SECTION 12. Notices. All notices and other communications hereunder shall be in
writing and shall be deemed to have been duly given if mailed or transmitted by any standard form of telecommunication. Notices to the Initial Purchasers shall be directed to Merrill Lynch at One Bryant Park, New York, New York 10036, attention of
Syndicate Department, with a copy to ECM Legal; notices to the Company shall be directed to it at 1332 Blue Hills Avenue, Bloomfield, Connecticut 06002, attention of Robert Starr, Vice President and Treasurer. 

SECTION 13. No Advisory or Fiduciary Relationship. The Company acknowledges and agrees that (a) the purchase and sale of the
Securities pursuant to this Agreement, including the determination of the initial offering price of the Securities and any related discounts and commissions, is an arm’s-length commercial transaction between the Company, on the one hand, and
the several Initial Purchasers, on the other hand, (b) in connection with the offering of the Securities and the process leading thereto, each Initial Purchaser is and has been acting solely as a principal and is not the agent or fiduciary of
the Company, any of its subsidiaries or their respective stockholders, creditors, employees or any other party, (c) no Initial Purchaser has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to
the offering of the Securities or the process leading thereto (irrespective of whether such Initial Purchaser has advised or is currently advising the Company or any of its subsidiaries on other matters) and no Initial Purchaser has any obligation
to the Company with respect to the offering of the Securities except the obligations expressly set forth in this Agreement, (d) the Initial Purchasers and their respective affiliates may be engaged in a broad range of transactions that involve
interests that differ from those of the Company and (e) the Initial Purchasers have not provided any legal, accounting, regulatory or tax advice with respect to the offering of the Securities and the Company has consulted its own respective
legal, accounting, regulatory and tax advisors to the extent it deemed appropriate. 
 SECTION 14. Parties. This
Agreement shall each inure to the benefit of and be binding upon the Initial Purchasers and the Company and their respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or
corporation, other than the Initial Purchasers and the Company and their respective successors and the controlling persons and officers and directors referred to in Sections 7 and 8 and their heirs and legal representatives, any legal or
equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive benefit of the Initial Purchasers and the
Company and their respective successors, and said controlling persons and officers and directors and their heirs and legal representatives, and for the benefit of no other person, firm or corporation. No purchaser of Securities from any Initial
Purchaser shall be deemed to be a successor by reason merely of such purchase. 
 SECTION 15. Trial by Jury. The Company
(on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and each of the Initial Purchasers hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. 
 SECTION
16. GOVERNING LAW. THIS AGREEMENT AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF, THE STATE OF NEW YORK WITHOUT REGARD TO ITS CHOICE OF LAW
PROVISIONS. 
 SECTION 17. TIME. TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT. EXCEPT AS OTHERWISE SET FORTH HEREIN,
SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. 

  
 23 

 SECTION 18. Partial Unenforceability. The invalidity or unenforceability of any
Section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other Section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason determined to be
invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable. 
 SECTION 19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and
the same Agreement. 
 SECTION 20. Effect of Headings. The Section headings herein are for convenience only and shall not
affect the construction hereof. 

  
 24 

 If the foregoing is in accordance with your understanding of our agreement, please sign and
return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement among the Initial Purchasers and the Company in accordance with its terms. 

 

					
	Very truly yours,
	
	KAMAN CORPORATION
		
	By	 	/s/ William C. Denninger
		 	Name:	 	William C. Denninger
		 	Title:	 	 Senior Vice President &
 Chief Financial Officer

  

			
	 CONFIRMED AND ACCEPTED,
 as of the date first above written:

	
	 MERRILL LYNCH, PIERCE, FENNER &
SMITH INCORPORATED

		
	By	 	/s/ David Iwan
		 	Authorized Signatory
	
	RBS SECURITIES INC.
		
	By	 	/s/ Robert Hammer
		 	Authorized Signatory
		
		 	     Robert Hammer
		
		 	     Head of Equity and Structured Retail

 For themselves and as Representatives of the other Initial Purchasers named in Schedule A hereto. 

  
 25 

 SCHEDULE A 
 The initial offering price of the Securities shall be 100% of the principal amount thereof, plus accrued interest, if any, from the date of issuance. 

The purchase price to be paid by the Initial Purchasers for the Securities shall be 97% of the principal amount thereof. 

The interest rate on the Securities shall be 3.25% per annum. 
  

					
	 Name of Initial Purchaser
	  	Principal
Amount of
Securities	 
	 Merrill Lynch, Pierce, Fenner & Smith Incorporated
	  	$	65,000,000	  
	 RBS Securities Inc.
	  	$	20,000,000	  
	 J.P. Morgan Securities LLC
	  	$	7,000,000	  
	 Stifel, Nicolaus & Company, Incorporated
	  	$	2,000,000	  
	 CJS Securities, Inc.
	  	$	2,000,000	  
	 Sidoti & Company, LLC
	  	$	2,000,000	  
	 Stephens Inc.
	  	$	2,000,000	  
		  	 	 	 
	 Total
	  	$	100,000,000	 
		  	 	 	 

  
 Sch A - 1

 SCHEDULE B 
 Final Term Sheet 
 Pricing term sheet dated November 15, 2010 

to Preliminary Offering Memorandum dated November 15, 2010 
 (the “Preliminary Offering Memorandum”) 
 Kaman Corporation

 $100,000,000 
 3.25% Convertible Senior Notes due 2017 
 The information in this pricing term sheet
relates only to the offering of $100,000,000 aggregate principal amount of 3.25% Convertible Senior Notes due 2017 by Kaman Corporation and should be read together with the Preliminary Offering Memorandum and supersedes the information in the
Preliminary Offering Memorandum to the extent inconsistent with the information in the Preliminary Offering Memorandum. Terms used in this pricing term sheet but not defined herein have the respective meanings given to them in the Preliminary
Offering Memorandum. 
  

			
	Issuer:	  	Kaman Corporation.
		
	Ticker/Exchange for Common Stock:	  	KAMN/NASDAQ Global Select Market (“NASDAQ”).
		
	Title of Securities:	  	3.25% Convertible Senior Notes due 2017.
		
	Aggregate Principal Amount Offered:	  	$100,000,000 aggregate principal amount of notes (excluding the initial purchasers’ option to purchase up to $15,000,000 of additional aggregate principal amount of notes
solely to cover overallotments, if any)
		
	Net Proceeds of the Offering:	  	Approximately $96.3 million (or approximately $110.9 million if the initial purchasers exercise their overallotment option to purchase additional notes in full), after
deducting the initial purchasers’ discounts and commissions and estimated offering expenses of $0.7 million payable by the Issuer.
		
	Convertible Note Hedge and Warrant Transactions:	  	The cost of the convertible note hedge transactions, after being partially offset by the proceeds from the sale of the warrants, will be approximately $9.9 million. If the
over-allotment option is exercised, we will use a portion of the additional net proceeds (together with the proceeds from the sale of additional warrants) to increase the size of the convertible note hedge transactions. The exercise price of the
warrant transactions represents a 70% premium over the Closing Stock Price.
		
	Maturity:	  	The notes will mature on November 15, 2017, unless earlier purchased by the Issuer or converted.

  
 Sch
C - 1 

			
		
	Annual Interest Rate:	  	3.25% per annum.
		
	Interest Payment Dates:	  	Interest will accrue from November 19, 2010, and will be payable semiannually in arrears on May 15 and November 15 of each year, beginning on May 15,
2011.
		
	Issue Price:	  	100%, plus accrued interest, if any, from November 19, 2010.
		
	Closing Stock Price:	  	$26.12 on NASDAQ as of November 15, 2010.
		
	Conversion Premium:	  	Approximately 30% above the Closing Stock Price.
		
	Initial Conversion Price:	  	Approximately $33.96 per share of the Issuer’s common stock.
		
	Initial Conversion Rate:	  	29.4499 shares of the Issuer’s common stock per $1,000 principal amount of notes.
		
	Conversion Trigger Price:	  	Approximately $44.15, which is 130% of the Initial Conversion Price.
		
	Joint Book-Running Managers:	  	BofA Merrill Lynch and RBS.
		
	Trade Date:	  	November 15, 2010.
		
	Expected Settlement Date:	  	November 19, 2010.
		
	CUSIP Number:	  	483548 AD5
		
	Ranking:	  	The notes will be general unsecured obligations of Kaman Corporation. On a pro forma basis, as of October 1, 2010, after giving effect to the issuance of the notes and the use of
proceeds, we would have had approximately $83.3 million outstanding secured indebtedness, substantially all of which will represent borrowings under our amended and restated revolving credit agreement and term loan credit agreement, $100.8 million
of outstanding senior unsecured indebtedness and no subordinated indebtedness. As of October 1, 2010, in addition to our domestic subsidiaries serving as guarantors under our amended and restated revolving credit agreement and amended and restated
term loan credit agreement, our subsidiaries had $0.8 million of outstanding indebtedness and other liabilities (excluding intercompany liabilities).

  
 Sch
C - 1 

			
		
	Adjustment to Conversion Rate Upon a Conversion in Connection With a Make-Whole Fundamental Change:	  	The following table sets forth the stock prices and effective dates and the number of additional shares by which the conversion rate will be increased for a holder that converts a
note in connection with a make-whole fundamental change having such effective date and stock price:

  

																																													
	 Stock Price
	 
	 Effective Date
	  	$26.12	 	  	$30.00	 	  	$35.00	 	  	$40.00	 	  	$45.00	 	  	$50.00	 	  	$60.00	 	  	$70.00	 	  	$80.00	 	  	$90.00	 	  	$100.00	 
	 11/19/2010
	  	 	8.8349	  	  	 	6.3895	  	  	 	4.2649	  	  	 	3.0809	  	  	 	2.3455	  	  	 	1.8655	  	  	 	1.2944	  	  	 	0.9804	  	  	 	0.7847	  	  	 	0.6445	  	  	 	0.5373	  
	 11/15/2011
	  	 	8.8349	  	  	 	6.3662	  	  	 	4.2029	  	  	 	2.9480	  	  	 	2.1879	  	  	 	1.7046	  	  	 	1.1559	  	  	 	0.8668	  	  	 	0.6923	  	  	 	0.5672	  	  	 	0.4726	  
	 11/15/2012
	  	 	8.8349	  	  	 	6.3241	  	  	 	4.0684	  	  	 	2.7519	  	  	 	1.9795	  	  	 	1.5068	  	  	 	0.9949	  	  	 	0.7418	  	  	 	0.5905	  	  	 	0.4842	  	  	 	0.4038	  
	 11/15/2013
	  	 	8.8349	  	  	 	6.2694	  	  	 	3.8441	  	  	 	2.4767	  	  	 	1.7099	  	  	 	1.2622	  	  	 	0.8063	  	  	 	0.6016	  	  	 	0.4790	  	  	 	0.3933	  	  	 	0.3281	  
	 11/15/2014
	  	 	8.8349	  	  	 	6.0833	  	  	 	3.4617	  	  	 	2.0822	  	  	 	1.3559	  	  	 	0.9630	  	  	 	0.6023	  	  	 	0.4523	  	  	 	0.3629	  	  	 	0.2991	  	  	 	0.2498	  
	 11/15/2015
	  	 	8.8349	  	  	 	5.6165	  	  	 	2.8697	  	  	 	1.5328	  	  	 	0.9085	  	  	 	0.6137	  	  	 	0.3857	  	  	 	0.2960	  	  	 	0.2394	  	  	 	0.1972	  	  	 	0.1640	  
	 11/15/2016
	  	 	8.8349	  	  	 	4.7769	  	  	 	1.9173	  	  	 	0.7770	  	  	 	0.3911	  	  	 	0.2653	  	  	 	0.1900	  	  	 	0.1522	  	  	 	0.1246	  	  	 	0.1032	  	  	 	0.0861	  
	 11/15/2017
	  	 	8.8349	  	  	 	3.8834	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  	  	 	0.0000	  

  
 Sch
C - 1 

 The exact stock prices and effective dates may not be set forth in the table above, in which
case: 
  

	 	•	 	 if the stock price is between two stock prices listed in the table or the effective date is between two effective dates listed in the table, the number
of additional shares will be determined by a straight-line interpolation between the number of additional shares set forth for the higher and lower stock prices and the earlier and later effective dates, as applicable, based on a 365-day year.

  

	 	•	 	 if the stock price is greater than $100.00 per share (subject to adjustment in the same manner as the stock prices set forth in the column headings of
the table above), no additional shares will be added to the conversion rate. 

  

	 	•	 	 if the stock price is less than $26.12 per share (subject to adjustment in the same manner as the stock prices set forth in the column headings of the
table above), no additional shares will be added to the conversion rate. 

 Notwithstanding the foregoing, in
no event will the conversion rate exceed 38.2848 shares per $1,000 principal amount of notes, subject to adjustments in the same manner as the conversion rate as set forth in the Preliminary Offering Memorandum under “Description of
Notes—Conversion Rates—Conversion Rate Adjustments.” 
 Capitalization 

The following table sets forth our unaudited cash, cash equivalents, short-term and long-term cash investments and capitalization as of
October 1, 2010: 
  

	 	•	 	 on an actual basis; and 

  

	 	•	 	 on an as adjusted basis giving effect to (i) the issuance of $100 million of notes and the receipt of the net proceeds from the sale of the notes
after payment of the initial purchasers’ commissions and estimated offering expenses payable by us, (ii) the use of a portion of the proceeds from this offering to fund the net cost of the convertible note hedge and warrant transactions,
and (iii) the application of such net proceeds (assuming the use of $64.3 million of the net proceeds from this offering to repay portions of our amended and restated revolving credit agreement, which amounts we may re-borrow), as if such
events took place on October 1, 2010, reflecting the application of ASC 470-20 “Debt with Conversion and Other Options,” which requires issuers to separately account for the debt and equity components of convertible debt instruments
that allow for cash settlement. 

 In accordance with ASC 470-20 “Debt with Conversion and Other
Options,” we estimate that $100 million of the aggregate principal amount of the notes will be recognized (and, to the extent applicable, reflected in the table below ) as follows (in thousands): 

 

					
	 Equity component
	  	$	 11,590	  
	 Liability component:
	  			
	 Principal
	  	$	100,000	  
	 Less: debt discount
	  	 	(11,590	) 
		  	 	 	 
	 Net carrying amount
	  	$	 88,410	  
		  	 	 	 

  
 Sch
C - 1 

 You should read this table together with our consolidated financial statements and related
notes contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and our Quarterly Report on Form 10-Q for the fiscal quarter ended October 1, 2010, which are incorporated by reference in the Preliminary
Offering Memorandum. 
  

									
	 	  	As of October 1, 2010	 
	 	  	Actual	 	 	As Adjusted	 
	 Cash and cash equivalents
	  	$	11,946	  	 	$	34,123	  
		  	 	 	 	 	 	 	 
	 Debt
	  				 			
	 Notes payable
	  	$	768	  	 	$	768	  
	 Current portion of long-term debt
	  	 	5,000	  	 	 	5,000	  
	 Notes offered hereby
	  	 	—  	  	 	 	88,410	  
	 Long-term debt, excluding current portion
	  	 	100,550	  	 	 	36,250	  
		  	 	 	 	 	 	 	 
	 Total debt
	  	$	106,318	  	 	$	130,428	  
		  	 	 	 	 	 	 	 
	 Shareholders’ equity
	  				 			
	 Capital stock, $1 par value per share:
	  				 			
	 Preferred stock, 200,000 shares authorized; none outstanding
	  	$	—  	  	 	$	—  	  
	 Common stock, 50,000,000 shares authorized, voting, 26,042,901 issued (1)
	  	 	26,043	  	 	 	26,043	  
	 Additional paid-in capital
	  	 	94,737	  	 	 	96,008	  
	 Retained earnings
	  	 	314,792	  	 	 	314,792	  
	 Accumulated other comprehensive income (loss)
	  	 	(81,283	) 	 	 	(81,283	) 
	 Less 63,130 shares of common stock held in treasury, at cost
	  	 	(866	) 	 	 	(866	) 
		  	 	 	 	 	 	 	 
	 Total shareholders’ equity
	  	$	353,423	  	 	$	354,694	  
		  	 	 	 	 	 	 	 
	 Total Capitalization
	  	$	459,741	  	 	$	485,122	  
		  	 	 	 	 	 	 	 

  

	(1)	The number of shares outstanding does not include the following: 

  

	 	•	 	 1,032,522 shares of common stock issuable upon exercise of stock options outstanding as of October 1, 2010 under our 2003 Stock Incentive Plan
with a weighted average exercise price of approximately $20.58 per share; 

  

	 	•	 	 307,167 shares of common stock issuable upon the vesting of restricted stock awards granted to employees and outstanding as of October 1, 2010
under our 2003 Stock Incentive Plan, with a weighted average grant date fair value of $22.80 per share; 

  

	 	•	 	 21,700 shares of common stock issuable upon the settlement of stock appreciation rights outstanding as of October 1, 2010 under our 2003 Stock
Incentive Plan, with a weighted average exercise price of approximately $10.66 per share; 

  

	 	•	 	 1,101,834 shares of common stock reserved for future issuance under our 2003 Stock Incentive Plan as of October 1, 2010;

  

	 	•	 	 725,102 shares of common stock reserved for future sale under our Employees Stock Purchase Plan as of October 1, 2010; and

  

	 	•	 	 shares of our common stock issuable upon conversion of the notes offered hereby or exercise of hedge warrants. 

  
 Sch
C - 1 

 This communication is intended for the sole use of the person to whom it is provided by the sender. This
material is confidential and is for your information only and is not intended to be used by anyone other than you. This information does not purport to be a complete description of the notes or the offering. 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these
securities in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state. 
 Neither the notes nor any shares of common stock issuable upon conversion of the notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), or the
securities laws of any jurisdiction. Unless they are registered, the notes and any share of common stock issuable upon conversion of the notes may be offered only in transactions that are exempt from registration under the Securities Act and the
securities laws of any other jurisdiction. Accordingly, the notes are being offered and sold only to “qualified institutional buyers” (as defined in Rule 144A under the Securities Act). For further details about eligible offerees and
resale restrictions, see the section of the Preliminary Offering Memorandum captioned “Notice to Investors.” 
 A copy of the
final offering memorandum for the offering of the notes may be obtained by contacting: BofA Merrill Lynch, 4 World Financial Center, New York, NY 10080, Attention: Prospectus Department. 
 ANY DISCLAIMER OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS
COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM. 

  
 Sch
C - 1 

 SCHEDULE C 
 Issuer Written Information 
 Final Term Sheet in the form set forth on Schedule B

  
 Sch C - 1

 SCHEDULE D 
 Subsidiaries 
 Kaman Aerospace Group, Inc. 

Kaman Aerospace Corporation 
 Kamatics
Corporation 
 Kaman Precision Products, Inc. 
 RWG Frankenjura-Industrie Flugwerklager GmbH 
 Kaman UK Holdings Limited 

Brookhouse Holdings Limited 
 Brookhouse Group
Holdings Limited 
 Brookhouse 2004 Limited 
 Brookhouse Tooling Limited 
 Brookhouse Composites Limited 

Brookhouse Aerospace Limited 
 Kaman Industrial
Technologies Corporation 
 Minarik Corporation 

  
 Sch D - 1

 SCHEDULE E 
 List of Persons and Entities Subject to Lock-up 
 Brian E. Barents 

E. Reeves Callaway III 
 Candace A. Clark

 William C. Denninger 
 Ronald M.
Galla 
 Karen M. Garrison 
 A. William
Higgins 
 Edwin A. Huston 
 Neal J.
Keating 
 Eileen S. Kraus 
 George E.
Minnich 
 Thomas W. Rabaut 
 Gregory L.
Steiner 
 Richard J. Swift 
 John J.
Tedone 
 Jack Cahill 
 Stephen J.
Smidler 

  
 Sch E - 1

 Exhibit A – 1 
 FORM OF OPINION OF COMPANY’S COUNSEL 
 TO BE DELIVERED PURSUANT TO SECTION 5(b)

 [TO BE ATTACHED] 

  
 A – 1 - 1

 Exhibit A – 2 
 FORM OF OPINION OF COMPANY’S CHIEF LEGAL COUNSEL 
 TO BE DELIVERED PURSUANT TO
SECTION 5(b) 
 [TO BE ATTACHED] 

  
 A – 2 - 1

 Exhibit A – 3 
 FORM OF OPINION OF COMPANY’S LOCAL COUNSEL 
 TO BE DELIVERED PURSUANT TO
SECTION 5(c) 
 [TO BE ATTACHED] 

  
 A – 3 - 1

 Exhibit B 
 FORM OF LOCK-UP TO BE DELIVERED PURSUANT TO SECTION 5(h) 
 November 15, 2010

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 
 RBS Securities Inc. 
   as Representatives of the several 

  Initial Purchasers to be named in the 

  within-mentioned Purchase Agreement 

c/o Merrill Lynch, Pierce, Fenner & Smith Incorporated 
 One Bryant Park 
 New York, New York 10036 

 

	 	Re:	Proposed Public Offering by Kaman Corporation 

 Dear Sirs: 
 The undersigned, a stockholder [and an officer and/or director] of
Kaman Corporation, a Connecticut corporation (the “Company”), understands that Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch”) and RBS Securities Inc. propose to enter into a Purchase Agreement (the
“Purchase Agreement”) with the Company providing for the offering (the “Offering”) of $100,000,000 aggregate principal amount of the Company’s 3.25% Convertible Senior Notes due 2017 (the “Securities”). In
recognition of the benefit that such Offering will confer upon the undersigned as a stockholder [and an officer and/or director] of the Company, and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the undersigned agrees with each initial purchaser to be named in the Purchase Agreement that, during a period of 90 days from the date of the Purchase Agreement (the “Lock-up Period”), the undersigned will not, without the
prior written consent of Merrill Lynch, directly or indirectly, (a) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of, or
otherwise dispose of or transfer any shares of the Company’s common stock, par value $1.00 per share (the “Common Stock”), or any securities convertible into or exchangeable or exercisable for Common Stock, whether now owned or
hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition (collectively, the “Lock-Up Securities”), or exercise any right with respect to the registration of any of
the Lock-up Securities, or file or cause to be filed any registration statement in connection therewith, under the Securities Act of 1933, as amended, or (b) enter into any swap or any other agreement or any transaction that transfers, in whole
or in part, directly or indirectly, the economic consequence of ownership of the Lock-Up Securities, whether any such swap or transaction is to be settled by delivery of Common Stock or other securities, in cash or otherwise. The foregoing sentence
shall not apply to: 
 (i) transactions relating to shares of Common Stock acquired in open market transactions
after the completion of the Public Offering, or the exercise of any stock option to purchase shares of Common Stock pursuant to any benefit plan of the Company; 

  
 B-1

 (ii) transfers of shares of Common Stock or any security directly or
indirectly convertible into or exercisable or exchangeable for Common Stock as a bona fide gift or in connection with estate planning, including but not limited to, dispositions to any trust for the direct or indirect benefit of the undersigned
and/or the immediate family of the undersigned and dispositions from any grantor retained annuity trust established for the direct benefit of the undersigned and/or a member of the immediate family of the undersigned, or by will or intestacy;

 (iii) distributions of shares of Common Stock or any security directly or indirectly convertible into or
exercisable or exchangeable for Common Stock to limited partners, members, stockholders or affiliates of the undersigned, or to any partnership, corporation or limited liability company controlled by the undersigned or by a member of the immediate
family of the undersigned; or 
 (iv) the establishment of a trading plan pursuant to Rule 10b 5-1 under the 1934
Act for the transfer of shares of Common Stock, provided that such plan does not provide for the transfer of Common Stock during the Lock-Up Period; 
 provided, however, that (a) in the case of any transfer or distribution pursuant to clause (ii) or (iii), each donee or distributee shall sign and deliver a lock-up letter agreement
substantially in the form of this letter agreement (the “Lock-Up Agreement”) and (b) in the case of any transaction pursuant to clauses (i), (ii), (iii) or (iv), such transaction is not required to be reported during the Lock-Up
Period by anyone in any press release, public report or filing with the Securities and Exchange Commission or otherwise (other than a required filing on Form 5, Schedule 13D or Schedule 13G (or 13D-A or 13G-A) and no such press release, public
report or filing shall be made voluntarily during the Lock-Up Period. In addition, the undersigned agrees that, without the prior written consent of Merrill Lynch, it will not, during the Lock-Up Period, make any demand for or exercise any right
with respect to, the registration of any shares of Common Stock or any security directly or indirectly convertible into or exercisable or exchangeable for Common Stock. 
 Notwithstanding the foregoing, if: 
 (1) during the last 17 days of the Lock-up
Period, the Company issues an earnings release or material news or a material event relating to the Company occurs; or 
 (2)
prior to the expiration of the Lock-up Period, the Company announces that it will release earnings results or becomes aware that material news or a material event will occur during the 16-day period beginning on the last day of the Lock-up Period,

 Merrill Lynch may extend, by written notice to the Company, the restrictions imposed by this lock-up agreement until the expiration of the
18-day period beginning on the issuance of the earnings release or the occurrence of the material news or material event, as applicable. 
 The undersigned hereby acknowledges and agrees that written notice of any extension of the Lock-up Period pursuant to the previous paragraph will be delivered by Merrill Lynch to the Company (in
accordance with Section 12 of the Purchase Agreement) and that any such notice properly delivered will be deemed to have been given to, and received by, the undersigned. The undersigned further agrees that, prior to engaging in any transaction
or taking any other action that is subject to the terms of this lock-up agreement during the period from the date of this lock-up agreement to and including the 34th day following the expiration of the initial Lock-up Period, it will give notice thereof to the Company and will not
consummate such transaction or take any such action unless it has received written confirmation from the Company that the Lock-up Period (as may have been extended pursuant to the previous paragraph) has expired. 

  
 B-2

 The undersigned also agrees and consents to the entry of stop transfer instructions with the
Company’s transfer agent and registrar against the transfer of the Lock-Up Securities except in compliance with the foregoing restrictions. 
 This Lock-Up Agreement shall automatically terminate upon the earliest to occur, if any, of (1) either Merrill Lynch, on the one hand, or the Company, on the other hand, advising the other in
writing, prior to the execution of the Purchase Agreement, that they have determined not to proceed with the Offering, (2) termination of the Purchase Agreement before the sale of any Securities to the Initial Purchasers, or
(3) December 31, 2010, in the event that the Purchase Agreement has not been executed by that date. 
  

			
	Very truly yours,
		
	Signature:	 	 

			
		
	Print Name:	 	 

  
 B-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}]]